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Max O Bachmann,1 Allan Clark,1 William E Henley,2 John L Campbell,2
David Melzer3 and Nicholas Steel1*
1Population Health and Primary Care Group, Norwich Medical School,
University of East Anglia, Norfolk, UK
2Primary Care Research Group, University of Exeter Medical School, Exeter, UK
3Epidemiology and Public Health Group, University of Exeter Medical School, Exeter, UK
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Background: Shortfalls in the receipt of recommended health care have been previously reported in
England, leading to preventable poor health.
Objectives: To assess changes over 6 years in the receipt of effective health-care interventions for people
aged 50 years or over in England with cardiovascular disease, depression, diabetes or osteoarthritis;
to identify how quality varied with participant characteristics; and to compare the distribution of illness
burden in the population with the distributions of diagnosis and treatment.
Setting and participants: Information on health-care quality indicators and participant characteristics was
collected using face-to-face structured interviews and nurse visits in participants’ homes by the English
Longitudinal Study of Ageing in 2004–5, 2006–7, 2008–9 and 2010–11. A total of 16,773 participants
aged 50 years or older were interviewed at least once and 5114 were interviewed in all four waves;
5404 reported diagnosis of one or more of four conditions in 2010–11.
Main outcome measures: Percentage of indicated health care received by eligible participants for
19 quality indicators: seven for cardiovascular disease, three for depression, five for diabetes and four for
osteoarthritis, and condition-level quality indicator achievement, including achievement of a bundle of
three diabetes indicators.
Analysis: Changes in quality indicator achievement over time and variations in quality with participant
characteristics were tested with Pearson’s chi-squared test and logistic regression models. The size of
inequality between the hypothetically wealthiest and poorest participants, for illness burden, diagnosis and
treatment, was estimated using slope indices of wealth inequality.
Results: Achievement of indicators for cardiovascular disease was 82.7% [95% confidence interval (CI)
79.9% to 85.5%] in 2004–5 and 84.2% (95% CI 82.1% to 86.2%) in 2010–11, for depression 63.3%
(95% CI 57.6% to 69.0%) and 59.8% (95% CI 52.4% to 64.3%), for diabetes 76.0% (95% CI 74.1% to
77.8%) and 76.5% (95% CI 74.8% to 78.1%), and for osteoarthritis 31.2% (95% CI 28.5% to 33.8%)
and 35.6% (95% CI 34.2% to 37.1%). Achievement of the diabetes care bundle was 67.8% (95% CI
64.5% to 70.9%) in 2010–11. Variations in quality by participant characteristics were generally small.
Diabetes indicator achievement was worse in participants with cognitive impairment [odds ratio (OR) 0.5,
95% CI 0.4 to 0.7] and better in those living alone (OR 1.7, 95% CI 1.3 to 2.0). Hypertension care was
better for those aged over 74 years (vs. 50–64 years) (OR 3.2, 95% CI 2.0 to 5.3). Osteoarthritis care was
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better for those with severe (vs. mild) pain (OR 1.8, 95% CI 1.4 to 2.2), limiting illness (OR 1.8, 95% CI
1.5 to 2.1), and obesity (OR 1.6, 95% CI 1.2 to 2.0). Previous non-achievement of the diabetes care
bundle was the biggest predictor of non-achievement 2 years later (OR 3.3, 95% CI 2.2 to 4.7). Poorer
participants were always more likely than wealthier participants to have illness burden (statistically
significant OR 3.9 to 16.0), but not always more likely to be diagnosed or receive treatment (0.2 to 5.3).
Conclusions: Shortfalls in quality of care for these four conditions have persisted over 6 years, with
only half of the level of indicated health care achieved for osteoarthritis, compared with the other
three conditions. Quality for osteoarthritis improved slightly over time but remains poor. The relatively
high prevalence of specific illness burden in poorer participants was not matched by an equally high
prevalence of diagnosis or treatment, suggesting that barriers to equity may exist at the stage at diagnosis.
Further research is needed into the association between quality and health system characteristics at the
level of clinicians, general practices or hospitals, and regions. Linkage to routinely collected data could
provide information on health service characteristics at the individual patient level.
Funding: The National Institute for Health Research Health Services and Delivery Research programme.
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Plain English summary
People with long-term health conditions do not always receive the health care they need, and so maysuffer avoidable poor health. We aimed to find out if the quality of health care received by people in
England had improved over 6 years, for four common long-term health conditions: cardiovascular disease
(including heart disease and high blood pressure treatment), depression, diabetes and osteoarthritis. We
wanted to know if some people got better care than others, and if this was related to things such as their
wealth, education or social context.
We used information collected by interviewer and nurse visits to the homes of 16,773 people aged
50 years or older who had agreed to take part in a national survey called the English Longitudinal Study
of Ageing. They were asked questions about their health, disability, health care, education, employment,
money, social lives and well-being in 2004–5, 2006–7, 2008–9 and 2010–11.
We found that many people were still not receiving the care they needed, with little change over 6 years.
The percentage of good care received for osteoarthritis was only 32%, compared with 83% for
cardiovascular disease, 65% for depression and 76% for diabetes. There were no types of people who
consistently missed out on care, although people with cognitive impairment received worse care for
diabetes. Poorer people with specific illness burden may be less likely than wealthier people to receive a
diagnosis, but people with a diagnosis were generally equally likely to get good-quality care.
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Scientific summary
Background
Life expectancy at birth in high-income countries has increased by about 8 years since 1950, and
approximately half of this can be attributed to health care. Improvements in health care offer many
opportunities to increase the quality and length of life, and avoid some of the approximately 60,000
potentially avoidable deaths experienced annually by the population of England, which is more than in
comparable countries. Deficits in quality of care have been reported from high-income countries over many
years, and we have previously reported substantial variations in quality standards achieved in England for
older people with long-term conditions.
International evidence has identified effective care processes that can be described in quality indicators of
health care for many conditions. Quality indicators describe the minimum levels of acceptable health care,
based on evidence of effectiveness in increasing patient health and reducing the risk of morbidity.
Objectives
We aimed to assess changes over time in the receipt of effective healthcare interventions for people aged
50 years or older in England with cardiovascular disease, depression, diabetes or osteoarthritis; to identify
how quality varied with participant characteristics; and to compare the distribution of illness burden in the
population with the distributions of diagnosis and treatment.
Our three research questions were:
1. How does the prevalence of good quality of health care vary over time?
2. What characteristics are shared by people aged 50 years or older who received, or did not receive,
specific items of recommended NHS or non-NHS care for cardiovascular disease, depression, diabetes
and osteoarthritis, in a national population-based study followed up for 6 years?
3. Are factors such as wealth, patient education, physical activity, obesity and co-existing other chronic
conditions, or practical factors such as good eyesight and marital status, independently associated with
the quality of health care received, from burden of illness to diagnosis and, finally, to treatment?
Methods
The English Longitudinal Study of Ageing (ELSA) is a national panel survey of people aged 50 years or
older living in private households in England. The original cohort was drawn from households that had
previously responded to the Health Survey for England (HSE) in 1998, 1999 and 2001, in order that it
should be nationally representative. The first wave was conducted in 2002–3, with successive waves
collected every 2 years since, up until 2010–11 (fifth wave). Replenishment cohorts were added in 2006–7
(sampled from HSE 2001–4) and 2008–9 (sampled from HSE 2006) to correct for the original cohort
ageing and loss to follow-up. Data collection took place via face-to-face interviews in participants’
homes, with additional biomedical information collected during nurse visits in 2004–5 and 2008–9.
ELSA interviews obtained in-depth data on participants’ demographics, finances, health, lifestyle and
psychosocial characteristics.
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Samples
The four waves of ELSA that we studied comprised 16,773 participants. For the longitudinal analyses of
ELSA we used data from the 5114 participants in the original cohort who responded at every successive
wave, excluding proxy responders. We also used cross-sectional samples including all eligible participants
at each wave: 2004–5, 2006–7, 2008–9 and 2010–11. For analysis of the diabetes care bundle, we used a
cross-sectional sample of all eligible participants in 2010–11, who had also been non-proxy participants in
2008–9 (n= 8222).
Outcome measures (quality indicator achievement)
Questions on quality of care for a range of conditions have been implemented in ELSA since 2004–5.
The quality indicators were developed using a rigorous process by researchers at RAND Corporation in
the USA, who combined the best available evidence with expert opinion to assess appropriateness of
treatment. They were then adapted for use in the UK by an expert panel of clinicians. The quality
indicators were selected for suitability of use in patient interviews and underwent testing before
implementation in ELSA. The quality indicators describe health-care processes, rather than health
outcomes, and were designed to describe minimum acceptable levels of care.
The English Longitudinal Study of Ageing included 32 quality indicators overall, of which 19 were used
in this study: seven quality indicators for cardiovascular disease (including five for ischaemic heart disease
and one quality indicator for each of hypertension and cerebrovascular disease), three for depression, five
for diabetes and four for osteoarthritis. ELSA also included seven questions about patient-centred health
care. We calculated achievement rates for the 19 quality indicators by dividing the number of participants
who reported receiving the indicated care by the number eligible for that care, expressed as a percentage.
If a participant was eligible for an indicator, the indicator was described as ‘triggered’. Quality scores at a
condition level were the total number of times indicators for each condition were achieved, divided by the
total number of times they were triggered for that condition.
Participant characteristics
Possible covariates for modelling receipt of care were selected by a multidisciplinary panel consisting of
academics, clinicians and public and patient representatives. The choices were based on clinical relevance,
feasibility to extract the data from ELSA and previous work. Covariates were grouped into five domains:
demographics, health and disability, health behaviours, physical measures, and psychological and social.
Continuous variables were transformed into tertiles or quintiles. Missing data were coded as an extra
category to maximise the sample available for analysis.
We used the slope order of inequality as an independent variable to estimate the relationship between
the illness burden, diagnosis and treatment, respectively, and the categorised measure of wealth. The
slope order of inequality consisted of wealth quintiles with values of 0.1, 0.3, 0.5, 0.7 and 0.9, that is the
mid-points of each quintile on a scale of zero (least wealthy) to one (most wealthy). Advantages of this
method of quantifying inequality are that it includes all participants; instead of just comparing the highest
and lowest quintiles, it accounts for the number of participants in each category and it provides a single
overall measure of inequality.
Analyses
The primary outcome was achievement of each quality indicator, which was the number of times the
indicator was achieved divided by the number of times it was triggered, expressed as a percentage, with
possible values between 0% and 100%. The quality indicator achievement at the level of each condition
(cardiovascular disease, depression, diabetes and osteoarthritis) was the number of times any indicator for
that condition was achieved divided by the number of times any indicator for that condition was triggered,
expressed as a percentage, with possible values between 0% and 100%. We calculated the percentage
change in quality indicator achievement between wave 2 and the most recent year of follow-up, and
tested the statistical significance of any changes in quality indicator achievement over time with a
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Pearson’s chi-squared test for comparing proportions. We generated a ‘care bundle’ of the three diabetes
quality indicators that described monitoring checks.
Logistic regression models investigated which participant characteristics were independently associated
with receipt of better-quality health care, at the level of health conditions. Each participant might have
been eligible for more than one quality indicator within each condition, and so for the regression
modelling we reshaped the data into ‘long’ format in Stata statistical software (StataCorp LP, College
Station, TX, USA), with each participant having a separate record for each indicator. Intraperson correlation
of outcomes was accounted for, and all data were weighted for historical non-response and non-response
since the last wave.
For the diabetes quality indicators, including the care bundle of three routine monitoring indicators, we
additionally explored which patient characteristics from one wave earlier (2008–9) were associated with
subsequent non-receipt of diabetes care at the latest wave (2010–11), using the 2010–11 cross-sectional
sample (n= 8222). Potential covariates were entered into logistic regressions on outcomes for achievement
of the care bundle and the fourth quality indicator [which assessed offering angiotensin-converting enzyme
(ACE) inhibitors to patients with diabetes and an additional cardiac risk factor]. All models were adjusted
for age, sex and differential non-response.
Multivariable logistic regression analysis was used to test for associations between age, sex and slope order
of wealth inequality, with respect to illness burden, diagnosis and treatment. Further tests of possible
covariates that might affect the population distribution of illness burden, diagnosis and treatment
were performed.
Results
The prevalence of receipt of indicated health care varied over time. Quality scores for condition were
82.7% [95% confidence interval (CI) 79.9% to 85.5%)] in 2004–5 and 84.2% (95% CI 82.1% to 86.2%)
at follow-up (2010–11) for cardiovascular disease (p= 0.53), 63.3% (95% CI 57.6% to 69.0%) and
59.8% (95% CI 52.4% to 64.3%) for depression (p= 0.21), 76.0% (95% CI 74.1% to 77.8%) and
76.5% (95% CI 74.8% to 78.1%) for diabetes (p= 0.67), and 31.2% (95% CI 28.5% to 33.8%) and
35.6% (95% CI 34.2% to 37.1%) for osteoarthritis (p< 0.001).
Achievement of the diabetes care bundle was 67.8% (95% CI 64.5% to 70.9%) in 2010–11. The diabetes
care bundle was not fully received in nearly one-third of participants (32.8% in 2008–9, 32.2% in
2010–11) and nearly half of those eligible were not offered ACE inhibitors (44.6% in 2008–9, 44.5%
in 2010–11). Previous non-achievement of the diabetes care bundle was the biggest predictor of
non-achievement 2 years later [odds ratio (OR) 3.3, 95% CI 2.2 to 4.7]. Participants were also more likely
to not receive the full bundle if they lacked diabetes self-management knowledge (OR 2.0, 95% CI 1.3 to
3.2) or were cognitively impaired (OR 1.8, 95% CI 1.1 to 2.9).
Participants’ characteristics associated with quality indicator achievement over time were assessed on
the 5114 participants who were interviewed in all four waves. There were few statistically significant
associations. Quality indicator achievement in diabetes was lower with cognitive impairment (OR 0.5, 95% CI
0.4 to 0.7) and higher for those living alone (OR 1.7, 95% CI 1.3 to 2.0). Quality indicator achievement
in hypertension was higher for those aged 75 and over (vs. 50–64 years) (OR 3.2; 95% CI 2.0 to 5.3). For
osteoarthritis, quality indicator achievement was higher for those with severe (vs. mild) pain (OR 1.8, 95% CI
1.4 to 2.2), limiting illness (OR 1.8, 95% CI 1.5 to 2.1) and obesity (OR 1.6, 95% CI 1.2 to 2.0).
Wealth was the major factor associated with illness burden and diagnosis. Poorer participants were always
more likely than wealthier participants to have illness burden (statistically significant OR 3.9 to 16.0), but
not always more likely to be diagnosed or receive treatment (statistically significant OR 0.2 to 5.3).
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Conclusions
Shortfalls in quality of care have persisted over 6 years, with less than half of indicated health care
achieved for osteoarthritis, compared with the other three conditions, although osteoarthritis was the
only condition where quality had improved over time. Illness burden was much more common in poorer
participants, but after diagnosis, there was remarkably little variation by participant characteristics,
suggesting that while treatment for these four conditions is usually equitable, barriers to equity may exist
at the stage at diagnosis. The shortfalls in quality of care by condition are much larger than the relatively
few small variations found by participant characteristics.
This project is the first to investigate a wide range of clinical, behavioural, psychosocial and
sociodemographic patient characteristics associated with subsequent receipt of care in older people in
England, encompassing four common health conditions. Using the ELSA cohort, we were able to link
reports of receipt of care indicated by evidence- and consensus-based standards developed specifically for
older people with in-depth, sophisticated measures of a range of patient characteristics. This approach
contrasts with previous research, which has typically been limited to exploring basic patient descriptors,
such as age and sex, available from routine records.
Limitations include that, although the ELSA cohort was selected to be representative of older people in
England, there has inevitably been some loss to follow-up with each wave. The effect has been minimised
by the ELSA sample replenishment, and by weighting of all analyses for differential non-response using
sampling weights. Quality of care was based on self-reports of care received up to 2 years previously, but
recall problems were minimised by the selection for ELSA of only those quality indicators that were suitable
for self-report, and by excluding participants if they had cognitive impairment and needed a proxy
responder to help them to answer the questions.
Implications for health care and research recommendations
The results are likely to be generalisable to the population of England aged 50 years or over, bearing in
mind the limitations discussed above, because the sample was large and selected to be nationally
representative, the results were weighted for non-response, and achievement rates were comparable with
the Quality and Outcomes Framework. They may also be generalisable with caution to other countries with
similar population demographics, but are likely to vary according to health system and availability of care.
Further research is needed to compare the results with measurements of quality of care from directly
observed clinical care and from medical records. As this research has shown that the substantial variations
in quality of care are generally not explained by participant characteristics, further research is needed into
the association between quality and health system characteristics at micro (individual clinician), meso
(general practice or hospital) and macro (regional and national) levels. Future research could use linked
data sets to examine the effect of health service characteristics on the quality of care received at individual
patient level. Different models of health care may improve quality of care received by older people, with
common features being strong primary care, the use of care plans and complete electronic medical
records. Promising models need to be tested in specific health-care contexts, and successful models
implemented in routine health care.
Further research could explore why quality is so much lower in osteoarthritis than for other conditions
studied, and also follow-up our preliminary finding that there may be system-level inequalities in the
receipt of diagnosis that make it harder for disadvantaged people with specific illness burden to receive an
appropriate diagnosis. These questions would benefit from a mixed qualitative and quantitative approach
to explore the delivery of care in different systems and link to outcomes.
SCIENTIFIC SUMMARY
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We found that participant’s self-reported receipt of indicated health care across time was variable both
between and within the four conditions studied. Shortfalls in quality of care have hardly changed over
6 years, with less than half as many quality indicators achieved for osteoarthritis as for the other conditions
studied. Barriers to equity may exist at the stage at diagnosis, but for those with one of the four diagnosed
health conditions studied, the persistent system-level deficits in the provision of care were generally
distributed equitably across the population.
Funding
Funding for this study was provided by the Health Services and Delivery Research programme of the
National Institute for Health Research.
DOI: 10.3310/hsdr03110 HEALTH SERVICES AND DELIVERY RESEARCH 2015 VOL. 3 NO. 11
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Hardcastle et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
xxiii

Chapter 1 Background and aims
Introduction
Life expectancy at birth in high-income countries has increased by about 8 years since 1950, and approximately
half of this can be attributed to health care.1 Improvements in health care offer many opportunities to increase
the quality and length of life. For example, the population of England experiences approximately 60,000
potentially avoidable deaths annually, which is higher than in comparable countries.2 Deficits in quality of care
have been reported from high-income countries over many years,3–6 and we have previously reported
substantial variations in quality standards achieved in England for older people with chronic conditions.7,8
A wealth of international evidence has identified care processes that are suitable quality indicators of
health care for many conditions. Quality indicators describe the minimum levels of acceptable health care,
based on evidence of effectiveness in increasing patient health and reducing the risk of morbidity.
The quality indicators used in this study were originally developed by researchers at RAND Corporation,
who combined the best available evidence with expert opinion to assess appropriateness of treatment,
and they were then adapted for use in the UK.9
The UK has a long-established ‘free at the point of use’ health-care system, with relatively strong primary
care services. Since 2004 there has been a major drive to improve receipt of indicated care through the
Quality and Outcomes Framework (QOF), a scheme to pay general practices according to their performance
with respect to quality indicators. Despite concentrated efforts to improve the quality of care, there is only
weak evidence of improvement in quality of care since the introduction of the QOF.10 Many geriatric
conditions commonly affecting older people, such as osteoarthritis, are not included in this scheme. There is
evidence that quality of care has not improved for some excluded conditions, such as falls.8,11,12 QOF data
are only available at the level of practices, precluding a detailed analysis of how individual patient
characteristics (such as age, sex or degree of deprivation) might influence receipt of care.
The English Longitudinal Study of Ageing (ELSA) is a national survey following a cohort of people aged
50 years or older every 2 years since 2002. Questions assessing receipt of quality of care using quality
indicators have been included since 2004. The baseline results derived from the 2004 data7 show that the
amount of care that people were eligible for, and the amount they subsequently received, was highest for
ischaemic heart disease (IHD) (83%) but lower for hypertension (72%), diabetes (74%), depression (64%)
and osteoarthritis (29%). It is not known if receipt of this indicated care has improved since 2004 or
whether or not patient characteristics are associated with variability in quality of care. ELSA has a broad
range of participant demographics, and using these data it is possible to extract much more information
on each participant than is available at a practice level. Gaining a clearer picture of who is at most risk of
receiving poor quality of care is needed in order to inform the design of targeted interventions to improve
quality of care, and to improve access for previously underserved groups.
Aims
Our objective was to analyse data from four waves from ELSA in order to identify opportunities for
improving health care in older adults in England.
We aimed to assess changes over time in the receipt of effective health-care interventions for people
aged ≥ 50 years in England with cardiovascular disease, depression, diabetes or osteoarthritis; to identify
how quality varied with participant characteristics; and to compare the distribution of illness burden in the
population with the distributions of diagnosis and treatment.
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We had three research questions:
1. Research question 1: how does the prevalence of good quality of health care vary over time?
2. Research question 2: what characteristics are shared by people aged ≥ 50 years who received or did not
receive specific items of recommended NHS or non-NHS care for cardiovascular disease, depression,
diabetes and osteoarthritis in a national population-based study followed up for 6 years?
3. Research question 3: are factors such as wealth, patient education, physical activity, obesity and
coexisting other chronic conditions, or practical factors such as good eyesight or marital status,
independently associated with the quality of health care received, from burden of illness to diagnosis
and, finally, to treatment?
Ethical approval
The English Longitudinal Study of Ageing received ethical approval from the National Research Ethics
Service (reference number 09/H0505/124). Participants gave written informed consent before taking part.
Background
Cardiovascular disease
Cardiovascular disease is an umbrella term for a number of associated conditions. ELSA gathered
information on achievement of quality indicators for IHD, hypertension and cerebrovascular disease (CVD)
(stroke). A systematic review of 17 quality-of-care papers reporting on the RAND Corporation’s Assessing
Care of Vulnerable Elders (ACOVE) quality indicators13 revealed that achievement rates are often high in
primary care settings for indicated care for hypertension (72%) and stroke (69%).
Data from all 8409 general practices in the UK between 2005 and 2006, collected for the QOF, showed
that quality indicator achievement for cardiovascular prescribing was generally high, with a mean
achievement for all 26 indicators of 79.0% (standard deviation 4.4%).14 This included antiplatelet therapy
(89.75%), hypertension (74.83%) and beta-blockers (50.94%). An audit of 254 general practitioners (GPs)
in the USA between 2007 and 2009, using quality indicators from the National Quality Forum and RAND
Corporation, found that eligible patients with coronary artery disease were prescribed lipid-lowering
medication on 76% of occasions and that beta-blockers were prescribed post myocardial infarction (MI) on
84% of occasions, though achievement for a quality indicator assessing prescriptions of antiplatelet
therapy was lower at 48%.15
Fürthauer et al.16 assessed adherence to nine quality indicators by 58 GPs covering a range of
cardiovascular conditions and interviewed patients and practitioners about the reasons for deviations from
guideline recommendations. Approximately 70% of non-adherence was accounted for by physicians’ lack
of knowledge and patients’ lack of awareness of the guidelines. Ludt et al.17 sought to identify patient and
practice characteristics that predicted good quality of care for prevention of cardiovascular disease using
data from the clinical records of 7846 patients across primary care settings in 10 European countries. They
did not find that practice factors predicted outcomes, but good risk factor control was more likely in those
with higher health-related quality of life and lower for those whose marital status was single or who had
achieved lower educational levels.
Diabetes
In 2009–10 the national audit on diabetes care18 reported that 1.8 million people were diagnosed with
type 1 or type 2 diabetes and registered with an English general practice (5.24% adult prevalence).
Despite 95.4% of patients with type 2 diabetes having consulted their GP at least once in the last year,
the proportion receiving all processes included in a bundle of nine diabetes quality indicators19 was low
(52.9%). Some processes [e.g. weight measurement 90.5% and glycosylated haemoglobin (HbA1c)
BACKGROUND AND AIMS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
2
measurement 92.6%] were more frequently measured than others (e.g. retinopathy screening 78.9%,
foot risk assessment 85.2% and renal risk assessment 54.4%). Similarly, De Wet et al.20 reported
compliance with 10 individual diabetes quality indicators and a ‘care bundle’ – a composite measure of the
individual quality indicators – in nine Scottish general practices (56,948 patients). Achievement of individual
quality indicators was high (ranging from 85.9% to 97.8%), but all-or-nothing receipt of the care bundle
was lower (58.4%).
There is considerable variation in the delivery of core diabetes care between providers.18 For example,
practices located in more deprived areas perform less well relative to their wealthier counterparts.21,22 Less
is known about patient factors, even though we need to better understand why such variation arises in
order to improve receipt of basic care processes.20 The national diabetes audit18 reported that social
deprivation, sex and time since diagnosis did not affect the likelihood of receiving a complete care bundle,
although patient age (< 55 years or ≥ 85 years vs. 55–84 years) and ethnicity (‘non-white’ vs. ‘white’
patients) were associated. Kontopantelis et al.22 analysed longitudinal data (2000–1 to 2006–7) from
23,920 patients with diabetes who were registered with one of 148 practices. Older patients (≥ 65 years
vs. 17–39 years), those with comorbidities (three or more vs. none), and number of years living with
diabetes (1–4 years vs. newly diagnosed) were more likely to receive a complete package, although no sex
effect was observed.
Osteoarthritis
Osteoarthritis is the most prevalent chronic joint disease globally.23 Key clinical practice guidelines
for osteoarthritis include non-pharmacological interventions (e.g. exercise and weight optimisation),
provision of information regarding the disease and treatments, and joint replacement for severe disease.23
Previous work assessing quality of care for osteoarthritis7 found that indicated care was received on only
29% of occasions. A meta-analysis of 17 studies using ACOVE quality indicators found that achievement
rates for quality indicators for osteoarthritis had an interquartile range of 29–41%.13 A recent review of
chronic disease management found similarly poor quality of care for osteoarthritis across the quality
domains of effectiveness, efficiency, safety, timeliness and appropriateness and patient-centred care,
despite the availability of several evidence-based clinical practice guidelines.23 A longitudinal study
following 268 patients newly referred to an orthopaedic specialist in the UK over 12 months found that
information was provided regarding their condition, pain management and exercise on 42%, 35% and
43% of occasions, respectively.24 There is a need for research to assess quality of care for osteoarthritis
over a longer time period. Using basic patient descriptors taken from medical records, Li et al.25 found that
receipt of advice on exercise and weight optimisation was not provided equitably across sex, age, disability
and levels of formal education in 1349 patients with osteoarthritis of the knee and/or hip.
Depression
Quality indicators of health-care processes for depression focus on the provision of pharmacological and
psychotherapy treatments. A recent meta-analysis13 of studies using quality indicators developed for the
ACOVE project found low achievement of quality indicators for depression in both primary care settings
(31%) and in nursing homes (16%). Duhoux et al.26 assessed adherence rates to 27 quality indicators for
depression in 915 adults who consulted a GP, regardless of the reason for the consultation, who also met
established criteria for a major depressive episode. Adherence to guidelines was high (> 75%) for around
one-third of assessed quality indicators, but less impressive for over half of quality indicators (< 60%
achievement). Only 52.2% of the sample received at least one minimally acceptable treatment for
depression (i.e. pharmacotherapy or psychotherapy). Patient characteristics that were associated with
receipt of indicated care included old age (≥ 65 years), having a comorbid anxiety disorder, having a family
physician, having supplementary insurance cover and the increasing severity of the depressive episode.
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Chapter 2 Methods
The English Longitudinal Study of Ageing
The English Longitudinal Study of Ageing is a survey of adults aged ≥ 50 years and their partners living in
private households in England. It began in 2002 and the respondents have been followed up with 2-yearly
interviews, or waves. There have been five waves of data released to date – wave 1 2002–3, wave 2 2004–5,
wave 3 2006–7, wave 4 2008–9 and wave 5 2010–11 – with a sixth wave due for release in early 2014. The
original sample (2002–3) was drawn from households that had previously responded to the Health Survey
for England (HSE) in 1998, 1999 and 2001. These years were chosen from the HSE because they were recent
and could provide a sufficiently large sample size to make the survey representative of all adults living in
England. The HSE is an annual cross-sectional household survey that gathers a broad range of biometric and
health data. It was intended that the original sample of ELSA in 2002–3 would be representative of older
people living independently in England. Further information about ELSA, including all questionnaires, is
available from the ELSA website.27 ELSA data are available from the UK Data Service.28
Scope of the English Longitudinal Study of Ageing
The aim of ELSA is ‘to explore what it means to grow older in the 21st century and to understand which
factors account for the variety of observed patterns’.29 There is, therefore, an emphasis in the interviews on
measuring change over time, with some measures being repeated exactly at each wave and others asking
about change or giving respondents the opportunity to amend or update previous responses. A core set of
modules on specific domains was included in all waves, with certain topics additionally covered at various
waves. ELSA aimed to cover a broad array of salient domains, using standardised measures where possible.
The modules common to all waves are listed in Table 1.
Data collection methods
Face-to-face interviews were conducted using computer-assisted personal interviews (CAPIs) and took place
in respondents’ homes. A self-completion questionnaire was also given to respondents for them to complete
and return at their convenience. If there were several respondents for a given household, interviews could be
conducted at the same time using concurrent interview techniques, with modules requiring private answers
still performed individually. Both the CAPI and self-completion instruments were piloted for each wave
approximately 1 year before the main data collection, using a separate sample of households.
Additionally, a nurse visited the respondents in waves 2 (2004) and 4 (2008), and collected anthropometric
data and blood samples. The blood samples were analysed for HbA1c and many other biomarkers.
The CAPI instrument used in ELSA adopted the technique of ‘feeding forward’ data. That is, certain
responses that individuals made in previous waves were used to improve consistency of their responses
across waves, or to aid recall. For example, a respondent who had previously reported a certain diagnosis
would be asked at subsequent waves to confirm that they previously had that diagnosis and whether or
not they still had it. Previous responses were also used in the routing of the computerised interviews.
Sample design
Three cohorts of participants make up the ELSA sample. Recruits were sourced from HSE samples, as these
were nationally representative. Households were eligible for ELSA if they contained at least one individual
from one of the respective core HSE samples who was still living at a private residential address in England
at the wave of ELSA at which that cohort was introduced. They also had to be age-eligible and had given
permission to be recontacted in the future (though they were not specifically informed of ELSA at HSE).
‘Cohort 1′ was introduced at wave 1 (2002) and was selected from HSE samples in 1998, 1999 and 2001,
with people being age-eligible if they were born on or before 29 February 1952. The HSE in 1999
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originally included a ‘boost’ sample that represented ethnic minorities, but funding constraints meant that
this sample were not included in ELSA. ‘Cohort 3′ was introduced at wave 3 (2006) to replenish the
ageing sample with people aged 50–52 years and was taken from HSE in 2001–4. ‘Cohort 4′ was
introduced at wave 4 (2008) to both replenish the youngest age range, as in cohort 3, and bolster the
sample of people aged 52–74 years that had lost numbers due to participant attrition over the waves. It
was sourced from people born between 1 March 1933 and 29 February 1958 who participated in HSE in
2006, which was chosen because it included a nurse visit with measures taken that could be compared
with those obtained in the wave 4 nurse visits.
Recruits selected for one of these cohorts were termed ‘core members’ of their respective cohort and
remained eligible to take part in ELSA at subsequent waves as long as they had not moved out of Britain or
had died. At each wave, partners of core members who lived in the household could also be interviewed.
From wave 2 onwards, core members who had moved out of the private sector (e.g. into a nursing home)
since the previous wave were approached for an ‘institution interview’. Proxy interviews were attempted if
cognitive impairment, physical or mental ill health prevented someone from participating in a face-to-face
interview. The person who answered on behalf of the respondent was aged ≥ 16 years and knew enough
about the individual’s circumstances to provide the required information. Not all of the core modules were
included in the proxy interviews, and we excluded proxies for the purposes of all our analyses. Box 1
summarises the different types of sample member eligible for ELSA. Further details of the sampling design
and fieldwork procedures can be found in the ELSA technical reports.31–34
TABLE 1 Core survey content overview
Module Description
Household demographics Answered by one person on behalf of the household. Collects basic demographic
characteristics of everyone in the household. Uses feed forward data from HSE
Individual demographics Answered by all. Included questions on marital status, family members and childhood
circumstances
Health Answered by all. Included self-reported general health; long-standing illness or disability;
eyesight and hearing; specific diagnoses, symptoms and care processes received; pain;
difficulties with activities and instruments of daily living; health behaviours; and quality of care.
Those aged ≥ 60 years were asked about falls and fractures
Social participation Answered by all. Covered frequency of participation in social activities, limitations to these
activities, their care giving and usage of public transport
Work and pensions Answered by all. Included current work activities; and current or past pensions, including
amounts if currently receiving them
Income and assets If a couple’s finances are kept together one of them answers. If separate, both answer. Asked
about all income and assets
Housing Answered by one person on behalf of the household. Included: current housing situation
(e.g. size, quality); housing-related expenses; ownership of durables and cars; expenditure on
food. House owners were asked about value of property, mortgage details, etc.
Cognitive function Answered by all at start of ‘private modules’ block. Measured cognitive function including
memory, speed, mental flexibility and numeracy
Expectations Answered privately by all. Measured expectations regarding financial decision-making and
certainty of future events
Psychosocial health Answered privately by all. Measured respondents’ views on life including a depression scale
and attitudes towards ageing
Walking speed Completed by those aged ≥ 60 years when safe to do so. Measured time taken to walk 2.4m
(taken twice)
Self-completion Completed either during other members’ private blocks or after and returned by post
Based on Banks et al.30
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Participant response rates
The technical reports for the first four waves of ELSA provide a variety of in-depth response rates.31–34 Here,
we report the ‘individual response rates’ from initial HSE samples to the entry wave of ELSA for each of the
three cohorts, the total number of core members at each wave and the ‘study response rate’ of cohort 1
core members (the longitudinal sample) across the five waves (Table 2). 67% of individuals determined to
be eligible for ELSA from HSE in 1998, 1999 and 2001 took part in ELSA wave 1.34 Of individuals from
HSE in 2001–4 who were eligible for ELSA as part of cohort 3, 60% were interviewed at wave 3.32
A response rate of 65% was achieved for cohort 4 core members sourced from HSE in 2006.31 Of the
11,392 core members from cohort 1 interviewed at wave 1, only 5315 (47%) completed all subsequent
waves up to and including wave 5. The replenishment samples from cohorts 3 and 4 meant that numbers
of all core members ranged from 8780 in wave 2 to 9886 in wave 4.
BOX 1 English Longitudinal Study of Ageing sample members
Core members were participants who were living within the household that participated in HSE (not all were
personally interviewed for HSE). They were age-eligible for ELSA (≥ 50 years of age) and had their first ELSA
interview at a private residential address in England.
Core partners were participants who, like core members, were living within the household at the time of the
HSE interview and were age-eligible for inclusion in ELSA. They differ from core members in that they were not
interviewed when first approached. Therefore, they were only approached by virtue of their being the partner
of a core member.
Younger partners were the cohabiting younger spouses or partners of core members, who had been living
within the household at the time of HSE and the first ELSA interview, but who were not age-eligible.
Older partners (for cohorts 3 and 4 only) were the cohabiting spouses or partners of age-eligible sample
members selected for ELSA, who had been living within the household at the time of the HSE or ELSA
interview, but were themselves over the ages eligible for these cohorts.
New partners were the cohabiting spouses or partners (of any age) of core members at the time of the ELSA
interview who had joined the household since the HSE interview.
TABLE 2 Core members and the longitudinal sample response rate across waves
Wave of ELSA
Total interviews
(all samples types), n
Total core members
(all available cohorts), n
Longitudinal sample
size (cohort 1), n
Longitudinal
sample retained
in next wave, %
Wave 1: 2002–3 12,100 11,392 11,392 100.0
Wave 2: 2004–5 9432 8780 8780 77.1
Wave 3: 2006–7 9771 8810 7197 63.2
Wave 4: 2008–9 11,050 9886 6018 52.8
Wave 5: 2010–11 10,274 9090 5315 46.7
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Creating the data sets for analysis
The core ELSA data (see Table 1 for included modules) for each wave were contained in separate data sets,
which needed to be merged into a single data set for analyses. Additionally, there were data sets containing
financial derived variables for waves 1–4 and data sets for nurse data collected at waves 2 and 4. Table 3
lists the data sets that were merged.
Before a data set was merged, the variables it contained were given a prefix that identified the wave to
which it belonged. Participants’ data were linked across data sets by a unique individual identification
number. For each merge, no participant was excluded, even if they had no data in the new data set or if
they had not been present in previous data sets. This allowed our final data set to include participants who
had missed a number of waves, or had joined the ELSA sample as part of cohorts 3 and 4. Table 4 displays
the number of participants merged at each step. There were 16,778 ELSA responders in the final data set.
New participants were added to the sample from the core data set at each wave owing to partners being
interviewed, or owing to the additions of cohorts 3 and 4.
Longitudinal and cross-sectional samples
To answer our research questions, cross-sectional samples from each wave of ELSA and a longitudinal
sample of those who were interviewed at all waves were required. Proxy interviews were excluded, as we
required accurate reporting of diagnoses and received care, as were interviews held in institutions, because
these would not be representative of those living in private residences. The 5114 ELSA cohort 1 core
members who were interviewed at all four waves, excluding proxies and those in institutions, formed our
longitudinal sample (Table 5). This represents 45.5% of the original sample of 11,233 who responded at
wave 1. The additions of cohorts 3 and 4 kept the cross-sectional samples above 8500 core members
each. For analysis of the diabetes care bundle, we used a cross-sectional sample of all core members in
2010–11, who had also been non-proxy participants in 2008–9 (n= 8222).
TABLE 3 English Longitudinal Study of Ageing data sets used to create the study data set
Data set
Filename as retrieved from UK Data
Archive Description
Wave 1 core data Wave_1_Core_Data_v2.1 Data from core ELSA modules for wave 1
Wave 1 financial derived
variables
Wave_1_Financial_Derived_Variables_v2 Financial variables derived by the Institute of
Fiscal Studies for wave 1
Wave 2 core data Wave_2_Core_Data_v2 Data from core ELSA modules for wave 2
Wave 2 financial derived
variables
Wave_2_Financial_Derived_Variables Financial variables derived by the Institute of
Fiscal Studies for wave 2
Wave 2 nurse data Wave_2_Nurse_Data_v2 Data obtained from the nurse visit in wave 2
Wave 3 core data Wave_3_Core_Data_Phase_2_v2 Data from core ELSA modules for wave 3
Wave 3 financial derived
variables
Wave_3_Financial_Derived_Variables Financial variables derived by the Institute of
Fiscal Studies for wave 3
Wave 4 core data Wave_4_Core_Data_Phase_2 Data from core ELSA modules for wave 4
Wave 4 financial derived
variables
Wave_4_Financial_Derived_Variables Financial variables derived by the Institute of
Fiscal Studies for wave 4
Wave 4 nurse data Wave_4_Nurse_Data Data obtained from the nurse visit in wave 4
Wave 5 core data elsa_wave_5_with_dvs_ Data from core ELSA modules for wave 5
METHODS
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Quality indicators
The health module of ELSA included questions on the receipt of health care, as described in quality
indicators. The quality indicators were originally developed by RAND Corporation for the ACOVE project35
and adapted for use in patient interview surveys in England9 to assess care for a range of common
medical conditions affecting older people, as described in more detail in Quality indicators in the English
Longitudinal Study of Ageing, below. Studies using these indicators have found a substantial shortfall in
quality of care in both the USA in 19996 and the ELSA.7
Composite measures of quality
It is possible to combine individual quality indicators into composites that summarise quality of care at a
higher level, such as for a condition or even for all health care in a system. There are both advantages
and disadvantages of this approach. Summary measures are useful for conveying a complex range of
information to policy-makers and the public, but important variations in individual health-care processes
can be masked if combined without care.36 Composites should, therefore, avoid overgeneralisation and
have a specific focus and aim, such as formative quality improvement for specific conditions.37
TABLE 4 Number of ELSA sample members added at each step of the merging process
Data set merged
Total sample
size, N
Number of participants
matched on merger
Number of participants not
matched on merger
Not in added
data set
New in added
data set
Wave 1 core data (start point) 12,100 N/A N/A N/A
Wave 1 financial derived variables 12,100 12,099 1 0
Wave 2 core data 12,208 9324 2776 108
Wave 2 financial derived variables 12,208 9432 2776 0
Wave 2 nurse data 12,208 7666 4542 0
Wave 3 core data 13,944 8043 4165 1736
Wave 3 financial derived variables 13,948 9767 4177 4
Wave 4 core data 16,636 8362 5586 2688
Wave 4 financial derived variables 16,636 11,050 5586 0
Wave 4 nurse data 16,636 8643 7993 0
Wave 5 core data 16,778 10,132 6504 142
N/A, not applicable.
TABLE 5 Sizes of the longitudinal and cross-sectional samples derived for analysis
Sample n
Wave 1 11,322
Wave 2 8688
Wave 3 8628
Wave 4 9578
Wave 5 8729
Longitudinal (all waves) 5114
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‘Care bundles’ are composites that comprise processes of care which should all be received by the eligible
population for certain conditions, such as annual monitoring checks for patients with diabetes. The ‘gap’ in
performance between individual indicators and the care bundle may be a more valid reflection of variation
in expected care delivery.20
There are a number of different methods for deriving composite measures, with different strengths and
weaknesses. Below, we describe the main methods.
Indicator-level achievement
Indicator-level achievement is the number of a group of indicators achieved, divided by the number of
that group of indicators triggered. This is the most straightforward measure to calculate, and the most
transparent in that it is clear where the underlying data come from. We use this measure to describe
quality indicator achievement for each of the four conditions in this study. Its weakness is that the most
prevalent conditions will drive the final composite score, and the scores for rare (but perhaps important)
conditions can be lost in the greater numbers.
Average indicator-level achievement
The mean of the set of indicators is calculated, representing the average rate at which the indicated care
was received. For example, if a condition had three quality indicators and their achievements at a given
wave were 75%, 80% and 85%, then the indicator-level achievement for that condition would be
(75+ 80+ 85)/3= 80%. This method is suitable for comparing heterogeneous samples, as it is not greatly
affected by the number of components included. Rare processes (those for which a comparatively small
sample are eligible) are given the same importance as common processes of health care.38
Patient-level achievement
This approach represents the average percentage of triggered aspects of care that were successfully met
for each participant per condition. It is calculated by dividing the number of quality indicators each
participant passed by the number they were eligible for per condition, taking the mean of the results and
expressing them as a percentage. For example, if a participant is eligible for all five diabetes quality
indicators at a given wave and passed three of them, their score would be 3/5= 0.6, or 60%. The mean
of all participants’ scores would be the average for that condition.
This method is best at assessing quality of care delivered to each patient. It can provide scores for
individual patients and can therefore be used in a wide range of statistical analyses.38
All-or-nothing achievement
In this method, the care for a patient is achieved only if all quality indicators for which they were eligible
for that condition were achieved. This approach is helpful when considering sets of quality indicators for a
condition that easily form ‘care bundles’, such as the three annual monitoring checks for diabetes. This is
a stringent criterion and in our data set we were able to apply the care bundle approach only to diabetes,
as the quality indicators available all map onto those required for annual diabetes checks. The patient-level
achievement is calculated as above for the set of indicators that make a care bundle. Those whose
percentage of received care was 100% were scored 0 and those who did not meet this criterion were
scored 1. This is used to predict who did not receive all the bundled care items, so the proportion of
eligible participants who were scored 1 is calculated.
The derived scores are intrinsically affected by the number of components included, as the more care
processes involved, the harder it is to achieve all of them,20 and so only a few carefully selected quality
indicators should be used with this method. Weighting can be hard to interpret with this approach and
common care processes (those for which a comparatively large sample is eligible) can dominate the
scoring.38 However, this method is amenable to a broad range of statistical analyses38 and may be more
clinically meaningful, as receipt of all indicated health care should be the ideal.
METHODS
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Quality indicators in the English Longitudinal Study of Ageing
In total, 32 quality of care indicators were used in ELSA. These quality indicators were adapted from a set
of 236 quality indicators originally developed in the USA for the ACOVE project39 for conditions chosen for
their prevalence, impact, effectiveness of treatment or prevention, importance in older people, feasibility of
measurement and potential for quality improvement. They were based on systematic reviews of evidence
of improved outcomes and focus on processes of care rather than health outcomes, as processes are under
the control of the health-care system and are not subject to the array of other factors that influence health
outcomes. Approximately half of the ACOVE indicators could be used in an interview survey without
the use of clinical records, and these were rated for validity by an expert panel of clinicians for validity
in patient interview surveys in England, using an adapted form of the RAND Corporation/University of
California in Los Angeles appropriateness method for combining evidence with expert opinion.9,40
The clinical panel reviewed the evidence for 119 quality indicators and scored them on the extent to which
they reflected good practice in England. Two rounds of anonymous rating were used, with face-to-face
discussion between the rounds. Indicators were excluded if the panel disagreed on their validity.
The quality indicators were designed to reflect the minimum acceptable standard of care rather than the
optimum, and the panel were informed that they were to be used in a national longitudinal panel survey.
The panel identified 17 of the 119 indicators that were not suitable for use in the UK. Forty-three of the
remaining 102 quality indicators were not piloted in ELSA owing to difficulties in implementing them,
or because they did not relate to conditions found to be a common cause of morbidity in HSE 2000.
A further 27 were not used in ELSA owing to problems found with their implementation in the pilots or
main survey.7 The remaining 32 indicators were incorporated in wave 2 of ELSA, with many also repeated
at subsequent waves. These covered 13 conditions: CVD (stroke), depression, diabetes mellitus, falls,
hearing problems, hypertension, IHD, osteoarthritis, osteoporosis, pain management, smoking cessation,
urinary incontinence and cataracts.
Generation of quality indicators
From wave 2 onwards, the health module contained questions that enabled generation of the quality
indicators developed by ACOVE and adapted for use in England that were implemented in ELSA.
In total, there are five quality indicators for diabetes, three for depression, one for CVD (stroke),
one for hypertension, five for IHD and four for osteoarthritis. There were also seven questions about
patient-centred care. Quality indicators were generated at every wave for which they were available
(see Availability of quality indicators across waves). A non-software specific syntax is given in Appendix 2.
Description of quality indicators and their generation from English
Longitudinal Study of Ageing questions
The quality indicators for each condition are described below. Each quality indicator starts with an ‘if’
clause that determines the eligible population, followed by a ‘then’ clause that states the indicated care.
The quality indicators specify that they are for those with the relevant condition who are aged ≥ 50 years
or over. Some of the quality indicators specify that treatment should be offered ‘at least once’ or relate to
treatments that are usually continuous in practice. For these quality indicators, participants who were
eligible at the current wave and had reported receiving the indicated treatment at a previous wave were
deemed to have also passed the indicator at the current wave. The derivation of each quality indicator
follows its description. Appendix 1 shows the translation of each quality indicator and patient-centred
question into its corresponding ELSA questions.
Cerebrovascular disease (stroke)
Stroke antihypertensives description
IF a person aged ≥ 50 years has had a previous stroke, THEN the patient should be offered
antihypertensive medication.
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Stroke antihypertensives generation
At each wave, participants were asked ‘Has a doctor ever told you that you have (or have had) any of
the conditions on this card [includes ‘stroke (cerebral vascular disease)’]?’ Participants who reported a
diagnosed stroke at that wave, or who confirmed a previous report of diagnosed stroke from an earlier
wave, formed the eligible sample if they had also given a yes/no response to the question ‘Did a doctor
or nurse ever suggest you take any medication to lower your blood pressure?’ at any wave up to and
including the current wave. Respondents from this sample passed the quality indicator if they answered
‘yes’ to this last question at least once.
Hypertension
Hypertension treatment description
IF a person aged ≥ 50 years remains hypertensive after non-pharmacological intervention, THEN
pharmacological antihypertensive treatment should be initiated.
Hypertension treatment generation
At each wave, participants were asked ‘Has a doctor ever told you that you have (or have had) any of
the conditions on this card (includes ‘high blood pressure or hypertension’)?’ Participants who reported
diagnosed hypertension at the current wave, or confirmed that they still had hypertension reported at an
earlier wave, formed the eligible sample if they had also given a yes/no response to the question ‘Did a
doctor or nurse ever suggest you take any medication to lower your blood pressure?’ at any wave up to
and including the current wave. Respondents from this sample passed the quality indicator if they
answered ‘yes’ to this last question at least once.
Ischaemic heart disease
Four of the five quality indicators for IHD specify that they are for those with established coronary heart
disease (CHD). We defined CHD as prevalent angina and/or MI. At each wave, participants were asked
‘Has a doctor ever told you that you have (or have had) any of the conditions on this card (includes
‘angina’ and ‘heart attack’)?’ We determined participants to have established CHD if they reported
angina or MI at the current wave, or confirmed that they still had angina and/or a previous report of MI.
Ischaemic heart disease cholesterol description
IF a person aged ≥ 50 years has established CHD and low-density lipoprotein (LDL) cholesterol > 3mmol/l,
THEN he or she should be offered an intervention to lower cholesterol.
Ischaemic heart disease cholesterol generation
Participants whom we determined to have established CHD at the current wave and who gave a yes/no
response to the question ‘Has any doctor talked to you about how to lower your cholesterol? This would
include changing your diet, losing weight, getting more exercise or taking medication’ formed the eligible
sample. Those who answered ‘yes’ to this question passed the indicator.
Ischaemic heart disease antiplatelets description
IF a person aged ≥ 50 years has established CHD and is not on warfarin, THEN he or she should be offered
antiplatelet therapy.
Ischaemic heart disease antiplatelets generation
Participants whom we determined to have established CHD at the current wave, who also answered ‘no’
to the question ‘Are you taking warfarin?’ and who gave a yes/no response to the question ‘Did a doctor
suggest that you take medication to thin your blood such as warfarin or aspirin, Plavix, Ticlid, or other
blood thinning medication?’ formed the eligible sample. Participants passed the indicator if they answered
‘yes’ to this last question.
METHODS
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Ischaemic heart disease smoking description
IF a person aged ≥ 50 years with established CHD smokes, THEN he or she should be offered counseling
for smoking cessation.
Ischaemic heart disease smoking generation
Participants were eligible for this quality indicator if we determined them to have established CHD at the
current wave, if they answered ‘yes’ to the question ‘Do you smoke cigarettes at all nowadays?’ at the
current wave and if they gave a yes/no response to the question ‘Has a doctor or nurse ever advised you
to stop smoking?’ at any wave up to and including the current wave. Participants passed the indicator if
they answered ‘yes’ to this last question at least once.
Myocardial infarction beta-blocker description
IF a person aged ≥ 50 years has had a recent MI, THEN he or she should be offered a beta-blocker.
Myocardial infarction beta-blocker generation
Unlike most other quality indicators, this quality indicator requires incident cases and not prevalent cases.
We determined participants to have incident MI if they reported a MI in response to the question ‘Has a
doctor ever told you that you have (or have had) any of the conditions on this card (includes ‘heart
attack’)?’ at the current wave, but not at the previous wave. Of these cases, those who gave a yes/no
response to the question ‘Did any doctor ever tell you that you should take a medication called a
beta-blocker?’ or indicated whether or not they were taking a beta-blocker in response to the question
‘Please could you show me the medications or the repeat prescription list for any medications you have
taken over the last week (checked against card F beta-blockers)?’ formed the eligible sample. Participants
from this sample passed the indicator if they either answered ‘yes’ to the former question, or indicated
that they were taking beta-blockers at the latter question.
International normalised ratio test description
IF a person aged ≥ 50 years is prescribed warfarin, THEN an international normalised ratio (INR) should be
determined at least every 12 weeks.
International normalised ratio test generation
Participants who reported CHD at the current wave were filtered to the question ‘Are you taking
warfarin?’ Those who answered ‘yes’ were then filtered to the question ‘Many doctors ask patients on
warfarin to get their blood tested regularly. The test checks how thin their blood is, and is sometimes
called an INR test. Do you get your blood checked for this?’ Participants who answered ‘yes’ to this
question were then filtered to the question ‘Have you had this blood test in the past 12 weeks?’ Those
who gave a yes/no response to this question formed the eligible population and passed the indicator if
their answer was ‘yes’.
Diabetes mellitus
Diabetes glycosylated haemoglobin description
IF a person aged ≥ 50 years has diabetes, THEN his or her HbA1c or fructosamine level should be measured
at least annually.
Diabetes glycosylated haemoglobin generation
At each wave from wave 2 onwards, participants were asked ‘Has a doctor ever told you that you have
diabetes?’ Those who responded ‘yes’ at any wave up to and including the current wave were filtered to
the question ‘Have you ever had a special blood test to see how well your blood sugar was controlled?
This test is called a glycosylated haemoglobin, or haemoglobin A1c, or fructosamine. This is a blood test
taken at a doctor’s surgery or health centre or laboratory’. Participants who gave a yes/no response to
this question at the current wave formed the eligible sample. Those who responded ‘yes’ to this question
were filtered to a further question that asked ‘Have you had this test (glycosylated haemoglobin or
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fructosamine) performed in the past 12 months?’ Eligible participants who responded ‘yes’ to this final
question passed the quality indicator.
Diabetes proteinuria description
IF a diabetic person aged ≥ 50 years does not have established renal disease and is not receiving an
angiotensin-converting enzyme (ACE) inhibitor or angiotensin II receptor blocker, THEN he or she should
receive an annual test for proteinuria.
Diabetes proteinuria generation
Participants who responded ‘yes’ to the question ‘Has a doctor ever told you that you have diabetes?’
at any wave up to and including the current wave were filtered to the question ‘I would like to check
whether any of the medications you are taking are on this list of ACE inhibitor or A2 receptor blockers
(show card G ACE inhibitors)?’ Those who answered ‘no’ to this question formed the eligible sample if
they also answered ‘no’ to the question ‘Has a doctor ever told you that your diabetes has caused trouble
with your kidneys?’ and gave a yes/no response to the question ‘Have you had a urine test for protein in
the last 12 months?’ Participants who answered ‘yes’ to this final question passed the indicator.
Diabetes cholesterol description
IF a diabetic person aged ≥ 50 years has a fasting total cholesterol level of ≥ 5mmol/l, THEN he or she
should be offered an intervention to lower cholesterol.
Diabetes cholesterol generation
Participants who responded ‘yes’ to the question ‘Has a doctor ever told you that you have diabetes?’
at any wave up to and including the current wave, and who also reported high cholesterol at the current
wave in response to the question ‘Has a doctor ever told you that you have (or have had) any of the
conditions on this card (includes ‘high cholesterol’)?’, were filtered to the question ‘Has any doctor talked
to you about how to lower your cholesterol? This would include changing your diet, losing weight, getting
more exercise or taking medication’. Those who answered this question formed the eligible sample.
Participants who answered ‘yes’ passed the indicator.
Diabetes ACE inhibitor description
IF a diabetic person aged ≥ 50 years has one additional cardiac risk factor (i.e. smoker, hypertension,
hypercholesterolemia or renal insufficiency/microalbuminuria), THEN he/she should be offered an ACE
inhibitor or receptor blocker.
Diabetes ACE inhibitor generation
Participants who responded ‘yes’ to the question ‘Has a doctor ever told you that you have diabetes?’
at any wave up to and including the current wave were filtered to the questions ‘Has a doctor discussed
with you whether you should take a medication called an ACE inhibitor or A2 receptor blocker?’ and ‘I
would like to check whether any of the medications you are taking are on this list of ACE inhibitor or A2
receptor blockers (show card G ACE inhibitors)?’ Those who gave a yes/no response to either of these
questions formed the eligible sample if they also met at least one of the following criteria:
l Answered ‘yes’ to the question ‘Do you smoke cigarettes at all nowadays?’
l Answered ‘yes’ to the question ‘Has a doctor ever told you that your diabetes has caused trouble with
your kidneys?’
l Answered ‘yes’ to the question ‘Has a doctor ever told you that you have protein in your urine?’
l Reported high cholesterol when asked ‘Has a doctor ever told you that you have (or have had) any of
the conditions on this card (includes ‘high cholesterol’)?’ at the current wave, or confirmed they still
have high cholesterol reported at a previous wave.
l Reported hypertension when asked ‘Has a doctor ever told you that you have (or have had) any of the
conditions on this card (includes ‘high blood pressure or hypertension’)?’ at the current wave, or
confirmed they still have hypertension reported at a previous wave.
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Waves 2 and 4 only (nurse data): their mean systolic blood pressure was ≥ 140mmHg or their mean
diastolic blood pressure was ≥ 90mmHg.
Eligible participants who answered ‘yes’ to either being offered or taking an ACE inhibitor/A2 receptor
blocker passed the indicator.
Diabetes foot check description
ALL diabetic persons aged ≥ 50 years should have an annual examination of his or her feet.
Diabetes foot check generation
Participants who responded ‘yes’ to the question ‘Has a doctor ever told you that you have diabetes?’ at
any wave up to and including the current wave were filtered to the question ‘Some doctors suggest that
some patients with diabetes have a regular foot examination. In the past year, has any doctor or nurse
examined your bare feet?’ Those who gave a yes/no response to this question formed the eligible
population. Participants who answered ‘yes’ passed the indicator.
Osteoarthritis
At each wave, participants were asked ‘Has a doctor ever told you that you have (or have had) any of
the conditions on this card [includes ‘arthritis (including osteoarthritis, or rheumatism)’]?’ Those who
reported arthritis were filtered to the question ‘Which type or types of arthritis do you have (includes
‘osteoarthritis’)?’ Participants who reported arthritis at a previous wave were also asked to confirm if they
still had the condition. Below, we refer to participants as having current osteoarthritis if they reported
osteoarthritis at the current wave, or confirmed that they still have arthritis previously reported, if the type
of arthritis was also osteoarthritis.
Osteoarthritis exercise description
IF an ambulatory person aged ≥ 50 years has had a diagnosis of symptomatic osteoarthritis of the knee for
longer than 3 months and has no contraindications to exercise and is physically and mentally able to
exercise, THEN a directed or supervised strengthening or aerobic exercise programme should have been
prescribed at least once.
Osteoarthritis exercise generation
All participants were asked ‘Are you often troubled with pain?’ All who responded ‘yes’ were filtered to
the question ‘How would you rate your pain if you were walking on a flat surface? Please rate your pain
from 0–10 for each of the following where 0 is no pain and 10 is severe or excruciating pain, as bad as
you can imagine’. Unless respondents stated that they could not walk or never walk, they were then
filtered to a set of questions that rated pain in different body parts, including their knees. Participants who
rated the pain in their knees from 1–10 (i.e. at least some pain), and who reported current osteoarthritis,
were filtered to the question ‘How long has the pain in your knee been bothering you?’ Respondents who
reported that the pain had been bothering them for over 3 months were then asked ‘Has a doctor or
nurse suggested that you receive physiotherapy or attend a supervised exercise program for your knee
pain?’ Participants were eligible for this quality indicator if they gave a yes/no response to this final
question at any wave up to and including the current wave and passed the indicator if their answer was
‘yes’ at least once.
Osteoarthritis education description
IF an ambulatory person aged ≥ 50 years has a diagnosis of symptomatic osteoarthritis, THEN education
regarding the natural history, treatment and self-management of the disease should be offered at
least once.
Osteoarthritis education generation
Participants with current osteoarthritis were filtered to the three questions ‘Has any doctor or nurse ever
talked to you about . . . what your arthritis or joint pain will be like as time goes on?’, ‘. . . how to keep
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your arthritis or joint pain from getting worse?’ and ‘. . . how your arthritis or joint pain will be treated?’
Those with osteoarthritis at the current wave were eligible for this quality indicator if they gave a yes/no
response to all three questions at any wave up to and including the current wave. Participants passed the
quality indicator if they answered ‘yes’ to all three questions at least once.
Osteoarthritis paracetamol description
IF oral pharmacological therapy is initiated to treat osteoarthritis among people aged ≥ 50 years, THEN
paracetamol should be the first drug used, unless there is a contraindication to use.
Osteoarthritis paracetamol generation
Participants with current osteoarthritis were filtered to the question ‘Some doctors suggest trying
paracetamol as the first medication for arthritis or joint pain. Did any doctor or nurse recommend you try
paracetamol before other medicines for your join pain?’ Those who gave a yes/no response to this
question at any wave up to and including the current wave formed the eligible sample. Participants passed
the indicator of they answered ‘yes’ at least once.
Osteoarthritis referral description
IF a person aged ≥ 50 years with severe symptomatic osteoarthritis of the knee or hip has failed to respond
to non-pharmacological and pharmacological therapy, THEN the patient should be offered referral to an
orthopaedic surgeon to be evaluated for total joint replacement within 6 months unless surgery
is contraindicated.
Osteoarthritis referral generation
All participants were asked ‘Are you often troubled with pain?’ All who responded ‘yes’ were filtered to
the question ‘How would you rate your pain if you were walking on a flat surface? Please rate your pain
from 0–10 for each of the following where 0 is no pain and 10 is severe or excruciating pain, as bad as
you can imagine’. Unless respondents stated that they could not walk or never walk, they were then
filtered to a set of questions that rated pain in different body parts, including their knees and hips.
Participants who rated the pain in their knee or hip from 6–10, and who reported current osteoarthritis,
were filtered to the question ‘Has your knee or hip pain been bothering you for more than 6 months?’
Those who responded ‘yes’ were then asked ‘Do exercises and medicines control the pain in your knee or
hip?’ If participants responded ‘no’, they were asked ‘Did any doctor recommend that you should have
surgery or joint replacement?’ All who gave a yes/no response to this final question were eligible for this
quality indicator and passed the indicator if their answer was ‘yes’.
Depression
All of the quality indicators for depression used incident cases only. At each wave, participants were asked
‘Has a doctor ever told you that you have (or have had) any of the conditions on this card (includes ‘any
emotional, nervous or psychiatric problems’)?’ Those reporting emotional, nervous or psychiatric problems
were filtered to a question that asked ‘What type of emotional, nervous or psychiatric problems do you
have (includes ‘depression’)?’ Participants who reported such problems at a previous wave were also asked
to confirm if they still had the condition. Below, we define incident depression as reports of depression at
the current wave, excluding those who reported depression at the previous wave.
Depression suicide description
IF a person aged ≥ 50 years receives a diagnosis of a new depression episode, THEN the diagnosing
physician should ask on the day of diagnosis if the person aged ≥ 50 years had any thoughts
about suicide.
Depression suicide generation
Participants reporting psychiatric problems were filtered to the question ‘When you talked about these
feelings with a doctor or nurse, did they ask you on that day if you had thoughts about suicide?’
Participants were eligible for this quality indicator if they reported incident depression and gave a yes/no
response to the question. Those who answered ‘yes’ passed the indicator.
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Depression treatment description
IF a person aged ≥ 50 years is diagnosed with clinical depression, THEN antidepressant treatment, talking
treatment or electroconvulsive therapy should be offered within 2 weeks after diagnosis unless within that
period the patient has improved, or unless the patient has substance abuse or dependence, in which case
treatment may wait until 8 weeks after the patient is in a drug- or alcohol-free state.
Depression treatment generation
Participants reporting depression were filtered to the question ‘I have some questions about any treatment
you may have had for your depression. Did a doctor or nurse suggest that you take medication, or see a
mental health professional for counselling?’ Those with incident depression were eligible for this quality
indicator if they responded to this question. Participants passed the indicator if the indicated that they
had been offered a form of treatment and answered ‘yes’ to the question ‘Did you start medication or
counselling within 2 weeks of being offered this treatment?’
Depression review description
IF a person aged ≥ 50 years has no meaningful symptom response after 6 weeks of treatment, THEN one
of the following treatment options should be initiated by the eighth week of treatment: medication dose
should be optimised (if initial treatment was medication), or medication should be initiated (if initial
treatment was psychotherapy alone), or referral to a psychiatrist should be offered.
Depression review generation
Participants reporting depression were filtered to the question ‘I have some questions about any treatment
you may have had for your depression. Did a doctor or nurse suggest that you take medication, or see a
mental health professional for counselling?’ Those who indicated that they were on a treatment for
depression were then asked ‘Did you start medication or counselling within 2 weeks of being offered this
treatment?’ Participants who answered ‘yes’ to this question were filtered to a question that asked ‘Did
you feel better within 6 weeks after starting to take medication, or seeing a mental health professional
for counselling?’ Those who answered ‘no’ were eligible for this quality indicator if they had incident
depression and gave a yes/no response to the question ‘Did any doctor or nurse start you on medication,
change the dose of the medication that you were taking or, change the medications to help you feel
better?’ Participants passed the indicator if they answered ‘yes’ to this final question.
Patient-centred care
Diabetes training description
Some people with diabetes receive training to help them manage their diabetes themselves. Have you ever
participated in a course or class about diabetes, or received special training on how you can live with your
diabetes from day to day?
Diabetes training generation
Participants who responded ‘yes’ to the question ‘Has a doctor ever told you that you have diabetes?’
at any wave up to and including the current wave were filtered to the question ‘Some people with
diabetes receive training to help manage their diabetes themselves. Have you ever participated in a course
or class about diabetes, or received special training on how you can live with your diabetes from day to
day?’ Participants formed the eligible sample if they gave a yes/no response to this question at any wave
and passed the indicator if they ever answered ‘yes’.
Diabetes knowledge description
How much do you think you know about managing your diabetes?
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Diabetes knowledge generation
Participants who responded ‘yes’ to the question ‘Has a doctor ever told you that you have diabetes?’ at
any wave up to and including the current wave were filtered to the question ‘How much do you think
you know about managing your diabetes?’ Possible responses were ‘just about everything you need to
know’, ‘most of what you need to know’, ‘some of what you need to know’, ‘a little of what you need
to know’ and ‘almost none of what you need to know’. Participants formed the eligible sample if they
gave a response and passed the indicator if they answered ‘just about everything you need to know’ or
‘most of what you need to know’.
Cholesterol explanation description
Has a doctor or nurse explained high cholesterol in a way you could understand?
Cholesterol explanation generation
Participants who reported high cholesterol in response to the question ‘Has a doctor ever told you that you
have (or have had) any of the conditions on this card (includes ‘high cholesterol’)?’ were filtered to the
question ‘Has a doctor or nurse explained high cholesterol in a way you could understand?’ Participants
formed the eligible sample if they gave a yes/no response to this question and passed the indicator if their
response was ‘yes’.
Cholesterol preferences description
Have doctors or nurses taken your preferences into account when making treatment decisions about your
high cholesterol?
Cholesterol preferences generation
Participants who reported high cholesterol in response to the question ‘Has a doctor ever told you that you
have (or have had) any of the conditions on this card (includes ‘high cholesterol’)?’ were filtered to the
question ‘Have doctors or nurses taken your preferences into account when making treatment decisions
about your high cholesterol?’ Participants formed the eligible sample if they gave a yes/no response to this
question and passed the indicator if their response was ‘yes’.
Blood pressure explanation description
Has a doctor or nurse explained high blood pressure in a way you could understand at any time since you
were first told you had high blood pressure?
Blood pressure explanation generation
Participants who reported hypertension in response to the question ‘Has a doctor ever told you that you
have (or have had) any of the conditions on this card (includes ‘high blood pressure or hypertension’)?’
at the current wave, or who confirmed that they still had hypertension reported at an earlier wave, were
filtered to the question ‘Has a doctor or nurse explained high blood pressure in a way you could
understand at any time since you were first told you had high blood pressure?’ Participants formed the
eligible sample if they gave a yes/no response to this question at any wave and passed the indicator if their
response was ‘yes’ at any wave.
Blood pressure choice description
In general, have doctors or nurses given you any choice about how to treat your high blood pressure?
Blood pressure choice generation
Participants who reported hypertension in response to the question ‘Has a doctor ever told you that you
have (or have had) any of the conditions on this card (includes ‘high blood pressure or hypertension’)?’
at the current wave, or who confirmed they still had hypertension reported at an earlier wave, were
filtered to the question ‘In general, have doctors or nurses given you any choice about how to treat your
high blood pressure?’ Participants formed the eligible sample if they gave a yes/no response to this
question at any wave and passed the indicator if their response was ‘yes’ at any wave.
METHODS
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Osteoarthritis treatment purpose description
Has any doctor or nurse ever talked to you about what the specific purpose of the treatment for your
arthritis or joint pain is?
Osteoarthritis treatment purpose generation
Participants with current osteoarthritis were filtered to the question ‘Has any doctor or nurse ever talked
to you about how your arthritis or joint pain will be treated?’ Those who answered ‘yes’ were then filtered
to the question ‘Has any doctor or nurse ever talked to you about what the specific purpose of the
treatment for your arthritis or joint pain is?’ Participants formed the eligible sample if they gave a yes/no
response to this last question at any wave and passed the indicator if their response was ‘yes’ at any wave.
Availability of quality indicators across waves
There were changes in the questions included in ELSA between the waves. As a result, not all quality
indicators could be generated at all waves. Table 6 displays the availability of the quality indicators.
All quality indicators were generated at wave 2. Wave 5 was the next most complete wave, where all
quality indicators except those for depression could be generated. Apart from wave 2, depression quality
indicators were available only at wave 4, and then only two out of the three could be derived.
For diabetes, CVD and osteoarthritis, there were at least two waves at which quality of care could be
compared using all quality indicators.
Variables
Potential covariates
Possible covariates were selected by a panel consisting of academics, clinicians, researchers and Patient and
Public Patient Involvement in Research (PPIRes) members of the team. The choices were based on clinical
relevance, feasibility to extract the data from ELSA and previous work. Covariates were grouped into five
domains: demographics, health and disability, health behaviours, physical measures, and psychological and
social measures. Table 7 lists all covariates that were used in any of the analyses in this work. Any relevant
descriptors, explanations and groups are also shown.
Standardised scales
Standardised scales available to use as covariates are described below.
Rose Angina Scale
The Rose Angina Scale is an epidemiological measure of angina pectoris.45 It defines angina according to
standard criteria as chest pain or discomfort that fulfils all of the following criteria:
l It is brought on by exertion.
l It is situated in the central or left anterior chest or left arm or sternum.
l It forces the subject to slow down or stop.
l It is relieved if the subject does slow down or stop.
l It is relieved within 10 minutes.
This is further subcategorised into:
l A: severe (grade II) if exertional pain came on while walking on level ground.
l B: not severe (grade I) if chest pain only came on when hurrying or walking uphill.
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TABLE 6 Availability of quality indicators across the waves of ELSA
Quality indicator Wave 2 Wave 3 Wave 4 Wave 5
Diabetes mellitus
Diabetes HbA1c ✓ ✓ ✓ ✓
Diabetes proteinuria ✓ ✓ ✓ ✓
Diabetes cholesterol ✓ ✓
Diabetes ACE inhibitor ✓ ✓ ✓ ✓
Diabetes foot check ✓ ✓ ✓ ✓
Cardiovascular disease
Stroke antihypertensives ✓ ✓ ✓ ✓
Hypertension treatment ✓ ✓ ✓ ✓
IHD cholesterol ✓ ✓
IHD antiplatelets ✓ ✓
IHD smoking ✓ ✓
MI beta-blocker ✓ ✓
INR test ✓ ✓
OA
OA exercise ✓ ✓ ✓ ✓
OA education ✓ ✓ ✓ ✓
OA paracetamol ✓ ✓ ✓ ✓
OA referral ✓ ✓ ✓ ✓
Depression
Depression suicide ✓ ✓
Depression treatment ✓ ✓
Depression review ✓
Patient-centred care
Diabetes training ✓ ✓ ✓
Diabetes knowledge ✓ ✓ ✓
Cholesterol explanation ✓
Cholesterol preferences ✓
Blood pressure explanation ✓
Blood pressure choice ✓
OA treatment purpose ✓ ✓ ✓
OA, osteoarthritis.
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TABLE 7 Full list of possible patient characteristics associated with quality of care
Covariate Description Groups
Demographics
Age groups Age. Participants ≥ 90 years old have their age
recorded as ‘over 90 years’ to help maintain
anonymity
50–64 years, 65–74 years, ≥ 75 years
Sex Women, men
Marital status Cohabiting/not cohabiting
NS-SEC Three-class version used Managerial/professional, intermediate,
routine/manual
Education Highest educational qualification achieved No qualifications, intermediate or degree
or higher education below a degree
Age-specific total
wealth quintile
Net financial wealth and physical wealth, private and
state pension, and primary housing value less
housing debt
Quintiles defined within the three age
bands
Weighting
(see Weighting)
Wave specific cross-sectional or
longitudinal
Health and disability
General health Self-reported general health Excellent/very good/good/fair/poor
Eyesight Self-reported eyesight Excellent/very good/good/fair/poor/blind
Hearing Self-reported hearing Excellent/very good/good/fair/poor
Chronic pain Self-reported severity of chronic pain None/mild/moderate/severe
Long-standing illness Whether or not reports long-standing illness, and
whether or not this illness limits activities
None/long-standing illness/limiting
long-standing illness
Basic activities of
daily living
Number of self-reported difficulties with basic
activities of daily living of dressing, walking across a
room, bathing, eating, getting in/out of bed and
using the toilet
None/one, two or more
Instrumental activities
of daily living
Number of self-reported difficulties with instrumental
activities of daily living of orientation, preparing
meals, shopping, using the telephone, taking
medications, housekeeping and money management
None/one, two or more
Health behaviours
Health literacy Number of correct responses to four questions on
health literacy. This was not available at 2008–9 so
was taken from 2010–11
No errors (high), one or more errors (low)
Alcohol consumption Self-reported frequency of alcohol consumption 1–2 days/week or less, 3–4 days/week
or more
Smoking history Smoking status Never smoked, smoked in past, currently
smokes
Physical activity level Classified using the reported level of work activity
and frequency of low, moderate and vigorous
leisure-time activity. Definition in ELSA wave 5
documentation (Banks et al.29)
Moderate/high, sedentary/low
Diet Whether eats five portions of fruit and/or vegetables
per day
Eats ‘5 a day’, does not eat ‘5 a day’
continued
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TABLE 7 Full list of possible patient characteristics associated with quality of care (continued )
Covariate Description Groups
Psychological and social measures
Access to GP The answer to ‘how easy or difficult is it to get to
your GP using your usual form of transport?’
Very easy/quite easy/quite difficult/very
difficult/unable to go/do not wish to go
Social detachment Social detachment is a multidimensional construct.
Four domains are derived: civic participation, leisure
activities, cultural engagement and social networks.
Those classified as detached on three or more of
these domains were classified as socially detached.
See ELSA wave 5 documentation for derivation27
Not socially detached, socially detached
Quality of life The CASP-19 scale41 transformed into tertiles High, medium, low
Cognitive impairment Composite score of prospective memory, attention,
processing speed, verbal fluency, orientation,
immediate word recall, delayed word recall and
numeracy. Component scores were standardised and
summed to form a cognitive performance scale. This
scale was then standardised and the bottom 10% of
scores were classified as cognitively impaired42
Not cognitively impaired, cognitively
impaired
Lives alone Whether or not respondent lives alone (reports no
cohabitors)
No, yes
LOC Respondents rated the extent to which they agreed
with the statement ‘what happens in life is often
determined by factors beyond [his/her] control’ on a
six-point Likert scale. Those who strongly/slightly
agreed were classified as having ‘external’ LOC and
those who strongly/slightly disagreed were classified
as having ‘internal’ LOC
Internal, external
Physical measures
BMI category Height and weight assessed in a nurse visit. BMI
calculated from weight/(height)2 and defined from
WHO criteria
Underweight/normal weight (≤ 25 kg/m2),
overweight (≥ 25, < 30 kg/m2), obese
(≥ 30 kg/m2)
HbA1c levels Used to define symptomatic diabetes, samples taken
in waves 2 and 4 for analysis of HbA1c. Symptomatic
diabetes defined as a fasting HbA1c level of ≥ 7.5%
(DCCT)
Has symptomatic diabetes/do not have
symptomatic diabetes
Total cholesterol Blood total cholesterol levels in mmol/l. QOF cut-off
of > 5mmol/l indicates high cholesterol
High cholesterol/acceptable cholesterol
MAP in mmHg Defined as the average arterial pressure during a
single cardiac cycle. MAP= diastolic BP+ 1/3
(systolic BP – diastolic BP)
High ≥ 110mmHg/regular < 110mmHg
Disease-specific variables
Comorbidities Number of comorbid conditions measured in ELSA ≥ 2/none or one
Previous care
(diabetes)
Whether or not the indicated care was achieved at
the previous wave for the care bundle of annual
monitoring checks (all-or-nothing achievement) and
diabetes ACE inhibitor. New cases since the last wave
were added as a separate category
Achieved, not achieved, new case
Knows mostly
everything about
managing diabetes
Responses to the question ‘How much do you think
you know about managing your diabetes?’
Just about everything/most of what they
need to know (yes), some/a little/almost
none of what you need to know (no)
Time since diagnosis
for all conditions
Measured in waves of ELSA (2-year increments) since
the diagnosis was reported. IHD split into time since
heart attack and time since angina. Hypertension
given in wave first diagnosed
Range of 0 (new case in 2010–11) to 3
(reported in 2004–5). Entered as ordinal
variable
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Centre for Epidemiological Studies – Depression scale
A short form of the Centre for Epidemiological Studies – Depression Scale (CES-D), consisting of eight
items, was included in the psychosocial health module at each wave from wave 2 onwards. Participants
were asked to say whether or not eight statements relating to symptoms of depression were true of them
in the past week, giving yes/no responses. The established criterion of likely depression is the presence of
four or more symptoms.43
Control, Autonomy, Self-realisation and Pleasure-19 quality of life scale
This scale is designed for use with older people and assesses quality of life over four domains, from which
its name is taken: Control, Autonomy, Self-realisation and Pleasure (CASP-19).41 It consists of 19 items,
which were asked of participants in the self-completion module. Responses to these items are summed,
after reverse scoring where necessary, to produce an overall measure of quality of life.
Activities of daily living
Markers of physical function available in ELSA included grip strength, walking speed, use of stick or
mobility aids, leg raise, tandem or side stand, and the ability to walk a quarter of a mile without special
equipment. We used the activities of daily living (ADL) scale in this study, as it is a well-known and widely
used measure of physical function.46,47
Definition of comorbidities
In our regression analyses we used a measure of comorbid conditions and these were defined as having
two or more comorbid conditions as opposed to one or none. This is a commonly used definition of
multimorbidity.48 This variable was created by counting the number of comorbid conditions that every
participant had out of a possible 16 conditions, and excluding those conditions closely related to the
specific condition. For example, those with osteoarthritis often also had the more general diagnosis of
‘arthritis’, and this was not counted as a condition comorbid to osteoarthritis. For diabetes, hypertension,
congestive heart failure, diabetes and high cholesterol were not considered comorbid conditions; for
depression, Alzheimer’s disease and dementia were not considered comorbidities. For IHD, hypertension,
prevalent angina, prevalent heart attack, heart murmur, arrhythmia, CVD and high cholesterol were not
considered comorbid conditions.
TABLE 7 Full list of possible patient characteristics associated with quality of care (continued )
Covariate Description Groups
CES-D depression
classification
Self-reported depressive symptoms (eight items) using
the CES-D scale43
Not depressed, depressed (≥ 4 symptoms)
Rose Angina Scale Defined as grade 2 on the Rose Angina Scale44 Has symptomatic angina/does not have
symptomatic angina
Joint replacement
payment (used in OA)
Was your joint replacement paid for by the NHS or
privately or a mixture of both?
NHS/private and mixed NHS private
payment
Cataract extraction
payment (used in
cataract)
Was your cataract extraction paid for by the NHS or
privately or a mixture of both?
NHS/private and mixed NHS private
payment
Symptomatic OA by
pain and disability45
Often troubled by pain in knee or hip, and this pain
was rated 5 or more out of 10 when walking on a
flat surface. Also had some or much difficulty or were
unable to walk a quarter of a mile
Has symptomatic OA/does not have
symptomatic OA
BMI, body mass index; BP, blood pressure; CASP-19, Control, Autonomy, Self-realisation and Pleasure-19 quality of life scale;
CES-D, Centre for Epidemiological Studies – Depression Scale; DCCT, Diabetes Control and Complications Trial; GP, general
practitioner; LOC, locus of control; MAP, mean arterial pressure; NS-SEC, National Statistics Socio-Economic Classification;
OA, osteoarthritis; WHO, World Health Organization.
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Excluded variables
It was agreed by the clinical screening panel that ethnicity should be tested for association with health
care; however, owing to < 2% of the sample being non-white this could not be used in the regression
analyses. Other covariates that were not included in analyses were country of birth (not specific enough as
recoded as UK or non-UK), geography (not available), internet use (missing data), employment status
(majority not employed as they were past retirement age) and fasting glucose measurements (not used in
QOF as a measure of diabetes). Previous work on ELSA accounted for the clustering and stratification of
the participants in the HSE. On advice from the ELSA data manager at the National Centre for Social
Research (NatCen), we did not include these variables as the ELSA sample is now effectively unclustered
owing to non-response and people moving.
Additional variables excluded from the diabetes care bundle analysis
A number of the selected covariates measure very similar concepts. To reduce colinearity, the clinical
screening panel selected one covariate to assess a domain where there were several options. Thus,
National Statistics Socio-Economic Classification (NS-SEC)49 was used to represent socioeconomic status,
and highest educational qualification and age-stratified wealth were excluded. Reports of long-standing
illness, including limiting long-standing illness, were used as a measure of overall health, and participants’
reports of general health and comorbidities were excluded. Variables for whether or not respondents
exceeded QOF criteria for high HbA1c and cholesterol were also excluded, as they were highly associated
with whether or not participants had previously received indicated care. Ratings of the accessibility of
participants’ GPs were excluded as < 10% of respondents’ ratings were anything other than ‘very easy’.
Data quality
Many covariates had missing data for some participants. In most cases, the frequency of missing data was
small (< 2%). However, the frequency of missing data was much larger for some covariates, particularly
those taken from the self-completion module or nurse visits, which had lower response rates or covariates
that were derived scales and required responses to all scale components. To maximise the samples
available for regression modelling, missing data were coded as an extra category for each covariate if the
frequency was > 2% (continuous covariates were first transformed into tertiles). This criterion was chosen
as a balance between including as many respondents as possible in the models and not causing
multicolinearity issues in models due to low category frequencies. The frequencies of all covariates’
categories were checked for the samples to be used in statistical models. Where there were < 10% of
responses in a category, we combined categories or, if combining categories was not suitable, excluded
the covariate on the basis of poor data quality.
Weighting
The English Longitudinal Study of Ageing is designed to be analysed either cross-sectionally or
longitudinally. Cross-sectional analysis uses data collected at a single wave, whereas longitudinal data
analysis uses data collected in more than one wave. Owing to non-response, the refreshment samples in
waves 3 and 4, and the original clustered recruitment from the HSE, sampling weights have been
calculated for use in analyses to allow for these factors.
Longitudinal weights were designed to adjust for historical non-response as well as to response since the
last wave; therefore, at wave 5 the longitudinal weights adjust for non-response to HSE as well as for
non-response to each wave of ELSA. Cross-sectional weights were designed to adjust the sample to be
representative of the English population ≥ 50 years old.
In our analyses we used the weighting where appropriate, depending on the wave used, and whether we
were performing cross-sectional or longitudinal analyses. The precise methods of calculating the weights are
given in the ELSA user guides and technical reports, available from the Economic and Social Data Service.
METHODS
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Statistical methods
All analyses described below were conducted using Stata SE version 12.1 (StataCorp LP, College Station,
Texas, USA).
Quality indicator achievement
The entire ELSA sample for this study consisted of all participants who had been interviewed at any of the
four waves (n= 16,773). The primary outcome was achievement of each quality indicator, which was the
number of times the indicator was achieved divided by the number of times it was triggered, expressed as
a percentage, with possible values between 0% and 100%. The quality indicator achievement at the level
of each condition (cardiovascular disease, depression, diabetes or osteoarthritis) was the number of times
any indicator for that condition was achieved divided by the number of times any indicator for that
condition was triggered, expressed as a percentage, with possible values between 0% and 100%
(see Table 9).
The percentage change in achievement was calculated between wave 2 and the most recent year of
follow-up, and the statistical significance of changes over time were tested with Pearson’s chi-squared test
for comparing proportions (see Table 10). Some data points were paired within individuals between wave
2 and the most recent year of follow-up, and some were not, as different individuals were eligible for
indicators at different waves. For this reason we did not use McNemar’s test for paired data, although
McNemar’s test would have had greater power and precision had it been appropriate to use. We excluded
‘don’t know’ responses from both the numerator and the denominator when calculating quality scores.
We used correlation analysis to investigate whether or not quality of care for one condition was associated
with quality of care in another.
Transitions in receipt of care across time
We explored the extent to which participants with diabetes, cardiovascular disease, osteoarthritis and
depression transitioned from non-receipt of indicated care to subsequently receiving it, and vice versa,
across the available waves of ELSA. To achieve this, we used cross-tabulations of whether or not an
indicator was passed at one wave with whether or not it was subsequently passed at the wave at which it
was next available. Some quality indicators were only available at one wave other than the baseline
(wave 2), either wave 4 or wave 5 (see Availability of quality indicators across waves). As a result, owing to
participant attrition and changes in individuals’ health status, sample sizes for these quality indicators were
too small for comparisons across waves. Additionally, sample sizes were too small for osteoarthritis referral
and osteoarthritis paracetamol was not suitable, as if paracetamol for pain relief was not the first
prescribed drug, this could never be rectified. We therefore report the proportions of individuals who
successfully transition from non-receipt of care to receiving their care, who transition from receipt of care
to subsequent non-receipt of care, and those who do not transition, for stroke antihypertensives,
hypertension treatment, diabetes HbA1c, diabetes proteinuria, diabetes ACE inhibitor, diabetes foot check,
all-or-nothing receipt of the care bundle for diabetes, osteoarthritis exercise and osteoarthritis education.
Modelling for longitudinal quality of care
For the modelling we used a longitudinal data set comprising only those participants who had completed
interviews at all four waves (n= 5114) (see Table 13). We calculated quality indicator achievement for
these 5114 participants in exactly the same way as we calculated it for the entire data set, described in
Quality indicator achievement – that is, the quality indicator achievement at the level of each condition
was the number of times any indicator for that condition was achieved divided by the number of times any
indicator for that condition was triggered, expressed as a percentage, with possible values between 0%
and 100% (see Table 15).
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For the regression, modelling we needed to calculate quality indicator eligibility by participant rather than
by condition, as the covariates were linked to participants rather than to conditions (cardiovascular disease,
depression, diabetes or osteoarthritis). Each participant might have been eligible for more than one
indicator within each condition, and so we reshaped the data into ‘long’ format in Stata statistical
software, with each participant having a separate record for each indicator. These person-indicator level
records of quality achievement were the unit of analysis for the modelling, using ‘svy’ commands in Stata
‘long’ format. This was done for each condition separately, and the outcome was expressed as the odds of
achievement of any quality indicator that a participant was eligible for, within the relevant condition, with
adjustment for participant characteristics. Intraperson correlation of outcomes was accounted for using
robust adjustment with Stata, with each participant’s unique identifier included in the regression equation
as a cluster variable. All data were weighted for historical non-response and non-response since the last
wave (see Table 15).
Age group (50–64, 65–74 and ≥ 75 years) and sex were included in all regression models, and the
following were examined as potential explanatory variables, and included in final models if they were
significantly associated with the outcome before adjustment for other variables: wealth, marital status,
education, socioeconomic status, NHS or independent sector delivery of joint surgery, general health,
eyesight, hearing, chronic pain, limiting illnesses, instrumental activities of daily living (IADL) (scale of 1–7),
ADL (scale of 1–6), GP access, the Rose Angina Scale,44 cognitive impairment, comorbidities, smoking,
eating five portions of fruit and vegetables a day, alcohol consumption, physical activity levels, body mass
index (BMI), blood pressure, blood glucose (HbA1c) levels, self-perceived social status, CASP-19, social
detachment, and depression (CES-D).
We categorised BMI according to the World Health Organization criteria,21 blood glucose [HbA1c ≥ 7.5%
(Diabetes Control and Complications Trial: DCCT) or 59mmol/mol (International Federation of Clinical
Chemistry and Laboratory Medicine: IFCC)] and cholesterol (≤ 5mmol/l or less) according to the QOF
criteria,8 and depression according to the CES-D (a score of 4 or more was classified as depression).22
A single fasting plasma glucose was used to estimate the prevalence of diabetes, rather than the
two separate measurements recommended by the World Health Organization. This approach is not
recommended for clinical care, but is acceptable at population level and has been used in other studies.50
It may overestimate diabetes51 but will also not identify the small number of people whose diabetes can be
detected only on an oral glucose tolerance test.52
All characteristics that were significantly associated with quality of care at the 5% level for the conditions
using univariate regression analyses were used in the final models.
Predicting non-receipt of indicated care for diabetes care bundles
We used the care bundle approach as an alternative method to model quality of care for diabetes, to
explore which characteristics were predictive of not receiving indicated care for diabetes 2 years later. For
the diabetes care bundle analyses we used a data set comprising ELSA core members at wave 5 who also
responded at wave 4 (n= 8222) (see Table 17). The latest outcomes were deemed to be the most clinically
relevant to model, so we used wave 5 outcomes and covariates from wave 4. A covariate of particular
interest was whether or not participants had previously received the indicated care.
We therefore had two outcomes: all-or-nothing receipt of the care bundle and whether or not the
diabetes ACE inhibitor quality indicator was passed. Separate logistic regression models were developed
for each of the two outcomes using the following process: short-listed covariates were first entered into
univariate regressions, adjusted for age and sex, and the models were weighted for non-response using
the wave 5 cross-sectional sample weights (see Weighting). All characteristics that were significantly
associated with quality of care at the 5% level for either outcome were then entered into a forced entry
logistic regression, adjusted and weighted as above, for both outcomes (see Table 17).
METHODS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
26
Patient characteristics associated with the illness burden, diagnosis and
treatment pathway
To examine whether or not factors such as wealth are associated with quality of health care received
through the care pathway, we defined burden of illness, diagnosis and treatment for four conditions from
data generated from the four waves of ELSA. We used the sample of ELSA core members who had been
interviewed at any of the four waves (n= 16,773).
Variable definitions
The illness burden for angina was defined as grade 2 on the Rose Angina Scale [pain or discomfort in
chest when walking at an ordinary pace on the level on most occasions or more often, which makes
subject stop or slow down if occurs while walking, and which then goes away within 10 minutes, and
which includes either sternum (any level), or left arm and left anterior chest]. Illness burden for diabetes
was defined as a fasting HbA1c level of > 7.5%. Illness burden for depression was defined as a score of
≥ 3 on the eight-item CES-D. The application of these standardised scales in ELSA has been described
previously. Illness burden for osteoarthritis was defined as self-reported pain in the hip or knee of ≥ 5 on a
scale of 0 to 10.
A medical diagnosis was considered to exist if a participant answered ‘yes’ when asked if a doctor had
ever told them they had the condition of interest. For arthritis, a follow-up question asked whether they
had been told that they had osteoarthritis, rheumatoid or other arthritis.
Treatment for depression and diabetes was defined by reported achievement of quality of care indicators,
derived through a robust process of literature reviews, expert panel assessment and piloting. For depression,
the quality indicator was about receipt of treatment since the previous wave: ‘if a person is diagnosed with
clinical depression, then antidepressive treatment, talking treatment or electroconvulsive treatment should
be offered within 2 weeks after diagnosis unless within that period the patient has improved, or unless the
patient has substance abuse or dependence, in which case treatment may wait until 8 weeks after the patient
is in a drug-or alcohol-free state’. For diabetes, treatment was measurement of HbA1c or fructosamine levels
in the preceding 12 months. Treatment for angina was defined as ever being offered or currently taking
beta-blockers (ELSA variables hebeta or hebetb). Treatment for osteoarthritis was defined as reporting ever
having had surgery for the condition; this excluded those with hips or knees replaced due to fracture. Data
on hip and knee replacements were available only for respondents aged 60 and over, and so respondents
aged < 60 years (n= 3186) were excluded from the analysis of osteoarthritis.
Wealth was defined as the sum of financial, physical and housing wealth plus state and private pension
income. Age was categorised into three groups: 50–59 years, 60–74 years and ≥ 75 years (see Table 20).
Analysis
We used two approaches to analysis: a main analysis using serial cross-sectional data and then a subsidiary
analysis using longitudinal data. Multivariable logistic regression analysis was used, with the outcome variables
defined as one of illness burden, medical diagnosis or treatment for each of the four conditions in each
cross-sectional wave (Stata statistical software version 12.1). This regression analysis was repeated for each
of the four waves of ELSA from 2004 to 2011 separately and then ‘overall’ for all four waves combined.
For the ‘overall’ analysis, the data were reshaped into ‘long’ format in Stata statistical software, with each
participant having a separate record for each indicator and wave, as explained earlier (see Statistical methods
and Modelling for longitudinal quality of care). Intraperson correlation of outcomes was accounted for using
robust adjustment with Stata, with each participant’s unique identifier included in the regression equation as
a cluster variable. Missing data were excluded from the analyses.
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The independent variables were age group, sex and slope order of inequality. We used the slope order of
inequality as an independent variable to estimate the relationship between the outcome measures and the
categorised measure of wealth. The slope order of inequality consisted of wealth quintiles with values of
0.1, 0.3, 0.5, 0.7 and 0.9, that is the mid-points of each quintile on a scale of zero (least wealthy) to one
(most wealthy). The slope order of inequality was modelled as a continuous variable, and its odds ratio
(OR) represents the ratio of the least wealthy compared with the wealthiest participant. This OR is also
known as a relative index of inequality. Advantages of this method of quantifying inequality are that it
includes all participants, instead of just comparing the highest and lowest quintiles, it accounts for the
number of participants in each category and it provides a single overall measure of inequality.
We included all participants in the main cross-sectional analysis in order to compare the distribution of
illness burden in the whole population with the distributions of diagnoses and treatments in the whole
population. This meant that diagnosis was assessed even in those who did not meet the criteria for ‘illness
burden’, and treatment was assessed even in those with no diagnosis. For the subsidiary analysis using
longitudinal data, we estimated the OR of receiving a diagnosis by a subsequent wave only for those who
had met the criteria for ‘illness burden’ in a previous wave, and then the likelihood of receiving treatment
only for those who had received a diagnosis in a previous wave. This was a subsidiary analysis as the
numbers of participants who could be followed over time in this manner was small, particularly for
treatment in angina and depression.
Others factors, such as health literacy, obesity, access to GP, comorbidities, education and health
behaviours, were used to investigate whether or not they had an additional impact on the care pathway as
well as wealth. This was performed not at each wave but as an overall measure, where burden of illness,
diagnosis and treatment were defined as having the burden of disease, diagnosis or receiving treatment at
any wave, respectively. The sensitivity analyses adjusted for age group, sex and slope index of inequality
at wave 5 as well as one other confounder at a time.
METHODS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
28
Chapter 3 Results
The results are presented in this chapter in the following four sections: Demographics for all waves ofthe English Longitudinal Study of Ageing, Achievement of quality indicators over time (this section also
gives the results for the diabetes care bundle and for transitions in quality over time), Regression modelling
for quality of care and Population distribution of illness burden, diagnosis and treatment.
Demographics for all waves of the English Longitudinal Study
of Ageing
At any of the four waves 16,773 participants were interviewed, of whom 3810 had at least one condition
at wave 2 and 5404 had at least one condition of interest at wave 5 (Table 8). The mean age of the
participants at baseline was 65.8 years (range 52 to > 90 years), and just under half were women. This
sample was used to address research question 1: how does the prevalence of good quality of health care
vary over time?
Achievement of quality indicators over time
Achievement of quality indicators
The eligibility and achievement rates of individual quality indicators for each wave of data for every
participant (n= 16,773) show that quality indicator pass rates varied substantially within conditions, with
the depression suicide indicator being achieved by 46.5% in wave 2 and treatment by 78.9% at the same
wave (Table 9). There was also variation between pass rates at different waves; the greatest percentage
increase in quality indicator achievement over the waves was seen in osteoarthritis exercise, where there
was a 20% improvement in passing the quality indicator, while the worst performing indicator was
depression treatment, with a 17% drop between the two waves where it was measured.
We used quality indicator achievement at condition level to see whether care for specific conditions had
increased or decreased over the 6 years of the study (Table 10). A statistically significant difference
between wave 2 (2004–5) and wave 5 (2010–11) was seen only for osteoarthritis quality indicators.
Although the achievement rates for osteoarthritis show a small increase, they are still very low (36% in
2010–11). We used the chi-squared test for associations, as the number of people with conditions at both
time points was small (n= 185 for cardiovascular disease, n= 6 for depression, n= 349 for diabetes and
n= 366 for osteoarthritis).
Those who reported ‘don’t know’ were not included in the analyses. The numbers reporting this were
extremely low and in wave 2 (total n at wave 2= 9432) only four did not know if they had been asked
about osteoarthritis and paracetamol use. This dropped to two at wave 5 (total n at wave 5= 10,274).
The offer of antihypertensive medication after a stroke was not known by 19 people at wave 2 and by two
at wave 5.
Associations of care between conditions
We assessed whether or not quality of care for one condition was associated with quality of care for
another condition at each wave that data were available (see Chapter 2, Availability of quality indicators
across waves, and Table 6). The only statistically significant association was at wave 2, with quality of care
for diabetes and cardiovascular disease correlated (r= 0.13, p= 0.035). No associations between quality of
care for other diseases were found at wave 2 (osteoarthritis and diabetes, r= 0.16, p= 0.18; osteoarthritis
and cardiovascular disease r= –0.044, p= 0.72; depression and osteoarthritis r= –0.17, p= 0.48;
depression and cardiovascular disease r= 0.20, p= 0.41; and depression and diabetes r= 0.43, p= 0.28).
At wave 3 quality of care for osteoarthritis and diabetes were not associated (r= 0.078, p= 0.27). At wave 4,
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TABLE 8 Characteristics of the ELSA participants interviewed at any of the four waves where quality of care
was measured
Characteristics 2004–5: wave 2 2006–7: wave 3 2008–9: wave 4 2010–11: wave 5
Total number at wave 9432 9771 1150 10,274
Age (years), mean 65.8 64.6 65.3 66.8
Rangea 52 to > 90 54 to > 90 56 to > 90 58 to > 90
Sex
Female, n (%) 4125 (47.3) 4295 (44.0) 4925 (44.6) 4569 (44.5)
Male, n (%) 5307 (56.3) 5476 (56.0) 6125 (55.4) 5705 (55.5)
Ethnicity
White, n (%), wave 2 9432 (97.5)
Non-white, n (%) 229 (2.4)
Education (highest qualification), n (%)
Degree or equivalent 2721 (16.2)
Intermediate 4335 (25.9)
No qualifications 5008 (29.9)
Missing 4709 (28.1)
Total net household financial wealth, £
Median 188,851 207,631 217,098 231,049
Range –111,700 to
9,297,227
–1,578,980 to
2.08 × 107
–255,580 to
3.93 × 107
–10,500 to
1.06 × 107
One or more conditions, n (%) 3868 (41) 4754 (49) 5404 (49) 3810 (37)
Number of conditions for which participants were eligible
Mean 1 1 1 1
Range 0 to 6 0 to 4 0 to 4 0 to 3
Number of indicators for which participants were eligible
Mean 1 1 1 1
Range 0 to 13 0 to 8 0 to 12 0 to 12
Clinical incidence over 2 years, n (%)
CVD 110 (1.2) 168 (1.6) 136 (1.4)
Depression 125 (1.3) 288 (2.7)
IHD 298 (3.1)
Osteoarthritis 877 (10.7) 1105 (11.8) 877 (10.7)
Hypertension 817 (12.8) 1599 (18.9) 933 (13.2)
Clinical prevalence, n (%)
Diabetes mellitus 739 (7.8) 1000 (10.1) 1330 (11.7) 1566 (14.6)
a All respondents aged > 90 years had their exact age withheld from released data.
RESULTS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
30
TABLE 9 Achievement rates for quality indicators at each wave of ELSA for all the participants interviewed at
that wave
Quality
indicator
(n= 32) or
patient-centred
question (n= 7)
2004–5, wave 2: %
pass rate (95% CI);
n pass/n eligible
2006–7, wave 3: %
pass rate (95% CI);
n pass/n eligible
2008–9, wave 4: %
pass rate (95% CI);
n pass/n eligible
2010–11,wave5:%
pass rate (95%CI);
npass/neligible
% change
wave 2 to
most recent
follow-up
wave
Stroke
antihypertensives
77.3 (71.0 to 83.5);
136/176
74.9 (70.7 to 79.2);
305/407
82.1 (78.5 to 85.7);
354/431
84.8 (81.4 to 88.2);
375/442
+ 7.5
Depression
suicide
46.5 (37.8 to 55.2);
60/129
N/A 57.8 (52.0 to 63.7);
162/280
N/A + 11.3
Depression
treatment
78.9 (71.9 to 86.0);
105/133
N/A 61.8 (56.0 to 67.4);
176/285
N/A – 17.1
Depression
review
75.8 (59.3 to 92.4);
22/29
N/A N/A N/A N/A
Diabetes HbA1c 83.0 (80.2 to 85.8);
562/677
83.5 (80.9 to 86.1);
648/776
80.4 (77.8 to 83.0);
723/899
82.0 (76.0 to 84.4);
815/994
– 1.0
Diabetes
proteinuria
83.2 (79.1 to 87.4);
263/316
80.9 (76.6 to 85.2);
263/325
78.4 (74.1 to 82.7);
279/356
79.5 (75.6 to 83.4);
326/410
– 3.7
Diabetes
cholesterol
85.6 (79.9 to 91.4);
125/146
N/A N/A 88.7 (82.2 to 95.0);
86/97
+ 3.1
Diabetes ACE
inhibitor
48.1 (44.3 to 52.0);
311/646
53.1 (49.2 to 56.9);
345/650
56.6 (53.2 to 59.9);
489/864
56.9 (53.7 to 60.1);
511/898
+ 8.8
Diabetes foot
check
83.7 (81.0 to 86.3);
606/724
82.3 (79.7 to 84.9);
671/815
81.8 (79.3 to 84.2);
781/955
82.8 (80.5 to 85.1);
863/1042
– 0.9
Hypertension
treatment
(prevalent
hypertension)
71.6 (68.0 to 75.1);
451/630
67.8 (64.8 to 70.9);
614/905
80.3 (78.0 to 82.6);
915/1139
74.6 (71.1 to 78.1);
453/607
+ 3.0
Hypertension
treatment
(incident
hypertension)
84.6 (82.9 to 86.3);
1423/1682
87.1 (85.9 to 88.3);
2736/3130
90.7 (89.7 to 91.6);
3277/3615
92.7 (91.8 to 93.5);
3299/3560
+ 8.1
IHD cholesterol 85.2 (80.0 to 90.3);
161/189
N/A N/A 86.2 (78.8 to 93.6);
75/87
+ 1.0
IHD antiplatelets 82.6 (78.8 to 86.5);
309/374
N/A N/A 82.4 (79.8 to 84.9);
719/873
– 0.2
IHD smoking 89.7 (84.8 to 94.7);
132/147
N/A N/A 90.7 (86.4 to 94.9);
165/182
+ 3.0
MI beta-blocker
(incident MI)
64.0 (53.9 to 74.2);
57/89
N/A N/A 75.6 (66.3 to 84.8);
65/86
+ 11.6
MI beta-blocker
(prevalent MI)
69.1 (60.8 to 77.4);
85/123
N/A N/A 72.8 (65.6 to 80.0);
110/151
+ 3.7
INR test 100 (100 to 100);
44/44
N/A N/A 93.9 (89.8 to 98.1);
124/132
– 6.1
OA exercise 26.1 (21.4 to 30.8);
88/337
34.6 (30.3 to 38.9);
161/465
41.6 (38.7 to 44.5);
459/1103
46.2 (43.5 to 48.9);
613/1326
+ 20.6
OA education 21.6 (17.7 to 25.3);
99/459
20.0 (18.3 to 21.8);
404/2019
25.6 (23.9 to 27.4);
606/2366
32.1 (30.3 to 33.9);
824/2569
+ 10.5
OA paracetamol 45.2 (40.6 to 49.8);
206/456
42.6 (38.7 to 46.4);
273/641
44.8 (41.9 to 47.7);
497/1109
46.0 (43.1 to 48.8);
552/1201
+ 0.8
continued
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TABLE 9 Achievement rates for quality indicators at each wave of ELSA for all the participants interviewed at
that wave (continued )
Quality
indicator
(n= 32) or
patient-centred
question (n= 7)
2004–5, wave 2: %
pass rate (95% CI);
n pass/n eligible
2006–7, wave 3: %
pass rate (95% CI);
n pass/n eligible
2008–9, wave 4: %
pass rate (95% CI);
n pass/n eligible
2010–11,wave5:%
pass rate (95%CI);
npass/neligible
% change
wave 2 to
most recent
follow-up
wave
OA referral 35.8 (28.3 to 43.3);
57/159
39.2 (31.0 to 47.3);
56/143
39.1 (29.8 to 48.4);
43/110
33.6 (24.8 to 42.5);
38/113
– 2.2
Diabetes training 25.4 (22.2 to 28.6);
184/724
29.8 (27.0 to 32.7);
290/972
33.2 (30.6 to 35.7);
426/1284
N/A + 7.8
Diabetes
knowledge
78.0 (74.9 to 81.0);
564/723
78.2 (75.3 to 81.0);
634/811
81.3 (78.9 to 83.8);
772/949
N/A + 3.3
Cholesterol
explanation
78.6 (76.7 to 80.5);
1356/1725
N/A N/A N/A N/A
Cholesterol
preferences
49.1 (46.7 to 51.4);
839/1708
N/A N/A N/A N/A
Blood pressure
explanation
68.7 (66.4 to 70.9);
1151/1676
N/A N/A N/A N/A
Blood pressure
choice
42.7 (40.3 to 45.1);
704/1648
N/A N/A N/A N/A
OA treatment
purpose
77.9 (72.2 to 83.6);
162/208
79.1 (76.3 to 81.8);
654/827
81.9 (80.0 to 84.1);
974/1189
N/A + 4.0
CI, confidence interval; N/A, not applicable; OA, osteoarthritis.
TABLE 10 Quality indicator achievement for the four conditions in each of the four waves (n= 16,773)
Condition
2004–5, wave 2:
% achievement
(95% CI); n pass/n
eligible
2006–7, wave 3:
% achievement
(95% CI); n pass/n
eligible
2008–9, wave 4:
% achievement
(95% CI); n pass/n
eligible
2010–11, wave 5:
% achievement
(95% CI); n pass/n
eligible aχ2
Cardiovascular
disease
82.7 (79.9 to 85.5);
703/843
N/A N/A 84.2 (82.1 to 86.2);
1148/1360
0.53
Depression 63.3 (57.6 to 69.0);
187/291
N/A 59.8 (52.4 to 64.3);
338/565
N/A 0.21
Diabetes 76.0 (74.1 to 77.8);
1867/2509
76.6 (74.8 to 78.5);
1927/2566
75.3 (73.5 to 77.1);
2272/3074
76.5 (74.8 to 78.1);
2661/3441
0.67
Osteoarthritis 31.2 (28.5 to 33.8);
450/1411
23.9 (22.4 to 25.4);
894/3268
31.2 (29.8 to 32.7);
1605/4688
35.6 (34.2 to 37.1);
2027/5209
< 0.001
CI, confidence interval; N/A, not applicable.
a Pearson’s chi-squared test was test to test for differences between the baseline wave (2) and the last wave that the
condition was measured in.
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depression and osteoarthritis and depression and diabetes care showed no associations (r= 0.18,
p= 0.11 and r= 0.037, p= 0.85, respectively). Likewise, there was no relationship between quality of care
at wave 4 for osteoarthritis and diabetes (r= 0.075, p= 0.23). At wave 5, similarly, there were no
associations found between quality of care in the different diseases (cardiovascular disease and diabetes
r= 0.14, p= 0.074; cardiovascular disease and osteoarthritis r= 0.057, p= 0.3; and osteoarthritis and
diabetes r= 0.039, p= 0.47)
Achievement of diabetes care bundle quality indicators
This analysis used participants who were core members at wave 5 and had also responded at wave 4
(n= 8222). Eligibility and non-achievements rates of the individual indicators that made up the diabetes
care bundle and the one indicator (diabetes ACE inhibitor) were calculated. At least one of the three
monitoring checks included in the care bundle was not received in 288 out of 907 cases in 2010–11
[weighted rate= 32.2%, 95% confidence interval (CI) 29.1% to 35.5%]. This is equivalent to achievement
of 67.8% for all three quality indicators in the bundle. The HbA1c test, proteinuria test and foot check
quality indicators had similar, low rates of non-achievement (weighted 2010–11 range= 17.4–22.8%),
although the ACE inhibitor quality indicator had much higher non-achievement (weighted 2010–11
score= 44.5%). The non-achievements of the individual quality indicators and the care bundle varied little
between waves in the study (Table 11).
Transitions in quality of care across time
Transitions from receiving indicated care in one wave to not receiving care in a subsequent wave, and also
from not receiving care to subsequently receiving care, were calculated for wave 2 to wave 3, wave 3 to
wave 4, and wave 4 to wave 5 for the quality indicators available at every wave (see Chapter 2, Availability
of quality indicators across waves) (Table 12). Different patterns were seen for different conditions. Two
quality indicators for cardiovascular disease could be derived at every wave: the quality indicator for stroke
antihypertensives and the quality indicator for hypertension treatment. The percentage of eligible
participants who did not receive the indicated care for stroke antihypertensives in either the earlier or
subsequent wave of each wave pairing ranged from 65.4% in waves 2–3 to 73.1% in waves 4–5. Only
26.9–34.6% transitioned to receiving their care at the subsequent wave. For hypertension treatment the
percentage of those who were not offered an antihypertensive who then transitioned to subsequently
passing the quality indicator was much higher (59.6–69.0%), though 31.0–40.4% continued to
not receive the indicated care. In contrast, only 1.5–2.8% of those who were previously offered
antihypertensive medication transitioned to not receiving this care at the subsequent wave.
A similar pattern to that seen with hypertension was observed in diabetes HbA1c, proteinuria and foot
check and the care bundle of these three indicators. Of eligible participants who did not receive all
indicated care in the bundle at the earlier wave, 51.7–54.5% did transition to receiving the care at the
subsequent wave, while 45.5–48.3% continued to not receive the full bundle. Of those who received all
TABLE 11 Non-achievement of quality indicators and the care bundle in 2008–9 and 2010–11 (n= 8222)
Quality indicator
2008–9 2010–11
Failed/eligible % (95% CI) Failed/eligible % (95% CI)
Diabetes HbA1c 130/692 20.0 (16.8 to 23.3) 154/861 17.4 (14.8 to 20.1)
Diabetes proteinuria 58/273 22.7 (17.3 to 28.0) 76/349 22.8 (18.0 to 27.6)
Diabetes foot check 129/735 17.8 (14.8 to 20.8) 150/905 17.5 (14.8 to 20.2)
Care bundlea 235/736 32.8 (29.2 to 36.4) 288/907 32.2 (29.1 to 35.5)
Diabetes ACE inhibitor 289/665 44.6 (40.6 to 48.6) 325/759 44.5 (40.7 to 48.3)
Percentages and CIs are adjusted for differential non-response.
a The care bundle comprised the HbA1c test, proteinuria test and foot check quality indicators.
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three annual monitoring checks at the earlier wave, only 19.4–24.2% subsequently transitioned to not
receiving the complete bundle, as 75.8–80.6 received all the indicated care at both waves across the wave
pairings. The diabetes quality indicator for ACE inhibitors showed a slightly different pattern. Achievement
of this quality indicator was lower (see Table 9), and a greater proportion (63.8–66.4%) of eligible
participants who were not offered the indicated medication at the earlier wave continued to not receive
the care at the subsequent wave. In comparison, only 17.0–22.6% of those who were offered the
indicated medication at the earlier wave subsequently transitioned to not pass the indicator.
As described above (see Achievement of quality indicators), achievements of the osteoarthritis quality
indicators were low. Most of the eligible participants who did not receive their indicated care continued to
subsequently not receive their care (osteoarthritis exercise 83.8–92.1%; osteoarthritis education
85.0–87.7%). Only a small minority transitioned to passing the quality indicators at the subsequent wave
(osteoarthritis exercise 7.9–16.2%; osteoarthritis education 12.3–15.0%).
Regression modelling for quality of care
Demographics for the longitudinal data set
In all four waves 5114 participants were interviewed, and the number with at least one condition of
interest in any wave ranged from 1998 to 2961 (Table 13). The mean age of participants was 65 years
(range 52 to > 90 years) in 2004–5 and just over half were women. This sample was used to address
TABLE 13 Baseline characteristics of the participants in the longitudinal data set who were interviewed in all four
waves (n= 5114)
Characteristics 2004–5 2006–7 2008–9 2010–11
Age (years), mean 64.8 66.6 68.7 70.9
Sex
Female, n (%) 2882 (56.4) 2882 (56.4) 2882 (56.4) 2882 (56.4)
Male, n (%) 2232 (43.6) 2232 (43.6) 2232 (43.6) 2232 (43.6)
One or more conditions, n (%) 1998 (39) 2738 (54) 2961 (58) 2290 (44.8)
Number of conditions for which participants were eligible
Mean 1 1 1 1
Range 0–6 0–4 0–4 0–3
Number of indicators for which participants were eligible
Mean 1 1 1 1
Range 0–13 0–7 0–8 0–8
Clinical incidence over 2 years, n (%)a
CVD 32 (0.7) 53 (1.1) 60 (1.2)
Depression 65 (1.3) 53 (1.1)
IHD 183 (3.7)
Osteoarthritis 415 (11.1) 372 (9.7) 415 (11.1)
Hypertension 253 (8.5) 453 (13.5) 334 (10.7)
Clinical prevalence, n (%)
Diabetes mellitus 351 (6.9) 447 (8.7) 542 (10.6) 634 (12.4)
a Incidence rates refer to the approximately 2 years since the previous survey wave or have been adjusted for 2 years.
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research question 2: what characteristics are shared by people aged ≥ 50 years who received or did not
receive specific items of recommended NHS or non-NHS care for cardiovascular disease, depression,
diabetes and osteoarthritis in a national population-based study followed up for 6 years? A detailed
breakdown of the whole ELSA sample by covariate and wave is given in Appendix 5.
Time varying covariates
Some covariates were expected to change over time, but in fact the changes we found in the data were
generally small. The greatest change in the number of participants reporting potentially time-varying
covariates was seen in cognitive impairment, which was reported by over twice as many participants in
wave 5 as in wave 2 (Table 14). This was explored further in the regression models, which found that the
only condition in which cognitive impairment was associated with quality was diabetes (see Associations
between quality of care and patient characteristics and Table 16). Only 5.8% more participants with
diabetes also had cognitive impairment in wave 5 than did those in wave 2.
TABLE 14 Changes in time-varying covariates between wave 2 and wave 5 in the longitudinal data set (n= 5114)
Covariate
Wave 2
(n unless % stated)
Wave 5
(n unless % stated)
Change
(n unless % stated)
Cognitively impaired 256 557 + 301
Cognitively impaired and diabetes 29 89 + 60
Cognitively impaired as percentage of
participants with diabetes
8.2% 14.0% 5.8%
Mean number of ADLs
1 472 558 + 86
2 186 237 + 51
3 95 111 + 16
4 56 67 + 11
5 34 50 + 24
6 11 12 + 1
Mean number of IADLs
1 537 518 – 19
2 218 189 – 29
3 90 68 – 22
4 38 32 – 6
5 17 24 + 7
6 4 5 + 1
7 4 6 + 2
MAP > 110mmHg 458 372 – 86a
HbA1c ≥ 7.5% DCCT values 89 132 + 43a
BMI
Normal/underweight 1231 1159 – 72a
Overweight 2033 1931 – 102a
Obese 1328 1405 + 77a
MAP, mean arterial pressure.
a p≤ 0.05 paired samples t-test.
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Quality indicator achievement in the entire data set of 16,773 participants is reported earlier in this results
chapter (see Tables 10 and 11). Here, we report quality indicator achievement in the smaller longitudinal
data set of 5114 participants who were used for regression modelling, before going on to give the
regression results. Quality achievement for this data set was very similar to that for the entire data set.
Receipt of indicated care in 2010–11 varied substantially and ranged from 89% (95% CI 85% to 92%)
for CVD to 34% (95% CI 32% to 36%) for osteoarthritis (Table 15). As a further check that the data sets
were similar, we compared the overall quality indicators achievement in both data sets. Overall, quality
indicator achievement dropped slightly from 59% (95% CI 57% to 61%) in 2004–5 to 54% (95% CI
53% to 55%) in 2010–11 (p< 0.001), giving a drop of 3.4% for the core longitudinal sample of
5114 participants. This compared with an overall 3.7% drop in achievement of quality indicators using the
16,773 participants who had been interviewed at any wave of ELSA.
Associations between quality of care and patient characteristics
We found few statistically significant associations between quality of care and most participant
characteristics (Table 16 and Figure 1). This analysis was conducted as described in Chapter 2 (see Statistical
methods andModelling for longitudinal quality of care). For each condition, univariate models tested each of
the covariates listed in Table 7 for association with quality indicator achievement at the 5% level of statistical
significance. For all covariates that were associated at the 5% level for each condition, we ran a multivariate
model that also included age and sex (see Table 16).
We found univariate associations between CVD and wealth, BMI and CASP-19. In the multivariate model
only increased wealth was associated with poorer care for CVD. Hypertension care was associated in the
univariate analyses with age, BMI and mean arterial blood pressure. In the final multivariate model only
increasing age was associated with better care for hypertension. IHD care showed univariate associations
with age, cognitive impairment, physical activity level, mean arterial blood pressure and cohabiting status,
and in the final multivariate regression model, only cohabiting status and increased age were significantly
associated with quality of care.
Diabetes care was associated with socioeconomic classification, wealth, cognitive impairment, physical
activity and cohabiting status in the univariate analyses. In the multivariate model, only being cognitively
impaired and living alone were associated with quality of care for diabetes.
TABLE 15 Quality indicator achievement in the longitudinal data set (n= 5114)
Condition
Wave 2 Wave 3 Wave 4 Wave 5
n pass/n
eligible % (95% CI)
n pass/n
eligible % (95% CI)
n pass/n
eligible % (95% CI)
n pass/n
eligible % (95% CI)
CVD 61/73 83.6
(74.9 to 92.2)
160/205 78.0
(72.3 to 83.8)
208/248 83.9
(79.3 to 88.5)
264/298 88.6
(85.0 to 92.2)
Depression 105/157 67.5
(60.4 to 74.6)
73/118 61.9
(52.7 to 71.0)
Diabetes 935/1245 76.3
(73.7 to 79.0)
1081/1428 77.5
(75.0 to 80.0)
1273/1732 75.2
(72.9 to 77.6)
1541/2048 76.6
(74.6 to 78.7)
Hypertension 222/320 69.4
(64.3 to 74.5)
219/324 67.6
(62.5 to 72.7)
169/247 68.4
(62.6 to 74.3)
208/268 77.6
(72.6 to 82.6)
IHD 321/375 77.7
(72.2 to 83.1)
701/820 81.4
(78.4 to 84.4)
Osteoarthritis 229/780 29.4
(25.8 to 32.9)
512/1989 22.4
(20.4 to 24.3)
788/2508 28.3
(26.3 to 30.2)
1091/2986 33.6
(31.7 to 35.5)
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TABLE 16 Participant baseline characteristics significantly associated with longitudinal achievement of quality
indicators, multivariate logistic regression adjusted for weighted data
Conditiona Characteristic % quality indicator achievement OR (95% CI)
CVD Wealth
Quintile 1 (poorest) 92 1.0
Quintile 2 84 0.4 (0.1 to 1.1)
Quintile 3 84 0.4 (0.1 to 1.0)
Quintile 4 69 0.2 (0.1 to 0.5)
Quintile 5 (richest) 87 0.5 (0.2 to 1.3)
Diabetes Cognitive impairment
No 77 1.0
Yes 63 0.5 (0.4 to 0.7)
Cohabiting
Lives with partner 69 1.0
Lives alone 79 1.7 (1.3 to 2.0)
Hypertension Age (years)
50–64 61 1.0
65–74 79 2.2 (1.6 to 3.1)
75+ 86 3.2 (2.0 to 5.3)
IHD Age (years)
50–64 89 1.0
65–74 87 1.0 (0.6 to 1.6)
75+ 79 0.5 (0.3 to 0.8)
Cohabiting
Lives with partner 81 1.0
Lives alone 88 1.8 (1.3 to 2.5)
Osteoarthritis Pain
Mild 30 1.0
Moderate 30 1.0 (0.8 to 1.2)
Severe 42 1.8 (1.4 to 2.2)
Limiting Illness
No 26 1.0
Yes 37 1.8 (1.5 to 2.1)
BMI
Under-/normal weight (< 25 kg/m2) 26 1.0
Overweight (25 to 30 kg/m2) 29 1.2 (0.9 to 1.5)
Obese (> 30 kg/m2) 37 1.6 (1.2 to 2.0)
a Covariates associated with quality of care that were included in the multivariate analyses with age and sex for the five
diseases were for CVD: wealth, BMI and CASP-19; for diabetes: socioeconomic status (NS-SEC), wealth, cognitive
impairment, physical activity level and cohabiting status; for hypertension: BMI and mean arterial pressure; for ischaemic
heart disease: cognitive impairment, physical activity level, mean arterial presure and cohabiting status; and for
osteoarthritis: pain, BMI, limiting illness, ADL, IADL, frequency of alcohol intake, physical activity level, CASP and
cohabiting status.
Only those variables that were statistically significant at the 5% level are listed.
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Osteoarthritis care was associated with age, pain, BMI, limiting illness, ADL, IADL, frequency of alcohol
consumption, physical activity level, CASP and cohabiting status at the univariate 5% level, but only
obesity, limiting illness and pain remained significantly associated with better quality of care for
osteoarthritis in the multivariate model.
We did not model depression as the relatively small number of participants with depression in the
longitudinal data set (see Table 15) led to very small numbers of participants with depression and specific
covariates. Instead, we included depression as a covariate in the regression models for the other condition,
and, notably, depression was not associated with worse quality of care. The full results from the
multivariate regression models, including statistically non-significant results, are reported in Appendix 6.
Demographics for the diabetes care bundle
The sample for modelling associations between participant characteristics and achievement of the diabetes
care bundle consisted of ELSA core members at wave 5 who had also responded at wave 4 (n= 8222).
At wave 5, 907 (11.0%) of this sample had diabetes and were eligible for at least one quality indicator in
the diabetes care bundle and 759 (9.2%) had diabetes with additional cardiac risk factors and were
eligible for the diabetes ACE inhibitor quality indicator. Participants in these two groups tended to
comprise more males than the whole sample, had more respondents in the 75-and-older age group and
fewer in the youngest group, were more likely to be from the lowest socioeconomic classification and had
a greater proportion with no educational qualification (Table 17).
Logistic regression models for the diabetes care bundle
Participant characteristics were modelled on subsequent non-receipt of care two years later. The key
predictor of non-receipt of care for the diabetes care bundle was non-receipt 2 years earlier, which more
than trebled the odds of subsequent non-receipt of the care bundle (OR 3.26, 95% CI 2.24 to 4.74;
p< 0.001) and increased the odds nearly sevenfold for the diabetes ACE inhibitor quality indicator for
diabetes with other cardiac risk factors (OR 6.94, 95% CI 4.54 to 10.60; p< 0.001) (Table 18). Besides
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and logistic regression ORs. OA, osteoarthritis; Q, quintile.
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TABLE 17 Participant characteristics in the sample for the diabetes care bundle modelling
Covariate
Whole sample
(n= 8222), n (%)
Care bundle
(n= 907), n (%)
Diabetes ACE inhibitor
(n= 759), n (%)
Sex
Female 4561 (55.5) 425 (46.8) 363 (47.8)
Male 3661 (44.5) 483 (53.2) 396 (52.2)
Age (years)
50–64 4250 (51.7) 369 (40.7) 306 (40.3)
65–74 2533 (30.8) 316 (34.8) 274 (36.10)
75+ 1439 (17.5) 222 (24.5) 179 (23.58)
NS-SEC
Managerial/professional 2827 (34.4) 249 (27.5) 207 (27.3)
Intermediate 2085 (25.4) 208 (22.9) 173 (22.8)
Routine 3193 (38.8) 432 (47.6) 364 (48.0)
Missing 117 (1.4) 18 (2.0) 15 (2.0)
Previous carea
Achieved – 496 (54.7) 342 (45.1)
Not achieved – 225 (24.8) 240 (31.6)
New case – 175 (19.3) 144 (19.0)
Missing – 11 (1.2) 33 (4.4)
Eyesight
Good to excellent 7227 (87.9) 726 (80.0) 602 (79.3)
Fair to blind 995 (12.1) 181 (20.0) 157 (20.7)
Hearing
Good to excellent 6610 (80.4) 673 (74.2) 563 (74.2)
Fair to poor 1612 (19.6) 234 (25.8) 196 (25.8)
Chronic pain
None/mild 5893 (71.7) 545 (60.1) 438 (57.7)
Moderate/severe 2278 (27.7) 354 (39.0) 315 (41.5)
Has long-standing illness
No 3761 (45.7) 121 (13.4) 100 (13.2)
Yes 1725 (21.0) 318 (35.0) 253 (33.3)
Yes – limiting 2735 (33.3) 468 (51.5) 406 (53.5)
Difficulties with basic ADL
None/one 7588 (92.3) 783 (86.3) 651 (85.8)
Two or more 634 (7.7) 124 (13.7) 108 (14.2)
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TABLE 17 Participant characteristics in the sample for the diabetes care bundle modelling (continued )
Covariate
Whole sample
(n= 8222), n (%)
Care bundle
(n= 907), n (%)
Diabetes ACE inhibitor
(n= 759), n (%)
ADL
None/one 7560 (92.0) 773 (85.2) 649 (85.5)
Two or more 662 (8.1) 134 (14.8) 110 (14.5)
Cognitive impairment
No 6757 (82.2) 699 (77.0) 593 (78.1)
Yes 634 (7.7) 115 (12.7) 96 (12.7)
Missing 831 (10.1) 93 (10.4) 70 (9.2)
Health literacy
High 5798 (70.5) 548 (60.4) 470 (61.9)
Low 2069 (25.2) 278 (30.7) 227 (29.9)
Missing 355 (4.3) 81 (8.9) 62 (8.2)
Time since diagnosisb
Wave 5 (new case) – 165 (18.2) 134 (17.7)
Wave 4 – 216 (23.8) 176 (23.2)
Wave 3 – 154 (17.0) 126 (16.6)
Wave 2 – 371 (40.9) 371 (40.9)
Alcohol consumption
1–2 times/week or less 4538 (55.2) 579 (63.8) 498 (65.6)
3–4 times/week or more 2670 (32.5) 178 (19.6) 148 (19.5)
Missing 1014 (12.3) 150 (16.5) 113 (14.9)
Physical activity level
Moderate/high 5907 (71.8) 499 (55.0) 406 (53.5)
Sedentary/low 2314 (28.1) 407 (44.8) 353 (46.5)
Smoking status
Never 3258 (39.6) 304 (33.5) 251 (33.1)
In past 3828 (46.6) 478 (52.7) 394 (51.9)
Current smoker 1108 (13.5) 123 (13.6) 113 (14.9)
Diet
Eats ‘5-a-day’ 3113 (37.9) 320 (35.3) 267 (35.2)
Does not eat ‘5-a-day’ 2393 (29.1) 259 (28.6) 229 (30.2)
Missing 2716 (33.0) 328 (36.2) 263 (34.7)
continued
DOI: 10.3310/hsdr03110 HEALTH SERVICES AND DELIVERY RESEARCH 2015 VOL. 3 NO. 11
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Hardcastle et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
41
TABLE 17 Participant characteristics in the sample for the diabetes care bundle modelling (continued )
Covariate
Whole sample
(n= 8222), n (%)
Care bundle
(n= 907), n (%)
Diabetes ACE inhibitor
(n= 759), n (%)
Knows mostly everything about managing diabetes
Yes – 604 (66.6) 505 (66.5)
No – 123 (13.6) 109 (14.4)
Missing – 180 (19.9) 145 (19.1)
Married/civil partnership
Yes 5456 (66.4) 558 (61.5) 460 (60.6)
No 2765 (33.6) 348 (38.4) 299 (39.4)
Social detachment
Not detached 5631 (68.5) 523 (57.7) 432 (56.9)
Detached 961 (11.7) 142 (15.7) 125 (16.5)
Missing 1630 (19.8) 242 (26.7) 202 (26.6)
Quality of life (CASP-19)
High 2116 (25.7) 150 (16.5) 109 (14.4)
Mid 2534 (30.8) 252 (27.8) 216 (28.5)
Low 2351 (28.6) 328 (36.2) 295 (38.9)
Missing 1221 (14.9) 177 (19.5) 139 (18.3)
Locus of control
Internal 1659 (20.2) 134 (14.8) 108 (14.2)
External 5545 (67.4) 618 (68.1) 532 (70.1)
Missing 1018 (12.4) 155 (17.1) 119 (15.7)
CES-D depression classification
Not depressed 6970 (84.8) 708 (78.1) 579 (76.3)
Depressed 1132 (13.8) 179 (19.7) 163 (21.5)
Missing 120 (1.5) 20 (2.2) 17 (2.2)
Lives alone
No 2773 (33.7) 252 (27.8) 215 (28.3)
Yes 5140 (62.5) 618 (68.1) 512 (67.5)
Missing 309 (3.8) 37 (4.1) 32 (4.2)
a Previous care was assessed in wave 4.
b Time since diagnosis is measured in waves since the diagnosis was reported in ELSA and was entered into models as an
ordinal variable.
Model n: care bundle= 903; ACE inhibitor quality indicator= 757. Some cases were lost owing to missing values. The
reference category of each covariate is listed first. Frequency of missing data is not reported if these account for < 1%
of cases.
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TABLE 18 Associations between baseline characteristics and subsequent non-receipt of diabetes care 2 years later:
logistic regression
Covariate Care bundle, OR (95% CI) Diabetes ACE inhibitor, OR (95% CI)
Sex
Female 1.0 (–) 1.0 (–)
Male 1.14 (0.76 to 1.70) 1.11 (0.73 to 1.70)
Age group, years (trend)a 1.19 (0.95 to 1.49) 0.77 (0.60 to 1.00)b
50–64 1.0 (–) 1.0 (–)
65–74 1.26 (0.86 to 1.86) 0.91 (0.61 to 1.37)
75+ 1.40 (0.89 to 2.22) 0.57 (0.34 to 0.97)b
Previous carec
Achieved 1.0 (–) 1.0 (–)
Not achieved 3.26 (2.24 to 4.74)d 6.94 (4.54 to 10.60)d
New case 1.16 (0.35 to 3.81) 2.23 (0.66 to 7.49)
Missing – 2.17 (0.92 to 5.11)
NS–SEC (trend)a 1.24 (1.01 to 1.51)b 1.17 (0.94 to 1.45)
Managerial/professional 1.0 (–) 1.0 (–)
Intermediate 0.88 (0.55 to 1.41) 1.14 (0.68 to 1.91)
Routine/manual 1.41 (0.95 to 2.10) 1.36 (0.89 to 2.10)
Missing 1.41 (0.45 to 4.47) 1.53 (0.47 to 5.06)
Eyesight
Excellent/good 1.0 (–) 1.0 (–)
Fair/blind 0.96 (0.63 to 1.46) 1.03 (0.65 to 1.63)
Has long-standing illness (trend)a 0.96 (0.76 to 1.21) 1.04 (0.80 to 1.36)
No 1.0 (–) 1.0 (–)
Yes 0.96 (0.56 to 1.63) 0.96 (0.53 to 1.74)
Yes to limiting 0.91 (0.55 to 1.51) 1.06 (0.61 to 1.84)
Cognitively impaired
No 1.0 (–) 1.0 (–)
Yes 1.78 (1.09 to 2.89)b 1.63 (0.90 to 2.97)
Missing 1.59 (0.93 to 2.73) 1.04 (0.52 to 2.08)
Health literacy
High 1.0 (–) 1.0 (–)
Low 1.10 (0.77 to 1.57) 1.51 (1.01 to 2.26)b
Missing 0.93 (0.50 to 1.72) 2.46 (1.22 to 4.99)b
Time since diagnosis (waves) 1.04 (0.84 to 1.30) 0.99 (0.79 to 1.25)
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TABLE 18 Associations between baseline characteristics and subsequent non-receipt of diabetes care 2 years later:
logistic regression (continued )
Covariate Care bundle, OR (95% CI) Diabetes ACE inhibitor, OR (95% CI)
Knows everything about managing diabetes
Yes 1.0 (–) 1.0 (–)
No 2.03 (1.28 to 3.22)e 1.32 (0.77 to 2.26)
Missing 3.40 (1.16 to 9.94)b 2.46 (0.79 to 7.66)
BMI category (trend)a 0.97 (0.75 to 1.25) 0.70 (0.53 to 0.92)b
Under-/normal weight 1.0 (–) 1.0 (–)
Overweight 1.06 (0.59 to 1.91) 0.71 (0.37 to 1.37)
Obese 0.98 (0.55 to 1.73) 0.49 (0.26 to 0.90)b
Missing 0.88 (0.45 to 1.72) 0.64 (0.31 to 1.33)
Married/in civil partnership
Yes 1.0 (–) 1.0 (–)
No 1.09 (0.73 to 1.63) 2.17 (1.40 to 3.38)d
CES–D depression classification
No 1.0 (–) 1.0 (–)
Yes 0.92 (0.61 to 1.40) 0.98 (0.62 to 1.55)
Missing 0.68 (0.24 to 1.93) 2.96 (0.84 to 10.47)
Lives alone
No 1.0 (–) 1.0 (–)
Yes 0.75 (0.48 to 1.19) 0.96 (0.59 to 1.55)
Missing 0.66 (0.28 to 1.55) 0.78 (0.29 to 2.07)
Log-likelihood –519.22 –424.94
Wald χ2 86.54 134.17
p-value 0.000 0.000
Pseudo R2 0.103 0.198
n 903 757
a Linear trends were performed for appropriate covariates, which are displayed on the same line as the covariate name
followed by ‘(trend)’.
b p< 0.05.
c ’Previous care’ was assessed at wave 4 (2 years prior to the outcome).
d p< 0.001.
e p< 0.01.
All outcomes adjusted for age and sex, and weighted for differential non-response at wave 5. The reference category for
each covariate is the first category listed and has an OR of 1.0. An OR > 1.0 represents increased odds of subsequent
non-receipt of care, whereas an OR of < 1.0 indicates reduced odds of this.
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previous care, the two models diverged in their significant predictors. Respondents classified as cognitively
impaired had 78% increased odds of non-receipt of the care bundle (OR 1.78, 95% CI 1.09 to 2.89;
p= 0.021). Those who did not feel they knew at least most of what they needed to know about
managing their diabetes had double the odds of not receiving all three of the annual checks included in
the bundle (OR 2.03, 95% CI 1.28 to 3.22; p= 0.003), but knowledge of diabetes management was not
significantly associated with not being offered an ACE inhibitor (OR 1.32, 95% CI 0.77 to 2.26; p= 0.31).
On the other hand, patients with low health literacy had 50% higher odds for non-receipt of ACE inhibitor
(OR 1.51, 95% CI 1.01 to 2.26; p= 0.043) than those with high health literacy, with no significant
difference apparent for the care bundle. The odds of not being offered an ACE inhibitor were decreased in
the oldest age group (OR 0.57, 95% CI 0.34 to 0.97; p= 0.038) and in those categorised as obese (OR
0.49, 95% CI 0.26 to 0.90; p= 0.021), but were increased over twofold for those not married or in a civil
partnership (OR 2.17, 95% CI 1.40 to 3.38; p< 0.001).
Sensitivity analyses for missing data
Sensitivity analyses were conducted to determine whether or not using multiple imputation of missing data
would alter the final results for non-receipt of the diabetes care bundle and the ACE inhibitor/receptor
blocker quality indicator (Table 19). The results from the model using multiple imputation were remarkably
similar to the original models for both the care bundle and the ACE inhibitor quality indicator. A small
number of differences were evident. For the model assessing non-receipt of the ACE inhibitor quality
indicator, the difference found between those aged ≥ 75 years and those aged 50–64 years was no longer
TABLE 19 Comparison of logistic regression models predicting non-receipt of the diabetes care bundle, with and
without multiple imputation of missing data
Covariate
Missing data as a category,
OR (95% CI)
Multiple imputation of missing data,
OR (95% CI)
Sex
Female 1.0 (–) 1.0 (–)
Male 1.14 (0.76 to 1.70) 1.16 (0.78 to 1.72)
Age (years)
50–64 1.0 (–) 1.0 (–)
65–74 1.26 (0.86 to 1.86) 1.21 (0.83 to 1.78)
75+ 1.40 (0.89 to 2.22) 1.37 (0.86 to 2.17)
Previous care
Complete 1.0 (–) 1.0 (–)
Incomplete 3.26 (2.24 to 4.74)a 3.16 (2.17 to 4.61)a
New case 1.16 (0.35 to 3.81) 2.80 (1.47 to 5.31)b
NS-SEC
Managerial/professional 1.0 (–) 1.0 (–)
Intermediate 0.88 (0.55 to 1.41) 0.87 (0.53 to 1.43)
Routine/manual 1.41 (0.95 to 2.10) 1.37 (0.90 to 2.08)
Missing 1.41 (0.45 to 4.47) –
Eyesight
Excellent/good 1.0 (–) 1.0 (–)
Fair/blind 0.96 (0.63 to 1.46) 0.95 (0.63 to 1.43)
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TABLE 19 Comparison of logistic regression models predicting non-receipt of the diabetes care bundle, with and
without multiple imputation of missing data (continued )
Covariate
Missing data as a category,
OR (95% CI)
Multiple imputation of missing data,
OR (95% CI)
Has long-standing illness
No 1.0 (–) 1.0 (–)
Yes 0.96 (0.56 to 1.63) 0.93 (0.55 to 1.57)
Yes to limiting 0.91 (0.55 to 1.51) 0.90 (0.54 to 1.48)
Cognitively impaired
No 1.0 (–) 1.0 (–)
Yes 1.78 (1.09 to 2.89)c 1.78 (1.12 to 2.88)c
Missing 1.59 (0.93 to 2.73) –
Health literacy
High 1.0 (–) 1.0 (–)
Low 1.10 (0.77 to 1.57) 1.11 (0.77 to 1.62)
Missing 0.93 (0.50 to 1.72) –
Time since diagnosis (waves) 1.04 (0.84 to 1.30) 1.01 (0.81 to 1.25)
Knows everything about managing diabetes
Yes 1.0 (–) 1.0 (–)
No 2.03 (1.28 to 3.22)b 1.98 (1.25 to 3.13)c
Missing 3.40 (1.16 to 9.94)c –
BMI category
Under-/normal weight 1.0 (–) 1.0 (–)
Overweight 1.06 (0.59 to 1.91) 1.00 (0.55 to 1.82)
Obese 0.98 (0.55 to 1.73) 0.93 (0.52 to 1.65)
Missing 0.88 (0.45 to 1.72) –
Married/in civil partnership
Yes 1.0 (–) 1.0 (–)
No 1.09 (0.73 to 1.63) 1.06 (0.72 to 1.58)
CES–D depression classification
No 1.0 (–) 1.0 (–)
Yes 0.92 (0.61 to 1.40) 0.90 (0.59 to 1.36)
Missing 0.68 (0.24 to 1.93) –
Lives alone
No 1.0 (–) 1.0 (–)
Yes 0.75 (0.48 to 1.19) 0.73 (0.46 to 1.16)
Missing 0.66 (0.28 to 1.55) –
a p< 0.001.
b p< 0.01.
c p< 0.05.
All outcomes adjusted for age and sex, and weighted for differential non-response at wave 5. The reference category for
each covariate is the first category listed and has an OR of 1.0. An OR > 1.0 represents increased odds of subsequent
non-receipt of care, whereas an OR of < 1.0 indicates reduced odds of this.
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significant, though the ORs and CIs were very similar. Cognitive impairment became significant (p< 0.05)
in this model when using multiple imputation. The biggest difference between the two methods was
apparent for the ‘new case’ category in the ‘previous care’ covariate, that is those reporting a diagnosis of
diabetes only at the latest wave (2010–11). These participants were found to be at greatly increased odds
of not receiving the care bundle and/or the ACE inhibitor quality indicator in the models using multiple
imputation. However, it should be noted that, as we cannot tell at what point between the two waves
these participants were told they had diabetes, it is inappropriate to draw conclusions on their likelihood of
not receiving care. It may be the case that they have not had the diagnosis for sufficiently long to have the
opportunity to receive a complete care cycle. Thus, we feel that it is sensible to treat the ‘new case’
category as if it were a special kind of ‘missing data’ in its own right.
Population distribution of illness burden, diagnosis
and treatment
Demographics
The sample of participants aged 50 years or over who had responded to at least one wave of ELSA from
wave 2 in 2004–5 until wave 5 in 2010–11 and were core members was used to address research
question 3: are factors such as wealth, or patient education, physical activity, obesity, coexisting other
chronic conditions or practical factors such as good eyesight or marital status independently associated
with the quality of health care received, from symptoms to diagnosis and, finally, to treatment?
There were 12,765 core members in the sample, and 8729 in wave 5, of whom slightly over half were
women, and slightly over half were aged ≥ 60 years (Table 20). Diagnosed diabetes, angina and
osteoarthritis were more prevalent with increasing age, but the opposite trend was seen with depression,
with 10% of the youngest age group reporting a diagnosis compared with only 3% in the oldest age
group. The highest prevalence of all conditions was seen in the poorest quintile. For example, the
prevalence of depression was 4% in the wealthiest quintile and 11% in the least wealthy.
TABLE 20 Characteristics of ELSA participants at wave 5 (2010–11) and self-reported medical diagnosis of the
diagnosed conditions
Characteristics n Angina, % Depression, % Diabetes, % Osteoarthritis, %
Sex
Male 3886 8.2 5.4 13.3 19.8
Female 4843 6.3 7.8 9.4 32.9
Age (years)
50–59 1906 2.2 10.1 7.2 17.1
60–74 4766 5.8 7.0 11.0 28.1
75+ 2057 15.0 2.9 15.0 34.1
Wealth quintile
1 (wealthiest) 1716 3.4 4.1 6.0 21.5
2 1714 4.9 5.9 8.0 24.2
3 1723 6.6 5.7 11.3 25.7
4 1716 8.2 6.7 13.6 31.6
5 (poorest) 1715 12.9 11.5 16.7 33.1
Missing 145 5.5 4.8 9.7 20.0
Total 8729 7.2 6.7 11.1 27.1
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There was very little variation in the prevalence of illness burden, diagnosis and treatment between the
waves for each of the four conditions (Table 21).
Modelling with illness burden, diagnosis and treatment
The hypothetically poorest participant had higher odds of illness burden than the hypothetically richest for
each of the four conditions at all four time points (ORs ranging from 3.9 to 16.0) (Table 22). The odds
were generally smaller for diagnosis (ORs 0.6 to 5.3) and appropriate treatment (ORs 0.2 to 3.3). The
substantially higher illness burden in less wealthy participants was not matched by higher levels of
diagnosis and treatment (Figure 2).
For angina, the overall OR for meeting the criteria for illness burden was 7.6, indicating that the
hypothetically least wealthy individual was almost eight times more likely to have angina symptoms
(defined by the Rose Angina Scale) than the wealthiest. The OR for reported medical diagnosis was 4.5,
suggesting that some less wealthy people with angina symptoms had not received a diagnosis of angina,
as the expected OR for equitably distributed diagnosis would be 7.6. The OR for treatment was 3.2, and
again the expected OR for equitably distributed treatment would have been around 8.
For depression, the overall OR for illness burden was 6.4, while for medical diagnosis it was 3.3 and for
treatment it was 2.6, again suggesting that some poorer people with illness burden of depression were
less likely to have received a diagnosis or indicated health care.
For diabetes, the overall ORs for illness burden were 4.2 and 4.0 for diagnosis, suggesting that diabetes
diagnosis was distributed equitably. However, the OR for treatment was 0.9 and not statistically different
from 1, again suggesting that some less wealthy people with medically diagnosed diabetes had not
received treatment, as the expected OR for equitably distributed treatment would have been around 4.
TABLE 21 Prevalence of illness burden, self-reported medical diagnosis and treatment for angina, cataract,
depression, diabetes and osteoarthritis in four waves of ELSA
Wave Angina, n (%) Depression, n (%) Diabetes, n (%) Osteoarthritis, n (%)
Illness burden
Wave 2 (2004–5) 397 (4.6) 2037 (23.4) 160 (1.8) 1106 (12.7)
Wave 3 (2006–7) 300 (3.6) 1929 (23.3) N/A 917 (11.1)
Wave 4 (2008–9) 300 (3.1) 2049 (21.4) 220 (2.3) 1088 (11.4)
Wave 5 (2010–11) 254 (2.9) 1956 (22.4) N/A 1046 (12.0)
Medical diagnosis
Wave 2 668 (7.6) 402 (4.6) 715 (8.2) 1861 (21.4)
Wave 3 591 (7.1) 490 (5.9) 935 (11.3) 1952 (23.6)
Wave 4 645 (6.7) 601 (6.3) 1215 (12.7) 2262 (23.6)
Wave 5 655 (7.5) 602 (6.9) 1413 (16.2) 2416 (27.7)
Treatment
Wave 2 85 (1.0) 98 (1.1) 552 (6.4) 202 (2.3)
Wave 3 N/A N/A 618 (7.5) 141 (1.7)
Wave 4 N/A 155 (1.6) 671 (7.0) 226 (2.4)
Wave 5 88 (1.0) N/A 748 (8.6) 208 (2.4)
N/A, data not available.
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We also calculated the ORs of receiving a diagnosis in a subsequent wave, only for those who were
estimated to have had the relevant long-term condition in a previous wave, and then the likelihood of
receiving treatment, only for those who had received a medical diagnosis in a previous wave. This is a
secondary analysis as the numbers of participants that could be followed over time in this manner was
small, particularly for treatment in angina and depression, and so these results should be interpreted with
great caution. The substantial inequalities in the estimated prevalence of conditions by wealth are similar
to Table 23, as expected, and subsequently the numbers are too small for the results to be statistically
significant. The general pattern, however, is consistent with less medical diagnosis and treatment in less
wealthy participants. Taking osteoarthritis as an example, ORs were 12.7 (95% CI 9.1 to 17.8) for
estimated prevalence in wave 3, 0.7 (95% CI 0.3 to 1.8) for diagnosis in wave 4 and 0.7 (95% CI 0.3 to
1.6) for treatment in wave 5 (Table 23).
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FIGURE 2 Illness burden, medical diagnosis and treatment of angina, depression, diabetes and osteoarthritis,
comparing the least wealthy with the most wealthy: overall ORs (adjusted for age and sex) and 95% confidence
bars (logistic regression).
TABLE 23 Odds ratios for meeting the ‘illness burden’ criteria for angina, depression, diabetes and osteoarthritis;
receiving a medical diagnosis for those who previously met the ‘illness burden’ criteria; and receiving treatment for
those with a previous diagnosis, comparing the least wealthy with the most wealthy: logistic regressiona
Condition
ORa (95% CI)
n receiving
treatmentb
Illness burden
(wave 3)
Medical diagnosis
(wave 4)
Treatment
(wave 5)
Angina 8.7 (5.5 to 13.8) 1.4 (0.5 to 4.0) 1.6 (0.3 to 9.0) 11
Osteoarthritis 12.7 (9.1 to 17.8) 0.7 (0.3 to 1.8) 0.7 (0.3 to 1.6) 30
Illness burden
(wave 2)
Medical diagnosis
(wave 3)
Treatment
(wave 4)
Depression 5.1 (4.3 to 6.2) 0.4 (0.1 to 1.4) 17.3 (0.5 to 604) 12
Diabetes 4.4 (2.5 to 8.0) 0.1 (0.0 to 3.6) 0.5 (0.2 to 1.1) 99
a Adjusted for age group and sex.
b Followed through the waves.
Waves used in analysis were the most recent with available data.
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Modelling with illness burden, diagnosis and treatment: additional covariates
The regression models immediately above for comparing the distribution by wealth of illness burden,
diagnosis and treatment, respectively (see previous section), were adjusted for age, sex and slope index of
inequality only. This section reports the results when additional covariates were added to the models above
and the results when one more covariate at a time was added to the models, which are presented
separately for illness burden (see Table 24), diagnosis (see Table 25) and treatment (see Table 26).
Illness burden
Table 24 presents the results for illness burden.
Having two or more comorbidities is associated with having increased odds of having angina illness burden
[OR 7.5 (95% CI 6.0 to 9.4)]; there is a smaller, but still significant effect for the other diseases. Having
poorer eyesight was also associated with increasing odds of having illness burden of all four diseases, with
ORs ranging from 2.5 (95% CI 1.5 to 4.1) for diabetes to 3.9 (95% CI 3.0 to 5.0) for osteoarthritis.
Difficulty in accessing a GP was also associated with increasing odds for having illness burden for all four
diseases [osteoarthritis OR 6.9 (95% CI 5.5 to 8.9)]. Looking at BMI, there was an increment in odds of
having illness burden the more the BMI increased for all the diseases, though the effect was lowest in
depression [overweight 0.9 (95% CI 0.8 to 1.0) and obese 1.2 (95% CI 1.1 to 1.4)].
TABLE 24 Associations between participant characteristics and illness burden for angina, depression, diabetes and
osteoarthritis: logistic regression, adjusted for age, sex and slope index of inequality
Covariate added to the age, sex and
slope index of inequality model
Angina,
OR (95% CI)
Depression,
OR (95% CI)
Diabetes,
OR (95% CI)
Osteoarthritis,
OR (95% CI)
Highest educational qualification vs. none
Degree or higher education 0.6 (0.5 to 0.8) 0.7 (0.7 to 0.8) 0.7 (0.5 to 1.0) 0.6 (0.5 to 0.7)
Physical activity level vs. sedentary
High 0.3 (0.2 to 0.5) 0.2 (0.2 to 0.3) 0.3 (0.2 to 0.5) 0.07 (0.05 to 0.09)
Comorbidities vs. none or one
Two or more 7.5 (6.0 to 9.4) 2.0 (1.8 to 2.2) 2.0 (1.5 to 2.6) 3.1 (2.7 to 3.5)
Eyesight vs. excellent
Fair/poor/blind 2.8 (2.1 to 4.0) 3.3 (2.8 to 4.0) 2.5 (1.5 to 4.1) 3.9 (3.0 to 5.0)
Cohabiting
vs. living alone 0.9 (0.8 to 1.1) 0.6 (0.5 to 0.6) 0.9 (0.7 to 1.2) 1.0 (0.9 to 1.2)
Access to GP
Difficult/impossible vs. very easy 2.4 (1.8 to 3.2) 4.3 (3.5 to 5.4) 1.5 (0.9 to 2.4) 6.9 (5.5 to 8.9)
Health literacy vs. literate
Health illiterate 0.8 (0.7 to 1.0) 0.7 (0.6 to 0.8) 0.8 (0.6 to 1.1) 0.7 (0.6 to 0.9)
BMI vs. normal/underweight
Overweight 1.5 (1.2 to 2.0) 0.9 (0.8 to 1.0) 1.7 (1.1 to 2.7) 1.4 (1.2 to 1.8)
Obese 2.3 (1.8 to 3.0) 1.2 (1.1 to 1.4) 4.0 (2.6 to 6.1) 3.7 (3.0 to 4.6)
DOI: 10.3310/hsdr03110 HEALTH SERVICES AND DELIVERY RESEARCH 2015 VOL. 3 NO. 11
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Hardcastle et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
51
Diagnosis
Very similar findings were seen in the adjusted diagnosis model, where the odds of having diagnosis of
angina were 11-fold if you had two or more comorbidities. There was still a gradient seen in increasing
BMI and increasing odds of being diagnosed for all four conditions (Table 25).
Treatment
For the treatment model, having comorbidities was less associated with angina [OR 0.9 (95% CI 0.3 to
2.7)] than in the diagnosis or illness burden models. Being more physically active was associated with
increased odds of being treated for angina [OR medium physical activity 3.3 (95% CI 1.2 to 8.6); OR high
physical activity 6.5 (95% CI 1.1 to 37.1)]. Depression and osteoarthritis treatment was associated with
being overweight or obese, and the strongest predictor for diabetes treatment was high physical activity
and not living alone [OR 1.5 (95% CI 0.5 to 4.2) and OR 1.5 (95% CI 0.9 to 2.5)], respectively (Table 26).
TABLE 25 Associations between participant characteristics and diagnosis for angina, depression, diabetes and
osteoarthritis: logistic regression, adjusted for age, sex and slope index of inequality
Covariate added to the age,
sex and slope index of
inequality model
Angina,
adjusted OR
(95% CI)
Depression,
adjusted OR
(95% CI)
Diabetes,
adjusted OR
(95% CI)
Osteoarthritis,
adjusted OR
(95% CI)
Highest educational qualification vs. none
Degree or higher education 0.7 (0.6 to 0.9) 1.2 (0.9 to 1.4) 0.7 (0.6 to 0.9) 0.9 (0.8 to 1.1)
Physical activity level vs. sedentary
High 0.4 (0.3 to 0.5) 0.5 (0.3 to 0.6) 0.3 (0.2 to 0.4) 0.5 (0.4 to 0.6)
Comorbidities vs. none or one
Two or more 11.0 (8.8 to 13.8) 1.3 (1.1 to 1.5) 1.9 (1.7 to 2.2) 1.7 (1.5 to 1.9)
Eyesight vs. excellent
Fair/poor/blind 2.5 (1.9 to 3.3) 1.8 (1.4 to 2.5) 1.7 (1.3 to 2.2) 1.6 (1.3 to 2.0)
Cohabiting
vs. living alone 0.9 (0.8 to 1.1) 0.7 (0.6 to 0.8) 1.0 (0.9 to 1.2) 1.0 (0.9 to 1.2)
Access to GP
Difficult/impossible vs. very easy 1.8 (1.4 to 2.3) 1.9 (1.4 to 2.6) 2.0 (1.6 to 2.6) 2.0 (1.0 to 2.5)
Health literacy vs. literate
Health illiterate 1.3 (1.0 to 1.6) 1.1 (0.9 to 1.3) 0.9 (0.8 to 1.0) 1.0 (0.9 to 1.1)
BMI vs. normal/underweight
Overweight 1.2 (1.0 to 1.6) 0.9 (0.8 to 1.2) 1.7 (1.3 to 2.1) 1.3 (1.1 to 1.5)
Obese 1.6 (1.3 to 2.0) 1.6 (1.3 to 2.0) 4.0 (3.1 to 5.0) 1.8 (1.5 to 2.1)
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TABLE 26 Associations between participant characteristics and treatment for angina, depression, diabetes and
osteoarthritis: logistic regression, adjusted for age, sex and slope index of inequality
Covariate added to the age,
sex and slope index of
inequality model
Angina, OR
(95% CI) after
adjusting for age,
sex, slope index
Depression, OR
(95% CI) after
adjusting for age,
sex, slope index
Diabetes, OR
(95% CI) after
adjusting for age,
sex, slope index
Osteoarthritis, OR
(95% CI) after
adjusting for age,
sex, slope index
Highest educational qualification vs. none
Intermediate 2.6 (1.1 to 6.0) 1.1 (0.6 to 2.0) 0.9 (0.5 to 1.5) 0.9 (0.7 to 1.1)
Degree or higher education 2.1 (1.1 to 6.0) 0.9 (0.5 to 1.7) 1.2 (0.6 to 2.3) 0.9 (0.7 to 1.2)
Physical activity level vs. sedentary
Medium 3.3 (1.2 to 8.6) 0.6 (0.2 to 1.7) 1.2 (0.6 to 2.5) 0.7 (0.5 to 0.9)
High 6.5 (1.1 to 37.1) 0.5 (0.1 to 1.4) 1.5 (0.5 to 4.2) 0.5 (0.4 to 0.8)
Comorbidities vs. two or more
None or one 0.9 (0.3 to 2.7) 1.2 (0.7 to 2.0) 1.1 (0.7 to 1.7) 1.3 (1.1 to 1.6)
Eyesight vs. excellent
Fair/poor/blind 1.5 (0.4 to 5.3) 1.1 (0.5 to 2.7) 2.2 (0.8 to 5.8) 1.1 (0.8 to 1.6)
Cohabiting
vs. living alone 1.4 (0.7 to 3.0) 1.2 (0.7 to 2.0) 1.5 (0.9 to 2.5) 1.0 (0.8 to 1.3)
Access to GP
Easy vs. very easy 1.7 (0.6 to 4.3) 1.2 (0.7 to 2.0) 0.9 (0.5 to 1.5) 1.2 (1.0 to 1.5)
Difficult/impossible vs.
very easy
2.4 (0.8 to 7.2) 1.5 (0.5 to 4.4) 0.9 (0.4 to 2.1) 2.2 (1.6 to 3.0)
Health literacy
Health illiterate vs. literate 1.7 (0.8 to 2.1) 0.7 (0.4 to 1.4) 1.0 (0.6 to 1.6) 0.8 (0.7 to 1.0)
BMI
Overweight vs.
normal/underweight
0.7 (0.2 to 2.1) 1.8 (0.9 to 3.5) 0.8 (0.3 to 1.9) 2.0 (1.4 to 2.7)
Obese vs.
normal/underweight
0.4 (0.2 to 1.3) 1.8 (0.9 to 3.7) 1.0 (0.4 to 2.3) 3.8 (2.7 to 5.2)
Joint replacement payment type
Private vs. NHS 1.7 (0.8 to 3.6)
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Chapter 4 Discussion
These analyses of quality of care and participant characteristics from the ELSA have shown that, despiterelatively high levels of quality achievement in cardiovascular disease and individual diabetes care
processes, important shortfalls in quality of care have persisted over 6 years. Shortfalls were greater for the
diabetes care bundle, for depression and particularly for osteoarthritis, with less than half of indicated health
care achieved for osteoarthritis compared with the other three conditions. Osteoarthritis was, however, the
only condition where quality had improved over time, perhaps partly because of the low starting point.
Variations in quality by participant characteristics were generally small, with the few statistically significant
associations including worse care for diabetes in participants with cognitive impairment, and better care in
those living alone. Hypertension care was better for those aged > 74 years, and osteoarthritis care was
better for those with greater pain, limiting illness and obesity. Previous non-achievement of the diabetes
care bundle was the biggest predictor of non-achievement 2 years later. The surprising lack of variation in
quality of care by participant characteristics suggests that future quality improvement interventions may be
more effective when directed at health-care delivery systems rather than at individuals.
The comparison of the distribution by wealth of illness burden with the distribution of diagnoses and
treatments showed that the relatively high prevalence of specific illness burden in poorer participants was
not matched by an equally high prevalence of diagnosis or treatment, suggesting that barriers to equity
may exist at the stage at diagnosis.
Comparison of main results with previous research
Quality indicator achievement
Our findings are broadly consistent with the findings of a systematic review by Askari et al.13 of 17 papers
reporting on achievement of the ACOVE quality indicators, which showed large variation between
conditions, and notably low rates for osteoarthritis quality indicators. This review only found a few
conditions with a stable pass rate range over multiple studies, and noted that caution is required in making
direct comparisons of quality indicator achievement between studies. Most indicators were reported in only
a small number of studies and were drawn from different countries and diverse populations (e.g. nursing
home residents or primary care settings).
For the cardiovascular disease indicators reported here, the proportion of eligible patients who reported
receiving care ranged between 64% for MI beta-blocker and 100% for INR test in wave 2. By wave 5
these figures ranged between 73% for MI beta-blocker and 94% for INR test. Improvements were
observed in the achievement rates for some indicators between waves 2 and 5 (stroke antihypertensives
+7%, hypertension treatment +8%, MI beta-blocker +12%). However, achievement rates of the
remaining indicators stayed constant across time with the exception of the INR test, which declined by
6% from the 100% attainment noted at wave 2. Askari et al.13 reported comparable achievement rates in
primary care settings for hypertension (72% vs. 75% prevalent hypertension treatment at wave 5) and
stroke (69% vs. 85% achievement in ELSA) indicators.
For the diabetes indicators, achievement rates in wave 2 ranged between 48% for ACE inhibitor and 83%
for diabetes HbA1c testing. By wave 5 these figures ranged between 57% for ACE inhibitor and 89% for
diabetes cholesterol test. Most diabetes indicators remained largely unchanged across time, with the
exception of the ACE inhibitor one, which increased by 9% between waves 2 and 5. Our findings are
broadly consistent with figures reported for 2009–10 in the recent National Diabetes Audit18 which examined
all available clinical records in the UK. This audit found achievement rates of 93%, 74% and 85% for HbA1c
checks, renal risk checks and foot checks, respectively. This compares with wave 5 data, where 82% patients
reported having HbA1c levels checked, 79% had a proteinuria check and 83% received a foot check.
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Receipt of care for depression at wave 2 was 46% (suicide), 79% (treatment) and 76% (review), and at
wave 4 was 58% (suicide) and 62% (treatment). Although depression is a condition included in the QOF
for UK general practice, the QOF indicators do not map perfectly to the criteria used in ELSA and no direct
comparisons can be made.
Achievement of the osteoarthritis indicators was lower than for any cardiovascular disease, depression or
diabetes indicators, ranging from 26% (education) to 45% (paracetamol) at wave 2, and from 32%
(education) to 46% (exercise) at wave 5. Although a prevalent condition in later life, osteoarthritis is not
included in the QOF. For both depression and osteoarthritis we found no national audit data that could be
compared with our sample. The review by Askari et al.13 found very similar rates of achievement of
osteoarthritis indicators (interquartile range 29% to 41%), which they described as ‘notably low’.
Transitions in quality indicator achievement over time
We explored transitions in quality indicator achievement across time by tabulating whether or not patients
received their care at a given wave with subsequent receipt of that care by the next wave. This allowed us to
investigate the rates of transitions from poor-quality care to good-quality care and vice versa, as well as the
rates of continued receipt of poor- or good-quality care. Not all quality indicators were suitable for this analysis
as some indicators (e.g. depression) referred to the management of incident disease within specific time scales.
For other quality indicators it was not possible to transition from receiving care at one wave to subsequently
not receiving it, as the indicated care either only needed to be provided once (osteoarthritis exercise and
education), or referred to the provision of long-term treatment (stroke antihypertensives). However, there
were relatively low rates of transitions from not receiving the care to subsequently receiving it, especially for
the two osteoarthritis quality indicators. The majority of eligible people who did not receive indicated care
continued to receive poor quality of care subsequently.
A different pattern emerged from the follow-up for the hypertension quality indicator, the three quality
indicators for annual monitoring checks for diabetes (HbA1c test, proteinuria and foot check) that compose
the diabetes care bundle, and the quality indicator assessing the prescription of ACE inhibitors to those with
diabetes and additional cardiac risk factors. For these quality indicators, more participants who did not
receive their care at a given wave transitioned to subsequently receiving it than to continuing to not receive
it. There were comparatively low rates of patients transitioning from receiving good quality of care to not
receiving their care (e.g. 2% to 3% for hypertension and 19% to 24% for the diabetes care bundle) in
relation to those who continued to receive poor-quality care (e.g. 31% to 40% for hypertension and 45%
to 48% for the diabetes care bundle). Overall, our results suggest that those participants who received poor
care tended to persistently receive poor care, and that time alone did not rectify deficits in care.
Participant characteristics associated with receipt of indicated health care
The results of multivariate logistic regression modelling for individual conditions found that very few of the
wide range of personal characteristics that we measured were significantly and independently associated
with eligible individuals achieving indicated care. At condition level, some participant characteristics were
associated with achievement of care. For example, achievement of diabetes care was higher for patients
without cognitive impairment, or for patients who lived alone than those cohabiting. In contrast, care
achievement for patients with osteoarthritis was associated with participants reporting severe pain or
having a limiting illness, or being obese compared with their healthier counterparts.
Modelling achievement of the care bundle for diabetes
This analysis included 8222 ELSA participants at wave 5 who also responded at wave 4, of whom 11%
had diabetes. Despite low non-achievement for the individual diabetes quality indicators (17% to 23%) in
wave 5, we found that at least one of the three bundled annual monitoring checks was not achieved in
one-third of eligible patients in 2010–11 (33%). Our figure is somewhat lower than data from the National
Diabetes Audit in 2009–10,18 which found that 47% of patients did not receive all nine National Institute
for Health and Care Excellence quality indicated diabetes care processes.
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Only a limited number of variables were found to be independently and significantly associated with
receipt of incomplete care. Previous (2008–9) non-achievement of the care bundle was the best predictor
of subsequent non-achievement 2 years later, increasing the odds of this by over threefold. Patients who
had previously reported in 2008–9 that they did not know ‘everything about managing their diabetes’ or
who were cognitively impaired were more likely to subsequently report not having a complete diabetes
care bundle. Individuals who were single or had low health literacy were more likely to report not having
been offered an ACE inhibitor. In contrast, people in the oldest age group, or classified as obese according
to their BMI category, were more likely to have been offered an ACE inhibitor.
The National Diabetes Audit modelled, in a cross-sectional sample, the impact of patient characteristics
(available from routine records) on the likelihood of receiving a complete bundle of care.18 Common to
both studies is the finding that only a limited number of patient characteristics explained variability in the
receipt of incomplete care. Patient social deprivation, sex and duration of diabetes were not found to
affect the likelihood of receiving complete care, but age and ethnicity were. Significant geographical
variation was observed across the 151 primary care trusts that contributed data.
The variations in indicator achievement by condition were much larger than those by participant
characteristics. This, together with the findings from the diabetes care bundle analysis, suggests that the
major causes of variations in health-care quality may lie elsewhere than with the patient, although ELSA
could not account for all patient factors which contribute to variation and are difficult to capture in a
survey, such as patient behaviour. We were unable to model health service performance data as they
are not in ELSA, although participants were asked to consent to linkage of ELSA data to NHS data
(e.g. Hospital Episode Statistics), which opens the possibility for future research on linked data sets.
Distribution of illness burden, diagnosis and treatment
This analysis suggested that barriers to equitable receipt of health care according to need may exist
predominantly at the stage at diagnosis rather than treatment. For angina, depression, diabetes and
osteoarthritis, the hypothetically poorest participant always had higher odds of illness burden than the
hypothetically richest. Poorer participants usually had no higher odds for subsequent receipt of diagnosis or
treatment. This serial cross-sectional analysis of four waves of ELSA included all eligible participants in each
wave in order to maximise the sample size. This approach means that some participants with a diagnosed
condition would no longer have had illness burden, if they were being successfully treated. Examples
would be diabetic participants whose blood sugar levels were being successfully controlled by treatment,
and participants with successfully treated depression. We checked our main results with the secondary
(longitudinal) analysis, which assessed subsequent diagnosis in those with illness burden, and subsequent
treatment in those with illness burden, and found a similar picture of inequalities in illness burden not
being fully addressed by appropriately greater levels of diagnosis and treatment for poorer participants.
Care-seeking behaviour and patient preferences may differ with wealth. Given the same information,
patients may be less likely to seek treatment than their doctors53,54 and pessimism about availability of
treatment may make older people reluctant to seek help.55 People from poorer backgrounds may view
living with illness burden (such as pain or emotional problems) as a normal part of ageing rather than a
disease.56 It is possible to imagine that the response of the primary care physician may also vary according
to the wealth of the patient, however subconsciously. For example, a physician might initially consider
symptoms such as aches and pains to be part of the tapestry of life, or the natural ageing process, when
they occur in a patient from a deprived background. The same symptoms in a wealthier, well-educated
and articulate patient might arguably be considered more unusual and, therefore, more likely to lead to a
diagnosis. Our results fit with research showing that while people from deprived groups were more likely
to have Rose angina, they were not more likely to receive a GP diagnosis of CHD.57 Comorbidity is more
common in deprived populations, and may make diagnosis of all conditions harder for doctors within the
constraints of a short consultation.58
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Strengths and limitations
This project is the first to investigate a wide range of clinical, behavioural, psychosocial and
sociodemographic patient characteristics as predictors of subsequent receipt of care in older people in
England, encompassing four common health conditions. Its major strengths include that this is the first
national cohort study to measure quality of care for a range of common chronic conditions, with
individual-level data on a wide range of participant characteristics. We were able to pair reports of receipt
of care indicated by evidence- and consensus-based standards developed specifically for older people35
with in-depth, sophisticated patient characteristics assessed using established measures, whereas previous
work has usually been limited to basic patient descriptors available from routine records (e.g. age or sex).
The quality indicators for all four conditions were developed using the same robust methods, and were
based on similar strengths of evidence of effectiveness.
Limitations include the difficulty, common to all longitudinal studies (particularly of ageing), of maintaining
a sample that is representative of the national population. The ELSA cohorts were selected from HSE to
be representative of people aged ≥ 50 years living in private accommodation in England. However, as
Table 2 shows, there was inevitably attrition of the sample over time. ELSA added replenishment samples
at waves 3 and 4 to bolster the younger age bands and correct for attrition to some extent. Therefore,
cross-sectional analyses, or comparisons of wave pairs, are less affected by this limitation. All analyses were
weighted for differential non-response, using longitudinal or cross-sectional sample weights as appropriate,
to mitigate any potential lack of representativeness. Ethnic groups other than white British represented
approximately 2% of the sample, which is reasonably representative of the population at that age in the
UK, and too small a sample to allow separate analysis of quality indicator achievement. It could be argued
that people who respond to ELSA over several years are also more likely to use and benefit from health
services. For example, their GP would have been notified of any abnormal results identified at the nurse
visit, and so we expect that the ELSA quality indicator achievement rates presented in this paper are likely
to be slightly higher than in the general population.
Minor technical problems with the computer-assisted questionnaire that filtered ELSA participants to
different parts of the ELSA questionnaire temporarily affected the sample sizes of those eligible for
diabetes cholesterol and IHD cholesterol quality indicators, as is explained in the ELSA wave 2
documentation.33 This did not affect the quality of data from those quality indicators.
The ELSA questionnaire, including the quality indicators, was based on self-reports about processes of care
that participants might have received up to 2 years previously. The indicators used in ELSA were highly
selected on the basis of suitability for use with self-report in an interview survey, as described in Chapter 2
(see Quality indicators in the English Longitudinal Study of Ageing). The ACOVE researchers compared
interview data and medical notes where feasible and found that the ACOVE interview data were
comparable with notes data, and for some indicators respondents remembered higher rates of
achievement than had been recorded in the medical notes. Approximately half of the 236 ACOVE
indicators could be used in an interview survey without the use of clinical records, and after conducting
literature reviews, expert clinical panel assessment for validity in England, and piloting in ELSA, only
32 indicators were taken forward for implementation in ELSA on the basis that they could be answered
meaningfully in a survey. For certain areas of care, recorded data are more likely to reflect actual clinical
practice, but for some chronic conditions and process of care measures, including prescription of
medication, self-reported data appear to be at least as accurate as clinical records. Clinical records do not
contain in-depth information on patient characteristics, and for some of the ELSA questions, such as the
presence of pain, it could be argued that the patient’s report is more likely to be accurate than the medical
record, and so finding a perfect data source is difficult. Self-reports tend to score the same as, or higher
than, medical records. ELSA did not include potential participants if they had severe cognitive issues, and
we excluded proxy respondents from our selected samples. Our findings are comparable with other work
as discussed above, including an audit of care for diabetes using all clinical records in the UK.59,60
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The statistical significance of the changes in achievement between wave 2 and the most recent year of
follow-up was tested with Pearson’s chi-squared test for comparing proportions (see Table 10). This test
was chosen because some data points were paired within individuals between wave 2 and the most recent
year of follow-up, and some were not, as different individuals were eligible for indicators at different
waves. For this reason we did not use McNemar’s test for paired data, although McNemar’s test would
have had greater power and precision had it been appropriate to use.
If key covariates change over time, and the analysis only considers baseline values, then this can be a
source of bias. In this study, changes in potentially time-varying covariates were generally small. The
greatest change in the number of participants reporting potentially time-varying covariates was seen in
cognitive impairment, which was reported by over twice as many participants in wave 5 as in wave 2
(see Chapter 3, Regression modelling for quality of care, Demographics for the diabetes care bundle, and
Table 14). The only condition in which cognitive impairment was associated with quality was diabetes,
and only 5.8% more participants with diabetes also had cognitive impairment in wave 5 than in wave 2.
Because the change over time was only 5.8%, any impact on the overall results was thought to be
minimal. To check this we also repeated the final regression model for diabetes in Table 19 with both the
baseline values for cognitive impairment and the value at wave 5. The result was that cognitive impairment
was no longer significant in wave 2 or wave 5, supporting the idea that there was no additional
explanatory effect from cognitive impairment at wave 5 that had not been captured by cognitive
impairment at wave 2.
If missing data are not properly accounted for, they can bias the results of a study. We considered the
alternate approaches of multiple imputation, and including missing data as a ‘missing’ category in the
analyses. We recognise that multiple imputation is a powerful and flexible approach for handling missing
data in epidemiological studies. However, as with all procedures for handling missing data, multiple
imputation has advantages and disadvantages. For example, although the chained equations approach
often works well in practice, it does not necessarily have a strong theoretical basis. Other multiple
imputation approaches typically require distributional assumptions (e.g. multivariate normality). Based on
our experience of other studies, we decided to adopt an alternative strategy for handling missing data: use
of a missing category. This approach, although ad hoc, is easily communicated to non-methodologists and
often gives results that are consistent with more formal model-based procedures (including multiple
imputation). We conducted sensitivity analyses to determine whether or not using multiple imputation of
missing data would alter the final results for the diabetes care bundle and the ACE inhibitor/receptor
blocker quality indicator (see Chapter 3, Regression modelling for quality of care, Demographics for the
diabetes care bundle, and Table 19). The results from the model using multiple imputation were generally
very similar to the original models for both the care bundle and the ACE inhibitor quality indicator.
One specific potential limitation of the analysis of distribution of illness burden, diagnoses and treatment is
that standardised measures were used to assess illness burden of depression, angina and diabetes, but
not illness burden of osteoarthritis and cataract. This means that the illness burden we attributed to
osteoarthritis and cataract may not be 100% specific for those conditions, as indeed they are not in clinical
situations. However, this lack of specificity in unlikely to vary with wealth, and so should not be a source of
bias. Self-reported data may be a source of bias if self-report varies by factors other than objective health
status, such as wealth or social experience. This is a recognised problem with some self-reported morbidity
data, but is less of a problem with measures of pain, where self-report is the best means of assessment.61
We did not adjust in the main analysis for related factors that are also more prevalent in poorer populations,
such as smoking, obesity and comorbidity, because none of these is a reason for not making a diagnosis.
Comorbid conditions are more common in those with lower socioeconomic status, but there is no evidence
that comorbidities make diagnosis less likely. On the contrary, a higher number of comorbid conditions in
older people may be associated with higher quality of care.62 We adjusted for the effects of adding
individual additional covariates in additional analyses found different patterns in different conditions, which
fits with other research showing that wealth acts differently in different conditions.63
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Generalisability
The results are likely to be generalisable to the population of England aged ≥ 50 years, bearing in
mind the limitations discussed above, because the sample was large and selected to be nationally
representative, the results were weighted for non-response, and achievement rates were comparable
with QOF. They may also be generalisable with caution to other countries with similar population
demographics, but are likely to vary according to health system and availability of care. Previous US studies
have used similar methods and found similar quality scores.
DISCUSSION
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Chapter 5 Conclusions
This project is the first to investigate a wide range of clinical, behavioural, psychosocial andsociodemographic participant characteristics as predictors of subsequent receipt of care in older people
in England, encompassing four common health conditions. The results show that there were persistent
shortfalls in quality for all conditions, and particularly for osteoarthritis, and that these changed little over
6 years of follow-up, although quality for osteoarthritis did improve slightly. The analysis of transitions
shows that the strongest predictor of future poor care was past poor care, which means that it was often
the same people who did not receive indicated care year after year. We found that quality varied little by
participant characteristics, despite the wide range of characteristics (e.g. patient education, socioeconomic
status, health and health behaviours, and cognition) available for analysis. There were some participant
characteristics that were significantly associated with achievement of quality indicators, but these were
generally different for the different conditions. For example, we found that participants with diabetes, and
who had cognitive impairment or who were cohabiting (as opposed to living alone), were more likely
to report poor-quality care. The good news is that, for those with one of the four diagnosed health
conditions studied, receipt of indicated care is generally distributed equitably across the population.
The implications for policy are that shortfalls in quality of care for these four common and important
long-term conditions have persisted over 6 years, despite much policy attention and major initiatives
such as payment for performance in primary care through the QOF. The variations in quality within and
between conditions are not, for the most part, explained by participant characteristics, so a different
source or sources of variation must be driving these. Health system characteristics are known to be strongly
associated with quality of care in other countries, and are a possible explanation for the shortfalls in quality
of care that are not explained by patient characteristics. Fisher et al.64 showed that health care is often
driven by the availability of specialist services rather than by the health needs of the population, with no
detectable difference in health outcomes.
Health system characteristics affect the quality of health care received by patients at micro
(individual clinician), meso (general practice or hospital) and macro (regional and national) levels. The
shortfall in quality was particularly marked for osteoarthritis. This research has found that the QOF seems
to have had little effect on the quality of care received by ELSA participants for the four conditions studied.
Common features of successful models of care for older people are strong generalist or primary care, the
use of care plans, and electronic medical records with continuity of care.65,66
Participant characteristics may not explain access to treatment, but they, especially wealth, do explain large
variations in the distribution of illness burden for the four conditions studied. The analysis of inequalities in
access to diagnosis and treatment presented here is preliminary and limited by the availability of data, but
suggests that less-wealthy people may be less likely to be diagnosed. This matters as, after diagnosis, the
results show that, for the most part, treatment is remarkably equitable. Diagnosis is a key step in equitable
access to treatment for those with long-term conditions.
Recommendations for further research
Further research could compare the results with measurements from directly observed clinical care and
from medical records. As this research has shown that the substantial variations in quality of care are
generally not explained by participant characteristics, further research is needed into the association
between quality and health system characteristics at micro (individual clinician), meso (general practice or
hospital) and macro (regional and national) levels. Future research could use linked data sets (such as the
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GP patient survey, and Hospital Episode Statistics) to examine the effect of health service characteristics on
the quality of care received at the individual patient level. For the few areas where specific participant
characteristics were associated with quality of care, further qualitative research could explore how
these characteristics affect treatment quality.
Further research could explore why quality is so much lower in osteoarthritis than for other conditions
studied, and this may include investigating GPs’ knowledge about treatment options, and availability of
further care such as physiotherapy. The preliminary finding that there may be system level inequalities in
the receipt of diagnosis that make it harder for disadvantaged people with specific illness burden to receive
an appropriate diagnosis could be investigated further. What are the barriers that may differentially hinder
access to an appropriate diagnosis? A mixed qualitative and quantitative approach could explore the
delivery of care in different systems, and link care to patient health outcomes.
CONCLUSIONS
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Appendix 1 Translating quality indicators to the
English Longitudinal Study of Ageing
Condition, quality indicator
abbreviated title and quality
indicator/question text Denominatora Numeratora
Corresponding ELSA variable(s)a
and question(s)
Diabetes mellitus
Diabetes HbA1c. IF a person aged
≥ 50 years has diabetes, THEN
his or her glycosylated
haemoglobin or fructosamine
level should be measured at
least annually
Age ≥ 50 years. All diabetes
cases up to current wave
(heacd)
Hesuga= ‘yes’ Heacd: Has a doctor ever told you
that you have diabetes?
Hesug: Have you ever had a
special blood test to see how well
your blood sugar was controlled?
This test is called a glycosylated
haemoglobin, or haemoglobin A1c,
or fructosamine. This is a blood
test taken at a doctor’s surgery or
health centre or laboratory
Hesuga: Have you had this test
(glycosylated haemoglobin or
fructosamine) performed in the
past 12 months?
Diabetes proteinuria. IF a
diabetic person aged ≥ 50 years
does not have established renal
disease and is not receiving an
ACE inhibitor or angiotensin II
receptor blocker, THEN he or she
should receive an annual test for
proteinuria
Age ≥ 50 years. All diabetes
cases up to current wave,
and hekidn= ‘no’, and
heacea= ‘not taking ACE
inhibitor or A2 receptor
blocker’
Hewee= ‘yes’ Hekidn: Has a doctor ever told
you that your diabetes has caused
trouble with your kidneys?
Heacea: I would like to check
whether any of the medications
you are taking are on this list of
ACE inhibitor or A2 receptor
blockers (show card G ACE
inhibitors)?
Hewee: Have you had a urine test
for protein in the last 12 months?
Diabetes cholesterol. IF a
diabetic person aged ≥ 50 years
has a fasting total cholesterol
level of ≥ 5mmol/l, THEN he or
she should be offered an
intervention to lower cholesterol
Age ≥ 50 years. All diabetes
cases up to current wave,
and ‘high cholesterol’ at
current wave, but not
at previous wave
Hechol= ‘yes’ Hediaa: Has a doctor ever told
you that you have (or have had)
any of the conditions on this card
(includes ‘high cholesterol’)?
Hechol: Has any doctor talked to
you about how to lower your
cholesterol? This would include
changing your diet, losing weight,
getting more exercise or taking
medication (asked if has diabetes
and high cholesterol)
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Condition, quality indicator
abbreviated title and quality
indicator/question text Denominatora Numeratora
Corresponding ELSA variable(s)a
and question(s)
Diabetes ACE inhibitor. IF a
diabetic person aged ≥ 50 years
has one additional cardiac risk
factor (i.e. smoker, hypertension,
hypercholesterolemia, or renal
insufficiency/microalbuminuria),
THEN he/she should be offered
an ACE inhibitor or receptor
blocker
Age ≥ 50 years. All diabetes
cases up to current wave,
and at current wave
[heska= ‘yes’, or systolic
blood pressure (BP) ≥ 140
or diastolic BP ≥ 90], or
hekidn= ‘yes’, or
heweea= ‘yes’, or reported
diagnosed ‘high cholesterol’
or ‘high blood pressure or
hypertension’, or prevalent
hypertension
Heace= ‘yes’ or
Heacea= ‘yes’
Hediaa: Has a doctor ever told
you that you have (or have had)
any of the conditions on this card
(includes ‘high blood pressure or
hypertension’ and ‘high cholesterol’)?
Hewee: Some doctors check to
see if patients with diabetes have
protein in their urine. Have you
had a urine test for protein in the
past 12 months? (This test may
also be called a microalbumin test,
and involves a first morning urine
sample or 24-hour urine collection)
Heweea: Has a doctor ever told
you that you have protein in your
urine?
Hekidn: Has a doctor ever told you
that your diabetes has caused
trouble with your kidneys?
Heska: Do you smoke cigarettes at
all nowadays?
Sysval: valid mean systolic BP
(measured)
Diaval: valid mean diastolic BP
(measured)
Heace: Has a doctor discussed
with you whether you should take
a medication called an ACE
inhibitor or A2 receptor blocker?
Heacea: I would like to check
whether any of the medications
you are taking are on this list of
ACE inhibitor or A2 receptor
blockers (show card G ACE
inhibitors)?
Diabetes foot check. ALL
diabetic persons aged ≥ 50 years
should have an annual
examination of his or her feet
Age ≥ 50 years. All diabetes
cases up to current wave
Heftchk= ‘yes’ Heftchk: Some doctors suggest
that some patients with diabetes
have a regular foot examination. In
the past year, has any doctor or
nurse examined your bare feet?
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Condition, quality indicator
abbreviated title and quality
indicator/question text Denominatora Numeratora
Corresponding ELSA variable(s)a
and question(s)
CVD
Stroke antihypertensives. IF a
person aged ≥ 50 years has had
a previous stroke, THEN the
patient should be offered
antihypertensive medication
Age ≥ 50 years. Newly
reported stroke (hediaa), or
confirmed stroke previously
reported (hediac)
Hehibpb1= ‘yes’ Hediaa: Has a doctor ever told
you that you have (or have had)
any of the conditions on this card
[includes ‘stroke (cerebral vascular
disease)’]?
Hediac: Whether confirms stroke
diagnosis
Hehibpb1: Did a doctor or nurse
ever suggest you take any
medication to lower your blood
pressure?
Hypertension
Hypertension treatment. IF a
person aged ≥ 50 years
remains hypertensive after
non-pharmacological intervention,
THEN pharmacological
antihypertensive treatment should
be initiated
Age ≥ 50 years. Newly
reported hypertension
(hediaa), or still has
hypertension previously
reported (hedias)
Hehibpb= ‘yes’ Hedias: Do you still have
(hypertension)?
Hehibpb: Some doctors suggest
that some patients take
medication to lower their blood
pressure. Did a doctor or nurse
ever suggest that you take
medication to lower your blood
pressure?
IHD
IHD cholesterol. IF a person aged
≥ 50 years has established CHD
and LDL cholesterol > 3mmol/l,
THEN he or she should be
offered an intervention to lower
cholesterol
Age ≥ 50 years. Diagnosed
high cholesterol at current
wave (hediaa) and
diagnosed angina or heart
attack (including MI or
coronary thrombosis) at
current wave (hediaa) or still
has angina (hedias) or
confirms heart attack
previously reported (hediac)
Hechol= ‘yes’ Hechol: Has any doctor talked to
you about how to lower your
cholesterol? This would include
changing your diet, losing weight,
getting more exercise or taking
medication
IHD antiplatelets. IF a person
aged ≥ 50 years has established
CHD and is not on warfarin,
THEN he or she should be
offered antiplatelet therapy
Age ≥ 50 years. Diagnosed
angina or heart attack
(including MI or coronary
thrombosis) at current wave
(hediaa) or still has angina
(hedias) or confirms heart
attack previously reported
(hediac), and Hehrtc= ‘no’
Hehrta= ‘yes’ Hehrtc: Are you taking warfarin?
Hehrta: Did a doctor suggest that
you take medication to thin your
blood such as warfarin or
aspirin, Plavix, Ticlid, or other
blood-thinning medication?
IHD smoking. IF a person aged
≥ 50 years with established CHD
smokes, THEN he or she should
be offered counselling for
smoking cessation
Age ≥ 50 years. Diagnosed
angina or heart attack
(including MI or coronary
thrombosis) at current wave
(hediaa) or still has angina
(hedias) or confirms heart
attack previously reported
(hediac), and heska= ‘yes’
Hecgstp= ‘yes’ Heska: Do you smoke cigarettes
at all nowadays?
Hecgstp: Has a doctor or nurse
ever advised you to stop smoking?
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Condition, quality indicator
abbreviated title and quality
indicator/question text Denominatora Numeratora
Corresponding ELSA variable(s)a
and question(s)
MI beta-blocker. IF a person
aged ≥ 50 years has had a
recent MI, THEN he or she
should be offered a beta-blocker
Age ≥ 50 years. Diagnosed
heart attack (including MI or
coronary thrombosis) at
current wave (hediaa) and
not at previous wave
Hebeta= ‘yes’ or
Hebetb= currently
taking beta-blockers
Hebeta: Did any doctor ever
tell you that you should take a
medication called a beta-blocker?
Hebetb: Please could you show
me the medications or the repeat
prescription list for any
medications you have taken over
the last week (checked against
card F beta-blockers)?
INR test. IF a person aged
≥ 50 years is prescribed warfarin,
THEN an INR should be
determined at least every
12 weeks
Age ≥ 50 years. Diagnosed
angina or heart attack
(including MI or coronary
thrombosis) at current wave
(hediaa) or still has angina
(hedias) or confirms heart
attack previously reported
(hediac), and Hehrtc= ‘yes’
Hehrte= ‘yes’ Hehrtc: Are you taking warfarin?
Hehrtd: Many doctors ask
patients on warfarin to get their
blood tested regularly. The test
checks how thin their blood is,
and is sometimes called an INR
test. Do you get your blood
checked for this?
Hehrte: Have you had this blood
test in the past 12 weeks?
OA
OA exercise. IF an ambulatory
person aged ≥ 50 years has had
a diagnosis of symptomatic
osteoarthritis of the knee for
longer than 3 months and has
no contraindications to exercise
and is physically and mentally
able to exercise, THEN a directed
or supervised strengthening or
aerobic exercise programme
should have been prescribed at
least once
Age ≥50 years. Diagnosed
osteoarthritis at current wave
(heart) or still has osteoarthritis
(hedids+ heart), and knee
pain (hekne) for more than
3 months (heknea)
Hekneb= ‘yes’ Heart: Which type or types
of arthritis do you have
(includes ‘osteoarthritis’)?
Hedids: Do you still have
(arthritis)?
Hekne: How would you rate the
pain in your knees? (‘Where 0 is
no pain and 10 is severe or
excruciating pain, as bad as you
can imagine.’ Range: 0–10)
Heknea: Has your knee pain been
bothering you for more than
3 months?
Hekneb: Has a doctor or nurse
suggested that you receive
physiotherapy or attend a
supervised exercise program for
your knee pain?
OA education. IF an ambulatory
person aged ≥ 50 years has a
diagnosis of symptomatic
osteoarthritis, THEN education
regarding the natural history,
treatment and self-management
of the disease should be offered
at least once
Age ≥ 50 years. Diagnosed
osteoarthritis at current
wave (heart) or still has
osteoarthritis
(hedids+ heart)
Hearta= ‘yes’ and
Heartb= ‘yes’ and
Heartc= ‘yes’
Has any doctor or nurse ever
talked to you about:
Hearta: What your arthritis or
joint pain will be like as time
goes on?
Heartb: How to keep your arthritis
or joint pain from getting worse?
Heartc: How your arthritis or joint
pain will be treated?
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Condition, quality indicator
abbreviated title and quality
indicator/question text Denominatora Numeratora
Corresponding ELSA variable(s)a
and question(s)
OA paracetamol. IF oral
pharmacological therapy is
initiated to treat osteoarthritis
among people aged ≥ 50 years,
THEN paracetamol should be the
first drug used, unless there is a
contraindication to use
Age ≥ 50 years. Diagnosed
osteoarthritis at current
wave (heart) or still has
osteoarthritis
(hedids+ heart)
Hearte= ‘yes’ Hearte: Did any doctor or nurse
recommend you to try
paracetamol before other
medicines for your joint pain?
OA referral. IF a person aged
≥ 50 years with severe
symptomatic osteoarthritis of the
knee or hip has failed to respond
to non-pharmacological and
pharmacological therapy, THEN
the patient should be offered
referral to an orthopaedic
surgeon to be evaluated for total
joint replacement within 6 months
unless surgery is contraindicated
Age ≥ 50 years. All
diagnosed cases of
osteoarthritis up to current
wave (heartoa), and knee
or hip pain for more than
6 months (hekne and
hehip), both rated 6–10,
and not controlled by
treatment (hepae= ‘no’)
Hepaf= ‘yes’ Hehip: How would you rate the
pain in your hips? (‘Where 0 is
no pain and 10 is severe or
excruciating pain, as bad as you
can imagine.’ Range: 0–10)
Hepac: Has your knee or hip pain
been bothering you for more than
6 months?
Hepad/hepmed:b Are you taking
or have you taken any medication
or exercises to control the pain in
your knee or hip?
Hepae/heknefb and hehipc:b Do
exercises and medicines control the
pain in your knee or hip?
Hepaf/hypesur:b Did any doctor
recommend that you should have
surgery or joint replacement?
Depression
Depression suicide. IF a person
aged ≥ 50 years receives a
diagnosis of a new depression
episode, THEN the diagnosing
physician should ask on the day
of diagnosis whether or not the
person aged ≥ 50 years had any
thoughts about suicide
Age ≥ 50 years. Diagnosed
depression at current wave,
but not at previous wave
(hediab)
Hepsye= ‘yes’ Hediab: Has a doctor ever told
you that you have (or have had)
any of the conditions on this card
(includes ‘any emotional, nervous
or psychiatric problems’)?
Hepsy: What type of emotional,
nervous or psychiatric problems do
you have (includes ‘depression’)?
Hepsye: When you talked about
these feelings with a doctor or
nurse, did they ask you on that day
if you had thoughts about suicide?
Depression treatment. IF a
person aged ≥ 50 years is
diagnosed with clinical
depression, THEN antidepressant
treatment, talking treatment, or
electroconvulsive therapy should
be offered within 2 weeks after
diagnosis unless within that
period the patient has improved,
or unless the patient has
substance abuse or dependence,
in which case treatment may
wait until 8 weeks after the
patient is in a drug- or
alcohol-free state
Age ≥50 years. Diagnosed
depression at current wave, but
not at previous wave (hediab),
and hepsya≠ ‘none’
Hepsyb= ‘yes’ Hepsya: I have some questions
about any treatment you may have
had for your depression. Did a
doctor or nurse suggest that you
take medication, or see a mental
health professional for counselling?
Hepsyb: Did you start medication
or counselling within 2 weeks of
being offered this treatment?
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Condition, quality indicator
abbreviated title and quality
indicator/question text Denominatora Numeratora
Corresponding ELSA variable(s)a
and question(s)
Depression review. IF a person
aged ≥50 years has no
meaningful symptom response
after 6 weeks of treatment, THEN
one of the following treatment
options should be initiated by the
8th week of treatment:
medication dose should be
optimised (if initial treatment was
medication), or medication should
be initiated (if initial treatment
was psychotherapy alone), or
referral to a psychiatrist should be
offered
Age ≥ 50 years. Diagnosed
depression at current wave,
but not at previous wave
(hediab), and Hepsyc= ‘no’
Hepsyd= ‘yes’ Hepsyc: Did you feel better within
6 weeks after starting to take
medication, or seeing a mental
health professional for counselling?
Hepsyd: Did any doctor or nurse
start you on medication, change
the dose of the medication that
you were taking or, change the
medications to help you feel
better?
Patient-centred care
Diabetes training. Some people
with diabetes receive training to
help manage their diabetes
themselves. Have you ever
participated in a course or class
about diabetes, or received
special training on how you can
live with your diabetes from day
to day?
Age ≥ 50 years. All diabetes
cases up to current wave
(heacd)
Heslfcr= ‘yes’ at
any wave
Heslfcr: Some people with
diabetes receive training to help
manage their diabetes themselves.
Have you ever participated in a
course or class about diabetes, or
received special training on how
you can live with your diabetes
from day to day?
Diabetes knowledge. How much
do you think you know about
managing your diabetes
(‘just about everything you need
to know’ or ‘most of what you
need to know’)?
Age ≥ 50 years. All diabetes
cases up to current wave
(heacd)
Heslfcb= 1
(‘just about
everything . . .’) or 2
(‘most . . .’)
Heslfcb: How much do you think
you know about managing your
diabetes? Do you know . . .
1 just about everything you need
to know; 2 most of what you need
to know; 3 some of what you
need to know; 4 a little of what
you need to know; or 5 almost
none of what you need to know?
Cholesterol explanation. Has
a doctor or nurse explained high
cholesterol in a way you could
understand?
Age ≥ 50 years. Diagnosed
high cholesterol at current
wave (hediaa), or confirms
still has high cholesterol
previously reported (hedias)
Hecholb= ‘yes’ at
any wave
Hedias: Do you still have (high
cholesterol)?
Hecholb: Has a doctor or nurse
explained high cholesterol in a
way you could understand?
Cholesterol preferences. Have
doctors or nurses taken your
preferences into account when
making treatment decisions
about your high cholesterol?
Age ≥ 50 years. Diagnosed
high cholesterol at current
wave (hediaa), or confirms
still has high cholesterol
previously reported (hedias)
Hecholc= ‘yes’ at
any wave
Hecholc: Have doctors or nurses
taken your preferences into
account when making treatment
decisions about your high
cholesterol?
Blood pressure explanation. Has
a doctor or nurse explained high
blood pressure in a way you
could understand at any time
since you were first told you had
high blood pressure?
Age ≥ 50 years. Newly
reported hypertension
(hediaa), or still has
hypertension previously
reported (hedias)
Hehibp= ‘yes’ at
any wave
Hehibp: Has a doctor or nurse
explained high blood pressure in a
way you could understand at any
time since you were first told you
had high blood pressure?
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Condition, quality indicator
abbreviated title and quality
indicator/question text Denominatora Numeratora
Corresponding ELSA variable(s)a
and question(s)
Blood pressure choice. In general,
have doctors or nurses given you
any choice about how to treat
your high blood pressure?
Age ≥ 50 years. Newly
reported hypertension
(hediaa), or still has
hypertension previously
reported (hedias)
Hehibpa= ‘yes’ at
any wave
Hehibpa: In general, have doctors
or nurses given you any choice
about how to treat your high
blood pressure?
OA treatment purpose. Has any
doctor or nurse ever talked to
you about what the specific
purpose of the treatment for
your arthritis or joint pain is?
Age ≥50 years. Diagnosed
osteoarthritis at current wave
(heart) or still has osteoarthritis
(hedids+ heart), and doctor
has discussed treatment
(Heartc= ‘yes’)
Heartd= ‘yes’ Heartc: Has any doctor or nurse
ever talked to you about how your
arthritis or joint pain will be
treated?
Heartd: Has any doctor or nurse
ever talked to you about what the
specific purpose of the treatment
for your arthritis or joint pain is?
OA, osteoarthritis.
a ELSA variables are displayed in bold font. The variable names are those used in the ELSA data set, downloaded from the
UK Data Archive: http://discover.ukdataservice.ac.uk/catalogue/?sn=5050&type=Data%20catalogue. The ‘he’ prefix
denotes a variable from the health section of ELSA.
b Variable names from wave 3 onwards.
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Appendix 2 Syntax to generate quality of care
variables
Recode multiresponse items to generate diagnostic variables
Recoding: waves 1 and 2 flashcard questions need recoding to gather up responses into one variable.
These variables are then used to calculate the prevalence rates for quality of care work; not needed after
wave 3 as replaced by feed forward variables.
Wave 1
Coded 0 if they mention having no problem (i.e. refusals and don’t knows are excluded)
make w1_dim01_d = 0 if w1_hedim01=96
label variable w1_dim01_d ‘Hypertension’
make w1_dim02_d = 0 if w1_hedim01=96
label variable w1_dim02_d ‘Angina’
make w1_dim03_d = 0 if w1_hedim01=96
label variable w1_dim03_d ‘Heart attack’
make w1_dim04_d = 0 if w1_hedim01=96
label variable w1_dim04_d ‘Congestive heart failure’
make w1_dim05_d = 0 if w1_hedim01=96
label variable w1_dim05_d ‘Heart murmur’
make w1_dim06_d = 0 if w1_hedim01=96
label variable w1_dim06_d ‘Abnormal heart rhythm’
make w1_dim07_d = 0 if w1_hedim01=96
label variable w1_dim07_d ‘diabetes or high blood sugar’
make w1_dim08_d = 0 if w1_hedim01=96
label variable w1_dim08_d ‘Stroke’
replace w1_dim01_d = 1 if (w1_hedim01=1 or w1_hedim02=1 or w1_hedim03=1 or w1_hedim04=1 or
w1_hedim05=1 or w1_hedim06=1 or w1_hedim07=1)
replace w1_dim02_d = 1 if (w1_hedim01=2 or w1_hedim02=2 or w1_hedim03=2 or w1_hedim04=2 or
w1_hedim05=2 or w1_hedim06=2 or w1_hedim07=2)
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replace w1_dim03_d = 1 if (w1_hedim01=3 or w1_hedim02=3 or w1_hedim03=3 or w1_hedim04=3 or
w1_hedim05=3 or w1_hedim06=3 or w1_hedim07=3)
replace w1_dim04_d = 1 if (w1_hedim01=4 or w1_hedim02=4 or w1_hedim03=4 or w1_hedim04=4 or
w1_hedim05=4 or w1_hedim06=4 or w1_hedim07=4)
replace w1_dim05_d = 1 if (w1_hedim01=5 or w1_hedim02=5 or w1_hedim03=5 or w1_hedim04=5 or
w1_hedim05=5 or w1_hedim06=5 or w1_hedim07=5)
replace w1_dim06_d = 1 if (w1_hedim01=6 or w1_hedim02=6 or w1_hedim03=6 or w1_hedim04=6 or
w1_hedim05=6 or w1_hedim06=6 or w1_hedim07=6)
replace w1_dim07_d = 1 if (w1_hedim01=7 or w1_hedim02=7 or w1_hedim03=7 or w1_hedim04=7 or
w1_hedim05=7 or w1_hedim06=7 or w1_hedim07=7)
replace w1_dim08_d = 1 if (w1_hedim01=8 or w1_hedim02=8 or w1_hedim03=8 or w1_hedim04=8 or
w1_hedim05=8 or w1_hedim06=8 or w1_hedim07=8)
Recode eye diseases wave 1
Coded 0 if they mention having no problem (i.e. refusals and don’t knows are excluded)
make w1_opt1_d=0 if w1_heopt1=96
label variable w1_opt1_d ‘glaucoma’
make w1_opt2_d=0 if w1_heopt1=96
label variable w1_opt2_d ‘diabetic eye disease’
make w1_opt3_d=0 if w1_heopt1=96
label variable w1_opt3_d ‘macular degeneration’
make w1_opt4_d=0 if w1_heopt1=96
label variable w1_opt4_d ‘cataract’
make w1_opt96_d=0 if w1_heopt1=96
label variable w1_opt96_d ‘no eye disease’
replace w1_opt1_d=1 if (w1_heopt1=1 or w1_heopt2=1 or w1_heopt3=1 or w1_heopt4=1)
replace w1_opt2_d=1 if (w1_heopt1=2 or w1_heopt2=2 or w1_heopt3=2 or w1_heopt4=2)
replace w1_opt3_d=1 if (w1_heopt1=3 or w1_heopt2=3 or w1_heopt3=3 or w1_heopt4=3)
replace w1_opt4_d=1 if (w1_heopt1=4 or w1_heopt2=4 or w1_heopt3=4 or w1_heopt4=4)
replace w1_opt96_d=1 if (w1_heopt1=96)
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Recode hedia which is the cardiovascular flashcard question merged with
hedix (any other heart conditions)
Coded 0 if they mention having no problem (i.e. refusals and don’t knows are excluded)
Recode dia and dib variables to make those who do not have a cardio problem= 96
make w1_dia01_d=0 if w1_hedia01=96
label variable w1_dia01_d ‘hypertension’
make w1_dia02_d=0 if w1_hedia01=96
label variable w1_dia02_d ‘Angina’
make w1_dia03_d=0 if w1_hedia01=96
label variable w1_dia03_d ‘MI’
make w1_dia04_d=0 if w1_hedia01=96
label variable w1_dia04_d ‘CHF’
make w1_dia05_d=0 if w1_hedia01=96
label variable w1_dia05_d ‘murmur’
label values w1_dia05_d recode
make w1_dia06_d=0 if w1_hedia01=96
label variable w1_dia06_d ‘abnormal rhythm’
make w1_dia07_d=0 if w1_hedia01=96
label variable w1_dia07_d ‘diabetes’
make w1_dia08_d=0 if w1_hedia01=96
label variable w1_dia08_d ‘stroke’
make w1_dia95_d=0 if w1_hedia01=96
label variable w1_dia95_d ‘other heart trouble’
make w1_dia96_d=0 if w1_hedia01=96
label variable w1_dia96_d ‘no diagnosed heart trouble’
replace w1_dia01_d=1 if (w1_hedia01=1 or w1_hedia02=1 or w1_hedia03=1 or w1_hedia04=1 or
w1_hedia05=1 or w1_hedia06=1 or w1_hedia07=1 or w1_hedia08=1 or w1_hedia09=1)
replace w1_dia02_d=1 if (w1_hedia01=2 or w1_hedia02=2 or w1_hedia03=2 or w1_hedia04=2 or
w1_hedia05=2 or w1_hedia06=2 or w1_hedia07=2 or w1_hedia08=2 or w1_hedia09=2)
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replace w1_dia03_d=1 if (w1_hedia01=3 or w1_hedia02=3 or w1_hedia03=3 or w1_hedia04=3 or
w1_hedia05=3 or w1_hedia06=3 or w1_hedia07=3 or w1_hedia08=3 or w1_hedia09=3)
replace w1_dia04_d=1 if (w1_hedia01=4 or w1_hedia02=4 or w1_hedia03=4 or w1_hedia04=4 or
w1_hedia05=4 or w1_hedia06=4 or w1_hedia07=4 or w1_hedia08=4 or w1_hedia09=4)
replace w1_dia05_d=1 if (w1_hedia01=5 or w1_hedia02=5 or w1_hedia03=5 or w1_hedia04=5 or
w1_hedia05=5 or w1_hedia06=5 or w1_hedia07=5 or w1_hedia08=5 or w1_hedia09=5)
replace w1_dia06_d=1 if (w1_hedia01=6 or w1_hedia02=6 or w1_hedia03=6 or w1_hedia04=6 or
w1_hedia05=6 or w1_hedia06=6 or w1_hedia07=6 or w1_hedia08=6 or w1_hedia09=6)
replace w1_dia07_d=1 if (w1_hedia01=7 or w1_hedia02=7 or w1_hedia03=7 or w1_hedia04=7 or
w1_hedia05=7 or w1_hedia06=7 or w1_hedia07=7 or w1_hedia08=7 or w1_hedia09=7)
replace w1_dia08_d=1 if (w1_hedia01=8 or w1_hedia02=8 or w1_hedia03=8 or w1_hedia04=8 or
w1_hedia05=8 or w1_hedia06=8 or w1_hedia07=8 or w1_hedia08=8 or w1_hedia09=8)
replace w1_dia95_d=1 if (w1_hedia01=95 or w1_hedia02=95 or w1_hedia03=95 or w1_hedia04=95 or
w1_hedia05=95 or w1_hedia06=95 or w1_hedia07=95or w1_hedia08=95 or w1_hedia09=95)
replace w1_dia96_d=1 if (w1_hedia01=96)
Recode hedib: non-cardio disease flashcard question
Coded 0 if they mention having no problem (i.e. refusals and don’t knows are excluded)
make w1_dib01_d=0 if w1_hedib01=96
label variable w1_dib01_d ‘chronic bronchitis/emphysema’
make w1_dib02_d=0 if w1_hedib01=96
label variable w1_dib02_d ‘asthma’
make w1_dib03_d=0 if w1_hedib01=96
label variable w1_dib03_d ‘arthritis’
make w1_dib04_d=0 if w1_hedib01=96
label variable w1_dib04_d ‘osteoporosis’
make w1_dib05_d=0 if w1_hedib01=96
label variable w1_dib05_d ‘cancer’
make w1_dib06_d=0 if w1_hedib01=96
label variable w1_dib06_d ‘Parkinson’s’
make w1_dib07_d=0 if w1_hedib01=96
label variable w1_dib07_d ‘psychiatric problems’
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make w1_dib08_d=0 if w1_hedib01=96
label variable w1_dib08_d ‘Alzheimer’s’
make w1_dib09_d=0 if w1_hedib01=96
label variable w1_dib09_d ‘dementia’
make w1_dib96_d=0 if w1_hedib01=96
label variable w1_dib96_d ‘none of these’
replace w1_dib01_d=1 if (w1_hedib01=1 or w1_hedib02=1 or w1_hedib03=1 or w1_hedib04=1 or
w1_hedib05=1 or w1_hedib06=1)
replace w1_dib02_d=1 if (w1_hedib01=2 or w1_hedib02=2 or w1_hedib03=2 or w1_hedib04=2 or
w1_hedib05=2 or w1_hedib06=2)
replace w1_dib03_d=1 if (w1_hedib01=3 or w1_hedib02=3 or w1_hedib03=3 or w1_hedib04=3 or
w1_hedib05=3 or w1_hedib06=3)
replace w1_dib04_d=1 if (w1_hedib01=4 or w1_hedib02=4 or w1_hedib03=4 or w1_hedib04=4 or
w1_hedib05=4 or w1_hedib06=4)
replace w1_dib05_d=1 if (w1_hedib01=5 or w1_hedib02=5 or w1_hedib03=5 or w1_hedib04=5 or
w1_hedib05=5 or w1_hedib06=5)
replace w1_dib06_d=1 if (w1_hedib01=6 or w1_hedib02=6 or w1_hedib03=6 or w1_hedib04=6 or
w1_hedib05=6 or w1_hedib06=6)
replace w1_dib07_d=1 if (w1_hedib01=7 or w1_hedib02=7 or w1_hedib03=7 or w1_hedib04=7 or
w1_hedib05=7 or w1_hedib06=7)
replace w1_dib08_d=1 if (w1_hedib01=8 or w1_hedib02=8 or w1_hedib03=8 or w1_hedib04=8 or
w1_hedib05=8 or w1_hedib06=8)
replace w1_dib09_d=1 if (w1_hedib01=9 or w1_hedib02=9 or w1_hedib03=9 or w1_hedib04=9 or
w1_hedib05=9 or w1_hedib06=9)
replace w1_dib96_d=1 if (w1_hedib01=96)
Recode heart: arthritis
Coded 0 if mentioned arthritis, 1 if the form of arthritis is dealt with by that variable
make w1_art1_d=0 if w1_heart10 & not missing(w1_heart1)
label variable w1_art1_d ‘osteoarthritis’
make w1_art2_d=0 if w1_heart10 & not missing(w1_heart1)
label variable w1_art2_d ‘rheumatoid arthritis’
make w1_art3_d=0 if w1_heart10 & not missing(w1_heart1)
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label variable w1_art3_d ‘other arthritis’
make w1_art8_d=0 if w1_heart10 & not missing(w1_heart1)
label variable w1_art8_d ‘unknown arthritis type’
replace w1_art1_d=1 if (w1_heart1=1 or w1_heart2=1 or w1_heart3=1)
replace w1_art2_d=1 if (w1_heart1=2 or w1_heart2=2 or w1_heart3=2)
replace w1_art3_d=1 if (w1_heart1=3 or w1_heart2=3 or w1_heart3=3)
replace w1_art8_d=1 if (w1_heart1=-8 or w1_heart2=-8 or w1_heart3=-8)
Recode hepsy
Coded 0 if mentioned psych difficulty, 1 if the form of psychiatric difficulty dealt with by that variable
make w1_psy1_d=0 if w1_hepsy10 & not missing(w1_hepsy1)
label variable w1_psy1_d ‘hallucinations’
make w1_psy2_d=0 if w1_hepsy10 & not missing(w1_hepsy1)
label variable w1_psy2_d ‘anxiety’
make w1_psy3_d=0 if w1_hepsy10 & not missing(w1_hepsy1)
label variable w1_psy3_d ‘depression’
make w1_psy4_d=0 if w1_hepsy10 & not missing(w1_hepsy1)
label variable w1_psy4_d ‘emotional problems’
make w1_psy5_d=0 if w1_hepsy10 & not missing(w1_hepsy1)
label variable w1_psy5_d ‘schizophrenia’
make w1_psy6_d=0 if w1_hepsy10 & not missing(w1_hepsy1)
label variable w1_psy6_d ‘psychosis’
make w1_psy7_d=0 if w1_hepsy10 & not missing(w1_hepsy1)
label variable w1_psy7_d ‘mood swings’
make w1_psy8_d=0 if w1_hepsy10 & not missing(w1_hepsy1)
label variable w1_psy8_d ‘manic depression’
make w1_psy95_d=0 if w1_hepsy10 & not missing(w1_hepsy1)
label variable w1_psy95_d ‘other psych problem’
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replace w1_psy1_d=1 if (w1_hepsy1=1 or w1_hepsy2=1 or w1_hepsy3=1 or w1_hepsy4=1 or
w1_hepsy5=1 or w1_hepsy6=1 or w1_hepsy7=1)
replace w1_psy2_d=1 if (w1_hepsy1=2 or w1_hepsy2=2 or w1_hepsy3=2 or w1_hepsy4=2 or
w1_hepsy5=2 or w1_hepsy6=2 or w1_hepsy7=2)
replace w1_psy3_d=1 if (w1_hepsy1=3 or w1_hepsy2=3 or w1_hepsy3=3 or w1_hepsy4=3 or
w1_hepsy5=3 or w1_hepsy6=3 or w1_hepsy7=3)
replace w1_psy4_d=1 if (w1_hepsy1=4 or w1_hepsy2=4 or w1_hepsy3=4 or w1_hepsy4=4 or
w1_hepsy5=4 or w1_hepsy6=4 or w1_hepsy7=4)
replace w1_psy5_d=1 if (w1_hepsy1=5 or w1_hepsy2=5 or w1_hepsy3=5 or w1_hepsy4=5 or
w1_hepsy5=5 or w1_hepsy6=5 or w1_hepsy7=5)
replace w1_psy6_d=1 if (w1_hepsy1=6 or w1_hepsy2=6 or w1_hepsy3=6 or w1_hepsy4=6 or
w1_hepsy5=6 or w1_hepsy6=6 or w1_hepsy7=6)
replace w1_psy7_d=1 if (w1_hepsy1=7 or w1_hepsy2=7 or w1_hepsy3=7 or w1_hepsy4=7 or
w1_hepsy5=7 or w1_hepsy6=7 or w1_hepsy7=7)
replace w1_psy8_d=1 if (w1_hepsy1=8 or w1_hepsy2=8 or w1_hepsy3=8 or w1_hepsy4=8 or
w1_hepsy5=8 or w1_hepsy6=8 or w1_hepsy7=8)
replace w1_psy95_d=1 if (w1_hepsy1=95 or w1_hepsy2=95 or w1_hepsy3=95 or w1_hepsy4=95 or
w1_hepsy5=95 or w1_hepsy6=95 or w1_hepsy7=95)
Wave 2
For dim variable use the same coding as wave 1
For dia variable use the same coding as wave 1
For dib variable use the same coding as wave 1
For opt variable use:
make w2_opt1_d=0 if w2_heopt1=96
label variable w2_opt1_d ‘w2 glaucoma’
make w2_opt2_d=0 if w2_heopt1=96
label variable w2_opt2_d ‘w2 diabetic eye disease’
make w2_opt3_d=0 if w2_heopt1=96
label variable w2_opt3_d ‘w2 macular degeneration’
make w2_opt4_d=0 if w2_heopt1=96
label variable w2_opt4_d ‘w2 cataract’
make w2_opt96_d=0 if w2_heopt1=96
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label variable w2_opt96_d ‘w2 no eye dis’
replace w2_opt1_d=1 if (w2_heopt1=1 or w2_heopt2=1)
replace w2_opt2_d=1 if (w2_heopt1=2 or w2_heopt2=2)
replace w2_opt3_d=1 if (w2_heopt1=3 or w2_heopt2=3)
replace w2_opt4_d=1 if (w2_heopt1=4 or w2_heopt2=4)
replace w2_opt96_d=1 if (w2_heopt1=96)
For arthritis variable use
make w2_art1_d=0 if w2_heart10 & not missing(w2_heart1)
label variable w2_art1_d ‘w2 osteoarthritis’
make w2_art2_d=0 if w2_heart10 & not missing(w2_heart1)
label variable w2_art2_d ‘w2 rheumatoid arthritis’
make w2_art3_d=0 if w2_heart10 & not missing(w2_heart1)
label variable w2_art3_d ‘w2 other arthritis’
make w2_art8_d=0 if w2_heart10 & not missing(w2_heart1)
label variable w2_art8_d ‘w2 unknown arthritis type’
replace w2_art1_d=1 if (w2_heart1=1 or w2_heart2=1)
replace w2_art2_d=1 if (w2_heart1=2 or w2_heart2=2)
replace w2_art3_d=1 if (w2_heart1=3 or w2_heart2=3)
replace w2_art8_d=1 if (w2_heart1=-8 or w2_heart2=-8)
For psy variable use
make w2_psy1_d=0 if w2_hepsy10 & not missing(w2_hepsy1)
label variable w2_psy1_d ‘w2 hallucinations’
make w2_psy2_d=0 if w2_hepsy10 & not missing(w2_hepsy1)
label variable w2_psy2_d ‘w2 anxiety’
make w2_psy3_d=0 if w2_hepsy10 & not missing(w2_hepsy1)
label variable w2_psy3_d ‘w2 depression’
make w2_psy4_d=0 if w2_hepsy10 & not missing(w2_hepsy1)
label variable w2_psy4_d ‘w2 emotional problems’
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make w2_psy5_d=0 if w2_hepsy10 & not missing(w2_hepsy1)
label variable w2_psy5_d ‘w2 schizophrenia’
make w2_psy6_d=0 if w2_hepsy10 & not missing(w2_hepsy1)
label variable w2_psy6_d ‘w2 psychosis’
make w2_psy7_d=0 if w2_hepsy10 & not missing(w2_hepsy1)
label variable w2_psy7_d ‘w2 mood swings’
make w2_psy8_d=0 if w2_hepsy10 & not missing(w2_hepsy1)
label variable w2_psy8_d ‘w2 manic depression’
make w2_psy95_d=0 if w2_hepsy10 & not missing(w2_hepsy1)
label variable w2_psy95_d ‘w2 other psych problem’
replace w2_psy1_d=1 if (w2_hepsy1=1 or w2_hepsy2=1 or w2_hepsy3=1 or w2_hepsy4=1 or
w2_hepsy5=1 or w2_hepsy6=1)
replace w2_psy2_d=1 if (w2_hepsy1=2 or w2_hepsy2=2 or w2_hepsy3=2 or w2_hepsy4=2 or
w2_hepsy5=2 or w2_hepsy6=2)
replace w2_psy3_d=1 if (w2_hepsy1=3 or w2_hepsy2=3 or w2_hepsy3=3 or w2_hepsy4=3 or
w2_hepsy5=3 or w2_hepsy6=3)
replace w2_psy4_d=1 if (w2_hepsy1=4 or w2_hepsy2=4 or w2_hepsy3=4 or w2_hepsy4=4 or
w2_hepsy5=4 or w2_hepsy6=4)
eplace w2_psy5_d=1 if (w2_hepsy1=5 or w2_hepsy2=5 or w2_hepsy3=5 or w2_hepsy4=5 or
w2_hepsy5=5 or w2_hepsy6=5)
replace w2_psy6_d=1 if (w2_hepsy1=6 or w2_hepsy2=6 or w2_hepsy3=6 or w2_hepsy4=6 or
w2_hepsy5=6 or w2_hepsy6=6)
replace w2_psy7_d=1 if (w2_hepsy1=7 or w2_hepsy2=7 or w2_hepsy3=7 or w2_hepsy4=7 or
w2_hepsy5=7 or w2_hepsy6=7)
replace w2_psy8_d=1 if (w2_hepsy1=8 or w2_hepsy2=8 or w2_hepsy3=8 or w2_hepsy4=8 or
w2_hepsy5=8 or w2_hepsy6=8)
replace w2_psy95_d=1 if (w2_hepsy1=95 or w2_hepsy2=95 or w2_hepsy3=95 or w2_hepsy4=95 or
w2_hepsy5=95 or w2_hepsy6=95)
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Generate incidence and prevalence for diagnosed conditions
Wave 1
Eye disease
make w1_eye_d=0 if w1_heopt1=96
replace w1_eye_d=1 if w1_heopt10 & w1_heopt1<96
Coronary heart disease
make w1_chd_d=0 if not missing(w1_finstat)
replace w1_chd_d=1 if w1_dim02_d=1orw1_dim03_d=1
Wave 2
NOTE: there was an error at w2 whereby not everyone with a cardiovascular disease at w1 was fed
forward to w2. This makes ascertaining prevalence rates for w2 CVD conditions tricky. We decided that
we would use report of the condition at w1 or w2 for prevalence of the typically chronic CVD conditions:
hypertension, heart attack, heart murmur, heart failure, diabetes and stroke. For angina and abnormal
heart rhythm, we will need to use the feed forward variable ‘confirms diagnosis from previous wave’
(hediac) and ‘still has condition from previous wave’ (hedias) for the conditions respectively, because many
reporting the condition at the previous wave may not still have it at w2.
Incident depression
make depres_d=0 if member of the sample at that wave
replace depres_d=1 if psy3_d=1 & w1_psy3_d!=1
Prevalent hypertension
make hibp_d=0 if member of the sample at that wave
replace hibp_d=1 if w1_dim01_d=1ordim01_d=1
Prevalent angina
make angina_d=0 if member of the sample at that wave
replace angina_d=1 if hediac2=1ordim02_d=1
Prevalent heart attack
make hrtattack_d=0 if member of the sample at that wave
replace hrtattack_d=1 if w1_dim03_d=1ordim03_d=1
Coronary heart disease/myocardial infarction
make chd_d=0 if member of the sample at that wave
replace chd_d=1 if angina_d=1orhrtattack_d=1
Prevalent congestive heart failure
make hrtfail_d=0 if member of the sample at that wave
replace hrtfail_d=1 if w1_dim04_d=1ordim04_d=1
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Prevalent heart murmur
make murmur_d=0 if member of the sample at that wave
replace murmur_d=1 if w1_dim05_d=1ordim05_d=1
Prevalent abnormal heart rhythm
make rhythm_d=0 if member of the sample at that wave
replace rhythm_d=1 if hedias6=1ordim06_d=1
Prevalent diabetes
make diab_d=0 if member of the sample at that wave
replace diab_d=1 if heacd=1
Prevalent stroke
make stroke_d=0 if member of the sample at that wave
replace stroke_d=1 if w1_dim08_d=1ordim08_d=1
Prevalent high cholesterol
make hichol_d=0 if member of the sample at that wave
replace hichol_d=1 if dia09_d=1
Prevalent lung disease
make lungdis_d=0 if member of the sample at that wave
replace lungdis_d=1 if hedids1=1ordib01_d=1
Prevalent asthma
make asthma_d=0 if member of the sample at that wave
replace asthma_d=1 if hedids2=1ordib02_d=1
Prevalent arthritis
make arthritis_d=0 if member of the sample at that wave
replace arthritis_d=1 if hedids3=1ordib03_d=1
Prevalent osteoporosis
make osteop_d=0 if member of the sample at that wave
replace osteop_d=1 if hedids4=1ordib04_d=1
Prevalent cancer
make cancer_d=0 if member of the sample at that wave
replace cancer_d=1 if hedids5=1ordib05_d=1
DOI: 10.3310/hsdr03110 HEALTH SERVICES AND DELIVERY RESEARCH 2015 VOL. 3 NO. 11
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Hardcastle et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
89
Prevalent Parkinson’s disease
make parkins_d=0 if member of the sample at that wave
replace parkins_d=1 if hedids6=1ordib06_d=1
Prevalent psychiatric difficulties
make psychdiff_d=0 if member of the sample at that wave
replace psychdiff_d=1 if hedids7=1ordib07_d=1
Prevalent Alzheimer’s disease
make alzheimers_d=0 if member of the sample at that wave
replace alzheimers_d=1 if hedids8=1ordib08_d=1
Prevalent dementia
make dementia_d=0 if member of the sample at that wave
replace dementia_d=1 if hedids9=1ordib09_d=1
Prevalent eye condition
make eye_d=0 if heopt1=96
replace eye_d=1 if heops=1or(heopt10 & heopt1<96)
Wave 3 onwards
Prevalent stroke
make stroke_d=0 if member of the sample at that wave
replace stroke_d=1 if hedimst=1 or hedacst=1
Incident depression
make depres_d=0 if member of the sample at that wave
replace depres_d=1 if hepsyde=1 & hedibps=1
Prevalent diabetes
make diab_d=0 if member of the sample at that wave
replace diab_d=1 if heacd=1at any previous wave
Prevalent hypertension
make hibp_d=0 if member of the sample at that wave
replace hibp_d=1 if hedimbp=1 or hedasbp=1
Prevalent angina
make angina_d=0 if member of the sample at that wave
replace angina_d=1 if hediman=1 or hedasan=1
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Prevalent heart attack
make hrtattack_d=0 if member of the sample at that wave
replace hrtattack_d=1 if hedimmi=1 or hedacmi=1
Coronary heart disease/myocardial infarction
make chd_d=0 if member of the sample at that wave
replace chd_d=1 if angina_d=1orhrtattack_d=1
Prevalent high cholesterol
make hichol_d=0 if member of the sample at that wave
replace hichol_d=1 if hedimch=1 or hedasch=1
Prevalent heart murmur
make murmur_d=0 if member of the sample at that wave
replace murmur_d=1 if hedimhm=1 or hedashm=1
Prevalent abnormal heart rhythm
make rhythm_d=0 if member of the sample at that wave
replace rhythm_d=1 if hedimar=1 or hedasar=1
Prevalent congestive heart failure
make hrtfail_d=0 if member of the sample at that wave
replace hrtfail_d=1 if hedimhf=1 or hedashf=1
Prevalent lung disease
make lungdis_d=0 if member of the sample at that wave
replace lungdis_d=1 if hediblu=1 or hedbslu=1
Prevalent asthma
make asthma_d=0 if member of the sample at that wave
replace asthma_d=1 if hedibas=1 or hedbsas=1
Prevalent arthritis
make arthritis_d=0 if member of the sample at that wave
replace arthritis_d=1 if hedibar=1 or hedbsar=1
Prevalent osteoporosis
make osteop_d=0 if member of the sample at that wave
replace osteop_d=1 if hedibos=1 or hedbsos=1
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Prevalent cancer
make cancer_d=0 if member of the sample at that wave
replace cancer_d=1 if hedibca=1 or hedbsca=1
Prevalent Parkinson’s disease
make parkins_d=0 if member of the sample at that wave
replace parkins_d=1 if hedibpd=1 or hedbspd=1
Prevalent psychiatric difficulties
make psychdiff_d=0 if member of the sample at that wave
replace psychdiff_d=1 if hedibps=1 or hedbdps=1
Prevalent Alzheimer’s disease
make alzheimers_d=0 if member of the sample at that wave
replace alzheimers_d=1 if hedibad=1 or hedbdad=1
Prevalent dementia
make dementia_d=0 if member of the sample at that wave
replace dementia_d=1 if hedibde=1 or hedbsde=1
Prevalent eye condition
make eye_d=0 if member of the sample at that wave
replace eye_d=1 if (heopsgl=1orheopsdi=1orheopsmd=1orheopsca=1)
or (heoptgl=1orheoptdi=1orheoptmd=1orheoptca=1)
Generate quality indicators
Wave 2 followed by subsequent waves.
Wave 2
dk=don’t knows
ref=refusals
Indicator stroke antihypertensives
IF a person aged 50 or older has had a previous stroke, THEN the patient should be offered
antihypertensive medication.
make w2_bpmed=w2_hehbpb
replace w2_bpmed=w2_hehbpb1 if (w2_hehbpb=-1)
make w2_basecvd4=0 if not missing(w2_finstat)
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replace w2_basecvd4=1 if w2_stroke_d=1 & w2_bpmed0 & not missing(w2_bpmed)
make w2_dkcvd4=0 if not missing(w2_finstat)
replace w2_dkcvd4=1 if w2_stroke_d=1 & w2_bpmed=-8
make w2_refcvd4=0 if not missing(w2_finstat)
replace w2_refcvd4=1 if w2_stroke_d=1 & w2_bpmed=-9
make w2_passcvd4=0 if w2_basecvd4=1
replace w2_passcvd4=1 if w2_basecvd4=1 & w2_bpmed=1
Indicator depression suicide
IF a person aged 50 or older receives a diagnosis of a new depression episode, THEN the diagnosing
physician should ask on the day of diagnosis whether the person aged 65 or older had any thoughts
about suicide.
make w2_basedep1=0 if not missing(w2_finstat)
replace w2_basedep1=1 if w2_depres_d=1 & w2_hepsye=0
make w2_dkdep1=0 if not missing(w2_finstat)
replace w2_dkdep1=1 if w2_depres_d & w2_hepsye=-8
make w2_refdep1=0 if not missing(w2_finstat)
replace w2_refdep1=1 if w2_depres_d & w2_hepsye=-9
make w2_passdep1=0 if w2_basedep1=1
replace w2_passdep1=1 if w2_basedep1=1 & w2_hepsye=1
Indicator depression treatment (first iteration, diagnosed depression)
IF a person aged 50 or older is diagnosed with clinical depression, THEN antidepressant treatment, talking
treatment, or electroconvulsive therapy should be offered within 2 weeks after diagnosis unless within that
period the patient has improved, or unless the patient has substance abuse or dependence, in which case
treatment may wait until 8 weeks after the patient is in a drug- or alcohol-free state.
make w2_basedep2=0 if not missing(w2_finstat)
replace w2_basedep2=1 if w2_depres_d & w2_hepsya=0 & not missing(w2_hepsya)
make w2_dkdep2=0 if not missing(w2_finstat)
replace w2_dkdep2=1 if w2_depres_d & w2_hepsya=-8
make w2_dkrdep2=0 if not missing(w2_finstat)
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replace w2_dkrdep2=1 if w2_depres_d & w2_hepsya<-7
make w2_passdep2=0 if w2_basedep2=1
replace w2_passdep2=1 if w2_basedep2=1 & w2_hepsyb=1
Indicator depression review
IF a person aged 50 or older has no meaningful symptom response after 6 weeks of treatment, THEN one
of the following treatment options should be initiated by the 8th week of treatment: medication dose
should be optimised (if initial treatment was medication), or medication should be initiated (if initial
treatment was psychotherapy alone), or referral to a psychiatrist should be offered.
make w2_basedep3=0 if not missing(w2_finstat)
replace w2_basedep3=1 if w2_depres_d & w2_hepsyc=2
make w2_passdep3=0 if w2_basedep3=1
replace w2_passdep3=1 if w2_basedep3=1 & w2_hepsyd=1
Indicator diabetes HbA1c
IF a person aged 50 or older has diabetes, THEN his or her glycosylated haemoglobin or fructosamine level
should be measured at least annually.
make w2_basediab1=0 if not missing(w2_finstat)
replace w2_basediab1=1 if w2_hesug0 & w2_hesuga-8 & not missing(w2_hesug)
make w2_passdiab1=0 if w2_basediab1=1
replace w2_passdiab1=1 if w2_basediab1=1 & w2_hesuga=1
Indicator diabetes proteinuria
IF a diabetic person aged 50 or older does not have established renal disease and is not receiving an ACE
inhibitor or angiotensin II receptor blocker, THEN he or she should receive an annual test for proteinuria.
make w2_basediab2=0 if not missing(w2_finstat)
replace w2_basediab2=1 if w2_hekidn!=1 & w2_heacea=2 & w2_hewee=0 & not missing(w2_hewee)
make w2_dkdiab2=0 if not missing(w2_finstat)
replace w2_dkdiab2=1 if w2_hekidn!=1 & w2_heacea=2 & w2_hewee=-8
make w2_dkrdiab2=0 if not missing(w2_finstat)
replace w2_dkrdiab2=1 if w2_hekidn!=1 & w2_heacea=2 & w2_hewee<-7
make w2_passdiab2=0 if w2_basediab2=1
replace w2_passdiab2=1 if w2_basediab2=1 & w2_hewee=1
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Indicator diabetes cholesterol
IF a diabetic person aged 50 or older has a fasting total cholesterol level of 5 mmol/l or greater, THEN he
or she should be offered an intervention to lower cholesterol.
make w2_basediab6=0 if not missing(w2_finstat)
replace w2_basediab6=1 if w2_heacd=1 & w2_hechol=0 & not missing(w2_hechol)
make w2_passdiab6=0 if w2_basediab6=1
replace w2_passdiab6=1 if w2_basediab6=1 & w2_hechol=1
Indicator diabetes ACE inhibitor
IF a diabetic person aged 50 or older has one additional cardiac risk factor (ie, smoker, hypertension,
hypercholesterolemia, or renal insufficiency/microalbuminuria), THEN he/she should be offered an
ACE inhibitor or receptor blocker.
make w2_highbp2=0 if not missing(w2_finstat)
replace w2_highbp2 = 1 if (w2n_sysval=140 & not missing(w2n_sysval)) or (w2n_diaval=90 & not
missing(w2n_diaval))
make w2_basediab8=0 if not missing(w2_finstat)
replace w2_basediab8 = 1 if w2_heacd=1 &
(w2_heska=1orw2_highbp2=1orw2_hekidn=1orw2_heweea=1orw2_hichol_d=1orw2_hibp_d=1)&
((w2_heace0 & not missing(w2_heace))or(w2_heacea=0 & not missing(w2_heacea)))
make w2_dkdiab8=0 if not missing(w2_finstat)
replace w2_dkdiab8=1 if w2_heacd=1 &
(w2_heska=1orw2_highbp2=1orw2_hekidn=1orw2_heweea=1orw2_hichol_d=1orw2_hibp_d=1)&
(w2_heace=-8 & w2_heacea=-8)
make w2_passdiab8=0 if w2_basediab8=1
replace w2_passdiab8 = 1 if w2_basediab8=1 & (w2_heace=1orw2_heacea=1)
Indicator diabetes foot check
ALL diabetic persons aged 50 or older should have an annual examination of his/her feet.
make w2_basediab9=0 if not missing(w2_finstat)
replace w2_basediab9=1 if w2_heacd=1 & not missing(w2_heftchk) & w2_heftchk=0
make w2_passdiab9=0 if w2_basediab9=1
replace w2_passdiab9=1 if w2_basediab9=1 & w2_heftchk=1
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Indicator hypertension treatment: incident hypertension
IF a person aged 50 or older remains hypertensive after non-pharmacological intervention, THEN
pharmacological antihypertensive treatment should be initiated.
make w2_basehyp2=0 if not missing(w2_finstat)
replace w2_basehyp2=1 if w2_dim01_d=1 & w1_dim01_d!=1 & w2_hehbpb=0 & not
missing(w2_hehbpb)
make w2_passhyp2=0 if w2_basehyp2=1
replace w2_passhyp2=1 if w2_basehyp2=1 & w2_hehbpb=1
Indicator hypertension treatment: prevalent hypertension
IF a person aged 50 or older remains hypertensive after non-pharmacological intervention, THEN
pharmacological antihypertensive treatment should be initiated.
make w2_basehyp2a=0 if not missing(w2_finstat)
replace w2_basehyp2a=1 if w2_hibp_d=1 & w2_hehbpb=0 & not missing(w2_hehbpb)
make w2_passhyp2a=0 if w2_basehyp2a=1
replace w2_passhyp2a=1 if w2_basehyp2a=1 & w2_hehbpb=1
Indicator ischaemic heart disease cholesterol (cholesterol first iteration)
reported IDH and reported high cholesterol (previous variable:
w2_basechol1a & w2_passchol1a)
IF a person aged 50 or older has established CHD and LDL cholesterol 3 mmol/l, THEN he or she should be
offered an intervention to lower cholesterol.
make w2_baseihd1=0 if not missing(w2_finstat)
replace w2_baseihd1=1 if w2_hichol_d=1 & (w2_angina_d=1orw2_hrtattack_d=1) & w2_hechol=0 & not
missing(w2_hechol)
make w2_passihd1=0 if w2_baseihd1=1
replace w2_passihd1=1 if w2_baseihd1=1 & w2_hechol=1
Indicator ischaemic heart disease antiplatelets
IF a person aged 50 or older has established CHD and is not on warfarin, THEN he or she should be
offered antiplatelet therapy.
make w2_baseihd2=0 if not missing(w2_finstat)
replace w2_baseihd2=1 if (w2_angina_d=1orw2_hrtattack_d=1) & (w2_hehrta=0 & not missing
(w2_hehrta)) & w2_hehrtc!=1
make w2_dkihd2=0 if not missing(w2_finstat)
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replace w2_dkihd2=1 if (w2_angina_d=1orw2_hrtattack_d=1) & w2_hehrta=-8 & w2_hehrtc!=1
make w2_passihd2=0 if w2_baseihd2=1
replace w2_passihd2=1 if w2_baseihd2=1 & w2_hehrta=1
Indicator ischaemic heart disease smoking
IF a person aged 50 or older with established CHD smokes, THEN he or she should be offered counselling
for smoking cessation.
make w2_baseihd3=0 if not missing(w2_finstat)
replace w2_baseihd3=1 if (w2_angina_d=1orw2_hrtattack_d=1) & not missing(w2_hecgstp)
& w2_hecgstp=0
make w2_dkihd3=0 if not missing(w2_finstat)
replace w2_dkihd3=1 if (w2_angina_d=1orw2_hrtattack_d=1) & w2_hecgstp=-8
make w2_passihd3=0 if w2_baseihd3=1
replace w2_passihd3=1 if w2_baseihd3=1 & w2_hecgstp=1
Indicator myocardial infarction beta-blocker: incident myocardial infarction
IF a person aged 50 or older has had a recent MI, THEN he or she should be offered a beta-blocker.
make w2_betab=0 if not missing(w2_finstat)
replace w2_betab=1 if w2_hebeta=1orw2_hebetb=1
replace w2_betab= if (mi(w2_hebeta)orw2_hebeta<0) & (mi(w2_hebetb)orw2_hebetb<0)
make w2_baseihd5=0 if not missing(w2_finstat)
replace w2_baseihd5=1 if w2_dia03_d=1 & w1_dim03_d!=1 & not missing(w2_betab)
make w2_dkihd5=0 if not missing(w2_finstat)
replace w2_dkihd5=1 if w2_dia03_d=1 & w1_dim03_d!=1 & (w2_hebeta=-8 & w2_hebetb=-8)
make w2_passihd5=0 if w2_baseihd5=1
replace w2_passihd5=1 if w2_baseihd5=1 & w2_betab=1
Indicator myocardial infarction beta-blocker: prevalent myocardial infarction
IF a person aged 50 or older has had a recent MI, THEN he or she should be offered a beta-blocker.
make w2_baseihd5a=0 if not missing(w2_finstat)
replace w2_baseihd5a=1 if w2_hrtattack_d=1 & not missing(w2_betab)
make w2_dkihd5a=0 if not missing(w2_finstat)
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replace w2_dkihd5a=1 if w2_hrtattack_d=1 & (w2_hebeta=-8 & w2_hebetb=-8)
make w2_passihd5a=0 if w2_baseihd5a=1
replace w2_passihd5a=1 if w2_baseihd5a=1 & w2_betab=1
Indicator international normalised ratio test
(IHD extra indicator – previously med3) limited to IHD (MI and angina) by questionnaire so aggregate as
IHD variable.
IF a person aged 50 or older is prescribed warfarin, THEN an INR should be determined at least every
12 weeks.
make w2_baseihd6=0 if not missing(w2_finstat)
replace w2_baseihd6=1 if w2_hehrtc=1 & (w2_hehrte=0 & not missing(w2_hehrte))
make w2_dkihd6=0 if not missing(w2_finstat)
replace w2_dkihd6=1 if w2_hehrtc=1 & w2_hehrtd=-8
make w2_passihd6=0 if w2_baseihd6=1
replace w2_passihd6=1 if w2_baseihd6=1 & w2_hehrte=1
Indicator osteoarthritis exercise
IF an ambulatory person aged 50 or older has had a diagnosis of symptomatic osteoarthritis of the knee
for longer than 3 months and has no contraindications to exercise and is physically and mentally able to
exercise, THEN a directed or supervised strengthening or aerobic exercise programme should have been
prescribed at least once.
make w2_baseoa2=0 if not missing(w2_finstat)
replace w2_baseoa2=1 if w2_hekneb=0 & not missing(w2_hekneb)
make w2_passoa2=0 if w2_baseoa2=1
replace w2_passoa2=1 if w2_baseoa2=1 & w2_hekneb=1
Indicator osteoarthritis education
IF an ambulatory person aged 50 or older has a diagnosis of symptomatic osteoarthritis, THEN education
regarding the natural history, treatment and self-management of the disease should be offered at least once.
make w2_alleduc=0 if not missing(w2_finstat)
replace w2_alleduc=1 if w2_hearta=1 & w2_heartb=1 & w2_heartc=1
replace w2_alleduc= if w2_hearta<0 or w2_heartb<0 or w2_heartc<0 or mi(w2_hearta,
w2_heartb, w2_heartc)
make w2_baseoa3=0 if not missing(w2_finstat)
replace w2_baseoa3=1 if w2_heartoa=1 & not missing(w2_alleduc)
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make w2_dkoa3=0 if not missing(w2_finstat)
replace w2_dkoa3=1 if w2_heartoa=1 & (w2_hearta=-8 or w2_heartb=-8 or w2_heartc=-8)
make w2_passoa3=0 if w2_baseoa3=1
replace w2_passoa3=1 if w2_baseoa3=1 & w2_alleduc=1
Indicator osteoarthritis paracetamol
IF oral pharmacological therapy is initiated to treat osteoarthritis among people aged 50 or older,
THEN paracetamol should be the first drug used, unless there is a contraindication to use.
make w2_baseoa4=0 if not missing(w2_finstat)
replace w2_baseoa4=1 if w2_heartoa=1 & w2_hearte=0 & not missing(w2_hearte)
make w2_dkoa4=0 if not missing(w2_finstat)
replace w2_dkoa4=1 if w2_heartoa=1 & w2_hearte=-8
make w2_passoa4=0 if w2_baseoa4=1
replace w2_passoa4=1 if w2_baseoa4=1 & w2_hearte=1
Indicator osteoarthritis referral
IF a person aged 50 or older with severe symptomatic osteoarthritis of the knee or hip has failed to
respond to non-pharmacological and pharmacological therapy, THEN the patient should be offered referral
to an orthopaedic surgeon to be evaluated for total joint replacement within 6 months unless surgery
is contraindicated.
make w2_baseoa6=0 if not missing(w2_finstat)
replace w2_baseoa6=1 if w2_hepae=2 & w2_hepaf=0 & not missing(w2_hepaf)
make w2_dkoa6=0 if not missing(w2_finstat)
replace w2_dkoa6=1 if w2_hepae=2 & w2_hepaf=-8
make w2_passoa6=0 if w2_baseoa6=1
replace w2_passoa6=1 if w2_baseoa6=1 & w2_hepaf=1
Patient-centered care
Indicator diabetes training
Some people with diabetes receive training to help manage their diabetes themselves. Have you ever
participated in a course or class about diabetes, or received special training on how you can live with your
diabetes from day to day?
make w2_basepat1=0 if not missing(w2_finstat)
replace w2_basepat1=1 if w2_heacd=1 & not missing(w2_heslfcr) & w2_heslfcr=0
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make w2_passpat1=0 if w2_basepat1=1)
replace w2_passpat1=1 if w2_basepat1=1 & w2_heslfcr=1
Indicator diabetes knowledge
How much do you think you know about managing your diabetes? (‘just about everything you need to
know’ or ‘most of what you need to know’).
make w2_basepat2=0 if not missing(w2_finstat)
replace w2_basepat2=1 if w2_heacd=1 & not missing(w2_heslfcb) & w2_heslfcb=0
make w2_dkpat2=0 if not missing(w2_finstat)
replace w2_dkpat2=1 if w2_heacd=1 & w2_heslfcb=-8
make w2_passpat2=0 if w2_basepat2=1
replace w2_passpat2=1 if w2_basepat2=1 & (w2_heslfcb=1 or w2_heslfcb=2)
Indicator cholesterol explanation
Has a doctor or nurse explained high cholesterol in a way you could understand?
replace w2_basepat3=1 if w2_hecholb=1 or w2_hecholb=2
make w2_passpat3=0 if w2_basepat3=1
replace w2_passpat3=1 if w2_basepat3=1 & w2_hecholb=1
Indicator cholesterol preferences
Have doctors or nurses taken your preferences into account when making treatment decisions about your
high cholesterol?
make w2_basepat4=0 if not missing(w2_finstat)
replace w2_basepat4=1 if w2_hecholc=1 or w2_hecholc=2
make w2_passpat4=0 if w2_basepat4=1
replace w2_passpat4=1 if w2_basepat4=1 & w2_hecholc=1
Indicator blood pressure explanation
Has a doctor or nurse explained high blood pressure in a way you could understand at any time since you
were first told you had high blood pressure?
make w2_basepat5=0 if not missing(w2_finstat)
replace w2_basepat5=1 if w2_hehbp=1 or w2_hehbp=2
make w2_passpat5=0 if w2_basepat5=1
replace w2_passpat5=1 if w2_basepat5=1 & w2_hehbp=1
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Indicator blood pressure choice
In general, have doctors or nurses given you any choice about how to treat your high blood pressure?
make w2_basepat6=0 if not missing(w2_finstat)
replace w2_basepat6=1 if w2_hehbpa=1 or w2_hehbpa=2
make w2_passpat6=0 if w2_basepat6=1
replace w2_passpat6=1 if w2_basepat6=1 & w2_hehbpa=1
Indicator osteoarthritis treatment purpose
Has any doctor or nurse ever talked to you about what the specific purpose of the treatment for your
arthritis or joint pain is?
make w2_basepat7=0 if not missing(w2_finstat)
replace w2_basepat7=1 if w2_heartoa=1 & (w2_heartd=1 or w2_heartd=2)
make w2_passpat7=0 if w2_basepat7=1
replace w2_passpat7=1 if w2_basepat7=1 & w2_heartd=1
Subsequent waves
Wave number is named X, one wave before is X-1, 2 waves before is X-2 and three waves before is X-3.
NB: not all indicators can be generated at every wave.
Indicator stroke antihypertensives
make wX_bpmed=wX_hehbpb
replace wX_bpmed=wX_hehbpb1 if (wX_hehbpb=-1)
make wX_basecvd4=0 if not missing(wX_finstat)
replace wX_basecvd4=1 if wX_stroke_d=1 & ((wX-3_bpmed>0 & not missing(wX-3_bpmed)) or
(wX-2_bpmed>0 & not missing(wX-2_bpmed)) or (wX-1_bpmed>0 & not missing(wX-1_bpmed)) or
(wX_bpmed>0 & not missing(wX_bpmed)))
make wX_passcvd4=0 if wX_basecvd4=1
replace wX_passcvd4=1 if wX_basecvd4=1 & (wX-3_bpmed=1orwX-
2_bpmed=1orwX-1_bpmed=1orwX_bpmed=1)
Indicator depression suicide
make wX_basedep1=0 if not missing(wX_finstat)
replace wX_basedep1=1 if wX_depres_d=1 & wX_hepsye>=0 & not missing(wX_hepsye)
make wX_passdep1=0 if wX_basedep1=1
replace wX_passdep1=1 if wX_basedep1=1 & wX_hepsye=1
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Indicator depression treatment
make wX_basedep2=0 if not missing(wX_finstat)
replace wX_basedep2=1 if wX_depres_d=1 & wX_hepsya>=0 & not missing(wX_hepsya)
make wX_passdep2=0 if wX_basedep2=1
replace wX_passdep2=1 if wX_basedep2=1 & wX_hepsyb=1
Indicator diabetes HbA1c
make wX_basediab1=0 if not missing(wX_finstat)
replace wX_basediab1=1 if wX_hesug>=0 & wX_hesuga>-8 & not missing(wX_hesug, wX_hesuga)
make wX_passdiab1=0 if wX_basediab1=1
replace wX_passdiab1=1 if wX_basediab1=1 & wX_hesuga=1
Indicator diabetes proteinuria
make wX_basediab2=0 if not missing(wX_finstat)
replace wX_basediab2=1 if wX_hekidn!=1 & wX_heacea=2 & wX_hewee>=0 & not missing(wX_hewee)
make wX_passdiab2=0 if wX_basediab2=1
replace wX_passdiab2=1 if wX_basediab2=1 & wX_hewee=1
Indicator diabetes cholesterol
make wX_basediab6=0 if not missing(wX_finstat)
replace wX_basediab6=1 if wX_diab_d=1 & wX_hechol>=0 & not missing(wX_hechol)
make wX_passdiab6=0 if wX_basediab6=1
replace wX_passdiab6=1 if wX_basediab6=1 & wX_hechol=1
Indicator diabetes ACE inhibitor
make wX_basediab8=0 if not missing(wX_finstat)
replace wX_basediab8=1 if wX_diab_d=1 &
(wX_heska=1orwX_hekidn=1orwX_heweea=1orwX_hichol_d=1orwX_hibp_d=1) &
( (wX_heace>0 & not missing(wX_heace)) or (wX_heacea>=0 & not missing(wX_heacea)) )
make wX_passdiab8=0 if wX_basediab8=1
replace wX_passdiab8=1 if wX_basediab8=1 & (wX_heace=1orwX_heacea=1)
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Indicator diabetes foot check
make wX_basediab9=0 if not missing(wX_finstat)
replace wX_basediab9=1 if wX_heftchk>=0 & not missing(wX_heftchk)
make wX_passdiab9=0 if wX_basediab9=1
replace wX_passdiab9=1 if wX_basediab9=1 & wX_heftchk=1
Indicator hypertension treatment: incident hypertension
make wX_basehyp2=0 if not missing(wX_finstat)
replace wX_basehyp2=1 if (wX_hedimbp=1 & wX_hedasbp!=1) & wX_hehbpb>=0 & not
missing(wX_hehbpb)
make wX_passhyp2=0 if wX_basehyp2=1
replace wX_passhyp2=1 if wX_basehyp2=1 & wX_hehbpb=1
Indicator hypertension treatment: prevalent hypertension
make wX_basehyp2a=0 if not missing(wX_finstat)
replace wX_basehyp2a=1 if wX_hibp_d=1 & wX_hehbpb>=0 & not missing(wX_hehbpb)
make wX_passhyp2a=0 if wX_basehyp2a=1
replace wX_passhyp2a=1 if wX_basehyp2a=1 & wX_hehbpb=1
Indicator ischaemic heart disease cholesterol
make wX_baseihd1=0 if not missing(wX_finstat)
replace wX_baseihd1=1 if wX_chd_d=1 & wX_hechol>=0 & not missing(wX_hechol)
make wX_passihd1=0 if wX_baseihd1=1
Indicator ischaemic heart disease antiplatelets
make wX_baseihd2=0 if not missing(wX_finstat)
replace wX_baseihd2=1 if wX_chd_d=1 & (wX_hehrta>=0 & not missing(wX_hehrta)) & wX_hehrtc!=1
make wX_passihd2=0 if wX_baseihd2=1
replace wX_passihd2=1 if wX_baseihd2=1 & wX_hehrta=1
Indicator ischaemic heart disease smoking
make wX_baseihd3=0 if not missing(wX_finstat)
replace wX_baseihd3=1 if wX_chd_d=1 & ((wX-3_hecgstp>0 & not missing(wX-3_hecgstp)) or
(wX_Hecgstp>0 & not missing(wX_Hecgstp)) )
make wX_passihd3=0 if wX_baseihd3=1
replace wX_passihd3=1 if wX_baseihd3=1 & (wX-3_hecgstp=1orwX_Hecgstp=1)
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Indicator myocardial infarction beta-blocker: incident myocardial infarction
make wX_betab=0 if wX_hebeta=2orwX_hebetb=2
replace wX_betab=1 if wX_hebeta=1orwX_hebetb=1
make wX_baseihd5=0 if not missing(wX_finstat)
replace wX_baseihd5=1 if wX_hedimmi=1 & wX-1_hedimmi!=1 & not missing(wX_betab)
make wX_passihd5=0 if wX_baseihd5=1
replace wX_passihd5=1 if wX_baseihd5=1 & wX_betab=1
Indicator myocardial infarction beta-blocker: prevalent myocardial infarction
make wX_baseihd5a=0 if not missing(wX_finstat)
replace wX_baseihd5a=1 if wX_hrtattack_d=1 & not missing(wX_betab)
make wX_passihd5a=0 if wX_baseihd5a=1
replace wX_passihd5a=1 if wX_baseihd5a=1 & wX_betab=1
Indicator ischaemic heart disease international normalised ratio test
make wX_baseihd6=0 if not missing(wX_finstat)
replace wX_baseihd6=1 if wX_hehrtc=1 & (wX_hehrte>=0 & not missing(wX_hehrte))
make wX_passihd6=0 if wX_baseihd6=1
replace wX_passihd6=1 if wX_baseihd6=1 & wX_hehrte=1
Indicator osteoarthritis exercise
make wX_baseoa2=0 if not missing(wX_finstat)
replace wX_baseoa2=1 if wX_heartoa=1 & ( (wX-3_hekneb>0 & not missing(wX-3_hekneb))
or(wX-2_hekneb>0 & not missing(wX-2_hekneb)) or (wX-1_hekneb>0 & not missing(wX-1_hekneb))
or (wX_hekneb>0 & not missing(wX_hekneb)) )
make wX_passoa2=0 if wX_baseoa2=1
replace wX_passoa2=1 if wX_baseoa2=1 & (wX-3_hekneb=1or wX-2_hekneb=1or
wX-1_hekneb=1or wX_hekneb=1)
Indicator osteoarthritis education
make wX_alleduc=0 if wX_hearta>0 & wX_heartb>0 & wX_heartc>0 & not missing(wX_hearta,
wX_heartb, wX_heartc)
replace wX_alleduc=1 if wX_hearta=1 & wX_heartb=1 & wX_heartc=1
make wX_baseoa3=0 if not missing(wX_finstat)
replace wX_baseoa3=1 if wX_heartoa=1 &
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(not missing(wX-3_alleduc)or not missing(wX-2_alleduc)or not missing(wX-1_alleduc)or not
missing(wX_alleduc))
make wX_passoa3=0 if wX_baseoa3=1
replace wX_passoa3=1 if wX_baseoa3=1 &
(wX-3_alleduc=1orwX-2_alleduc=1orwX-1_alleduc=1or wX_alleduc=1)
Indicator osteoarthritis paracetamol
make wX_baseoa4=0 if not missing(wX_finstat)
replace wX_baseoa4=1 if wX_heartoa=1 & ((wX-3_hearte>0 & not missing(wX-3_hearte)) or
(wX-2_hearte>0 & not missing (wX-2_hearte)) or (wX-1_hearte>0 & not missing (wX-1_hearte)) or
(wX_hearte>0 & not missing(wX_hearte)))
make wX_passoa4=0 if wX_baseoa4=1
replace wX_passoa4=1 if wX_baseoa4=1 & (wX-3_hearte=1or wX-2_hearte=1or
wX-1_hearte=1or wX_hearte=1)
Indicator osteoarthritis referral
make wX_baseoa6=0 if not missing(wX_finstat)
replace wX_baseoa6=1 if wX_heartoa=1 & wX_hehipc=2 & wX_hepsur>=0 & not missing(wX_hepsur)
make wX_passoa6=0 if wX_baseoa6=1
replace wX_passoa6=1 if wX_baseoa6=1 & wX_hepsur=1
Indicator diabetes training
make wX_basepat1=0 if not missing(wX_finstat)
replace wX_basepat1=1 if wX_diab_d=1 & ((w2_heslfcr>0 & not missing(w2_heslfcr)) or(w3_heslfcr>0
& not missing(w3_heslfcr)) or (wX_heslfcr>0 & not missing(wX_heslfcr)) )
make wX_passpat1=0 if wX_basepat1=1
replace wX_passpat1=1 if wX_basepat1=1 & (wX-2_heslfcr=1or wX-1_heslfcr=1or wX_heslfcr=1)
Indicator diabetes knowledge
make wX_basepat2=0 if not missing(wX_finstat)
replace wX_basepat2=1 if wX_diab_d=1 & not missing(wX_heslfcb) & wX_heslfcb>=0
make wX_passpat2=0 if wX_basepat2=1
replace wX_passpat2=1 if wX_basepat2=1 & (wX_heslfcb=1 or wX_heslfcb=2)
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Indicator osteoarthritis treatment purpose
make wX_basepat7=0 if not missing(wX_finstat)
replace wX_basepat7=1 if wX_heartoa=1 & ((wX-2_heartd>0 & not missing(wX-2_heartd)) or
(wX-1_heartd>0 & not missing(wX-1_heartd)) or(wX_heartd>0 & not missing(wX_heartd)) )
make wX_passpat7=0 if wX_basepat7=1
replace wX_passpat7=1 if wX_basepat7=1 & (wX-2_heartd=1orwX-1_heartd=1orwX_heartd=1)
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Appendix 3 Protocol: key changes
The dynamics of quality: a national panel study of
evidence-based standards
Primary outcome measures: owing to differences in the way questions were asked to the respondents,
quality indicators are not available for all conditions at all four waves; the following table shows
data availability.
Quality indicators for the four diseases Availability of data
Cardiovascular disease
Hypertension treatment All
IHD cholesterol 2 and 5
IHD antiplatelets 2 and 5
INR test 2 and 5
IHD smoking 2 and 5
MI beta-blocker 2 and 5
OA
OA exercise All
OA education All
OA paracetamol All
OA referral All
Receipt of hip or knee joint replacement if indicated, and whether received
through NHS or non-NHS health care
All for receipt of joint replacement;
4 and 5 for payment
Diabetes
Diabetes HbA1c All
Diabetes proteinuria All
Diabetes cholesterol 2 and 5
Diabetes ACE inhibitor 2, 4 and 5
Diabetes foot check All
Depression
Depression suicide 2 and 4
Depression treatment 2 and 4
Depression review 2
OA, osteoarthritis.
In addition to those indicators listed above, we can generate stroke antihypertensive use at all four waves.
DOI: 10.3310/hsdr03110 HEALTH SERVICES AND DELIVERY RESEARCH 2015 VOL. 3 NO. 11
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Hardcastle et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
107
Patient-centred care
l Diabetes training: waves 2 and 4.
l Diabetes knowledge: waves 2 and 4.
l Cholesterol explanation: wave 2 only.
l Cholesterol preferences: wave 2 only.
l Blood pressure explanation: wave 2 only.
l Blood pressure choice: wave 2 only.
l Osteoarthritis treatment purpose: waves 2 and 4.
Effects of loss of quality indicator data
Cardiovascular disease, osteoarthritis and diabetes have sufficient measurements for all the indicators for
longitudinal analyses. Depression has two quality indicators available in waves 2 and 4 for longitudinal
analyses. Unfortunately, one quality indicator was only asked at wave 2, so comparisons over time cannot
be drawn for that indicator.
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Appendix 4 Public and Patient Involvement in
Research report
The PPIRes project in Norfolk and Suffolk is a local initiative to enable and encourage volunteer membersof the public to collaborate with researchers in local trusts and universities. Our study had two PPIRes
steering committee members, Mrs Amander Wellings and Mr Dave Stott. They joined the study steering
group meetings and usefully contributed to the research team discussions about factors that might be
associated with quality of care. It is worth noting that it was difficult achieving meaningful patient
involvement in this study which largely evaluated professional practice.
After the first meeting there was discussion about whether or not ELSA could be used to explore
information regarding patient perceptions of their interactions with their clinician. There were also
discussions regarding what biographical factors should be used to predict quality of care. With regard to
patient perceptions, we used the patient-centred quality indicators. These are not ideal measures as they
were primarily designed to measure the performance of the health-care system and so focus on the offer
of effective care. The idea was to be able to give clinicians credit for offering/discussing good care, without
penalty if their patients made an informed decision not to take a particular treatment. The biographical
data discussion was based around availability and ethical considerations of using these data. Age, sex,
ethnicity and sexual orientation were mentioned, and barring sexual orientation (which is being asked in
wave 6 onwards and hence the data are not available for this work), these factors were included in the
modelling process. Geography was discussed; however, this is not routinely released to protect patient
confidentiality, and was not used in our analyses.
When we were amalgamating factors that might be associated with quality of care, a ‘long-list’ was sent
to the PPIRes representatives as a base on which they could build further ideas for us to model. The
following points were raised as ideas to follow up if possible:
l The proportion of patients: making use of telephone consultations or maybe using repeat prescriptions
or non-attending pre-booked appointments or using home visits or using emergency after hours/
weekend locum call-outs or having referrals to hospital consultants or other non-practice-based
specialist services?
l The proportion of patients: seeing multiple clinicians within a practice for the same or maybe
different ailments.
l Some other biographical factors might include patients’ mental health history (more than just the
CES-D depression scale) or pattern of illegal drug or alcohol use – more than the ‘days since having
had an alcoholic drink’ question. More ‘left field’, we wondered whether ELSA had any information on
patients’ religion.
l Geographical distance of patients’ homes to GP surgery, or even mode of transport from home to
surgery. In part this might tap in to the ‘access’ issue that remains a key strand of the national
health-care agenda. It might also link with the availability/mobility of carers or other helpful
family/neighbours?
l The proportion of patients who attend appointments accompanied by a carer, friend, family member or
other more formal ‘advocate’ or representative? Probably not captured in patient records or ELSA but
nonetheless interesting. Again quite easy to understand the additional pressures/encouragement for a
clinician to do more or appear to do more/better when there is a third – though arguably relatively
high status – independent presence in the consultation room.
l We also thought about the extent to which equity of health care might relate to the presentation
of multiple ailments at the same consultation? One can easily imagine patients – ourselves
included – saving up symptoms into a bundle that makes a surgery visit worthwhile/economical.
Though similar, we guess, to the ‘one more thing doctor before I leave’ scenario, we do not feel it is
entirely the same phenomena. It would be quite easy to see how some patients simultaneously
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presenting with say three or four problems might inadvertently downplay or forget the most critical
one – possibly due to consultation stress or issues of ‘cognition’. This could result in some GPs
understandably focusing more upon on the first or least problematic of presented symptoms. (We are,
however, well aware that GPs normally ask patients to focus on one problem per visit or invite them
produce a hierarchy of problems but in reality. . .) Empathising somewhat with the plight of clinicians
the phrase ‘hard to see the wood for the trees’ came to mind.
l One other variant of this phenomena could be patients with multiple problems, i.e. patients with
a pre-existing problem, for which they are already being treated but who subsequently develop
symptoms of other problems but about which they delay telling their GP, sometimes until its very
or too late. Why? We are both aware of some patients who feel they have used up their NHS
‘entitlement’ to health care by having just one health problem and therefore defer going to their GP
for fear of developing a practice reputation as a worrier or hypochondriac. How and when these
patients alert their GP to these other/secondary issues is interesting but probably not for this project?
l We know that some clinicians, previously inclined so to do, no longer mark or otherwise signal on
patients files their surgery reputation as being awkward, difficult, truculent, badly behaved – though
anecdotally are aware locally of things like NfN (Normal for Norfolk). That said we could fully
understand the temptation for clinicians not to be as thorough, sympathetic or caring towards certain
types of patient – even down to ushering them out of the consultation door as quickly as possible. We
cannot help but feel patient behaviour/reputation might well have a role in patients receipt of quality
health care though can think of no way of getting access to or testing this, well at least not as part of
this study. Whilst on this theme we wondered in that same ‘left field’ way, and howsoever broached
whether criminal conviction or even a propensity among some patients for ‘crying wolf’ might be
worth exploring.
l Finally we had an even wilder thought about whether a synergy between an individual patient’s profile
with that of his/her GP might be an interesting avenue to explore. We are not really expecting a
response to this one but believe we have read somewhere about evidence drawn from wider
therapeutic encounters to suggest the greater the ‘fit’ – biographical/social/political/personal, etc. –
between clinician and patient the more likely the patient is to feel they have received a better quality
of care. We even had some momentary some fun with the notion that ELSA might have enquired
about patients’ political affiliations!
l Patients being scared about going to their clinician – the ‘white coat syndrome’, e.g. how this
syndrome could affect some patients say with obesity/BMI. The GP says ‘lose weight‘ but the patient is
not emotionally ready to take this advice on board at that point resulting in them not going back to
the GP or at least not doing so for some considerable time or at a crisis, or looking for a different GP.
Also possibly elongating the time between the onset of a health condition and the patient actually
presenting themselves for a diagnosis and treatment. So link BMI with length of time from onset to
presentation. Also possibly link with alcohol consumption/smoking and presentation.
l The potentially important role of patients’ spouses in their quality of health care.
l Comparing/contrasting the optimists and pessimists, i.e. feeling satisfied how life has turned out and
feeling what has happened is out of their control. If one feels life is out of control it assumes cannot do
anything about improving my own health.
l Carer support – (a) Importance of cognitive status. This could usefully link to the availability and
importance to a patient having the support of a ‘carer’. With reference to ‘cognition’ there is an
important ‘time’ variable between a patient gaining their educational qualifications – possibly many
years ago – and their present cognitive state and therefore inability to actually use their education/
knowledge/skills ‘now’ to help them more effectively problem solve and ask for or gain the quality of
healthcare they so need. (b) Eyesight/hearing and linked it with the availability or otherwise and level of
carer support. (c) You rightly identified ‘access to care’ as a big issue in primary care. In this context you
began to explore the notion of ‘home visits and also a patient’s ability to walk to the surgery. Again
the role of a carer could be key in such patients accessing high quality GP care. Look at last wave to
see if cutbacks to care plays a part? Also could look at financial status e.g. total wealth amount of care
from the 1st wave to the last. Is this carer a paid carer in the questionnaire?
APPENDIX 4
NIHR Journals Library www.journalslibrary.nihr.ac.uk
110
These comments were mapped to the information that we could extract from the ELSA questionnaire, and
the following table shows the result of this mapping.
Mapping PPIRes ideas to ELSA data
Question/translation Use ability?
Telephone consults, repeat prescriptions, non-attendance,
home visits, locum call outs, number of hospital referrals,
use of non-practice based services
Not available, may be examined if linkage with GPPS if it
asks those questions
Multiple clinicians within a practice being seen by patient N/A
Mental health history – more than CES-D
Pattern of illegal drug use
Religion
N/A
N/A
General question in self-completion asks if member of
organisations/clubs/societies including church. Used in social
detachment measure (scorg)
Distance from house to surgery
Transport from house to surgery (access issues)
How easy is it for you to get to GP? In self-completion
module, scale very easy to don’t want to go
Attendance of carer/friend at GP visits N/A
Presentation of multiple ailments at one visit – ‘There’s one
more thing before I go doctor. . .’
Comorbidities measured no information on whether these
are all identified at one visit or several. Do have time since
diagnosis, perhaps could link together to see if diagnosed
with several conditions very quickly?
Multiple problems i.e. if being treated for one condition
and develop and second/third why do they not seek the
doctor’s advice earlier
Have a measure of comorbidities and also time since
diagnosis for the 4 main diseases of interest. Can’t measure
why they do not seek advice earlier
‘Normal for Norfolk’ (NfN)/crying wolf/patient behaviour If patient is ‘badly behaved’ or perceived as NfN do they get
worse health care? Can’t measure this
Synergy between GP and patient
Political affiliations
General question in self-completion asks if member of
organisations/clubs/societies including church. Used in social
detachment measure (scorg)
Time since diagnosis and BMI/alcohol/smoking – tests for
white coat syndrome – if I go to my GP she/he will tell me
to lose weight, stop drinking/smoking therefore I won’t go
about my disease/illness
Can look at, time since diagnosis going into main regression
model anyway. Also BMI/smoking/alcohol intakes
Role of spouses in quality of health care Have marital status, carer availability and whether the care is
useful or not
Sense of control and optimism/pessimism Sense of control in model, can’t really address the
differences between optimists/pessimists
Carer support part 1
Present cognition/knowledge i.e. there is a length of
time between when a person gets their qualifications
and present cognitive state. I take this to mean that
some old people feel a lack of control over their
environment e.g. using a computer, electronics etc.
as this is very different from what they learnt about
Could use sense of control CASP-19 this is already in model
Time between qualification to present day cannot do
DOI: 10.3310/hsdr03110 HEALTH SERVICES AND DELIVERY RESEARCH 2015 VOL. 3 NO. 11
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Hardcastle et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
111
Mapping PPIRes ideas to ELSA data
Question/translation Use ability?
Carer support part 2
Eyesight/hearing. Do you have sufficient support from
your carer due to these difficulties?
Sight and hearing in model. Also carer availability, see above
Carer support part 3
Access to care
Have there been cutbacks to care?
Role of carer in access to GP
Question asked in self-completion module
N/A
N/A, not applicable.
Comments on the role of Public and Patient Involvement from
Mrs Wellings
In my view the role of the public and patient involvement (PPI) member of the team often seemed vague
especially due to the statistical nature of this piece of research and the reliance on analysis of secondary
data. Much of what I thought as a lay member of the team ended up not being relevant within the
confines of the data. Much of the statistical debate went on without me really understanding what was
being discussed. There were none of the parts of research where PPI members can play an active role as
this research was not recruiting patients. I felt like the team tried to include me but it was often difficult. I
thought the study would be interesting as its policy and practical interventions seemed very good and I
could see where it could make a real difference to patient outcomes. ‘A clearer picture of who is at most
risk from poor quality care would inform the design of targeted interventions to improve quality of care,
and/or improve access for previously under-served groups. It would inform the further development and
refinement of national quality of care surveys: with co-applicant JC there is a real opportunity to follow up
results with targeted questions in the General Practice Patient Survey or similar surveys, to improve primary
care quality. This proposal is limited to four conditions, and if successful this methodology can be extended
to other common chronic conditions in primary care’ (quote from the protocol). My interest being, how
the health service seems to work better for some than others and why barriers exist and how we can
remove them. As a life-long carer of people with mental health problems, learning disabilities, autism and
stroke heart failure and head injury to name but a few of the conditions I have experience of, it is
important for me to make a visit to the GP as easy as possible. I would be interested in future work in this
area, but not a very large statistical study as I feel my strengths did not really reflect what was needed in
this team.
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Appendix 5 Detailed breakdown of the whole
English Longitudinal Study of Ageing sample
Detailed breakdown of the whole ELSA Sample by wave and covaraite
Covariate Wave 2, n (%) Wave 3, n (%) Wave 4, n (%) Wave 5, n (%)
Sex
Female 5307 (56) 5476 (56) 6125 (56) 5705 (56)
Male 4125 (44) 4295 (44) 4925 (44) 4569 (44)
Age (years)
50–64 4424 (48) 4919 (53) 5571 (52) 4718 (47)
65–74 2643 (29) 2371 (25) 3047 (28) 3061 (30)
75+ 2104 (23) 2053 (22) 2131 (20) 2316 (23)
NS-SEC
Managerial/professional 2557 (28) N/A 2769 (28) 3428 (35)
Intermediate 3612 (39) N/A 3919 (39) 2543 (26)
Routine 2993 (33) N/A 3258 (33) 3938 (40)
Highest educational qualification
None 5008 (30) N/A N/A 2665 (16)
Intermediate 4335 (36) N/A N/A 3967 (24)
Degree or higher education below a degree 2721 (16) N/A N/A 3563 (21)
Eyesight
Excellent/very good 8089 (86) 8301 (85) 9577 (87) 8881 (86)
Good/fair, poor, blind 1337 (14) 1463 (15) 1465 (13) 1381 (14)
General health
Excellent/good 6711 (72) 8868 (93) 7819 (74) 7176 (74)
Fair/poor 2583 (28) 666 (7) 2775 (26) 2549 (26)
Hearing
Good to excellent 7436 (79) 7689 (79) 8808 (80) 8121 (79)
Fair to poor 1992 (21) 2077 (21) 2233 (20) 2142 (21)
Chronic pain
None 5786 (62) 5942 (62) 6413 (61) 5861 (60)
Mild 968 (10) 1091 (11) 1252 (12) 1176 (12)
Moderate 1822 (20) 1733 (19) 2102 (20) 1888 (19)
Severe 715 (8) 761 (8) 819 (8) 797 (8)
Has long-standing illness
No 4103 (44) 4473 (46) 5057 (46) 4645 (45)
Yes 1982 (21) 2001 (20) 2208 (20) 2007 (20)
Yes: limiting 3341 (35) 3290 (34) 3776 (34) 3608 (35)
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Covariate Wave 2, n (%) Wave 3, n (%) Wave 4, n (%) Wave 5, n (%)
ADL
None/one 8586 (90) 8838 (90) 10,036 (91) 9309 (91)
Two or more 946 (10) 933 (10) 1014 (9) 965 (9)
IADL
None/one 8368 (89) 8717 (89) 9945 (90) 9562 (93)
Two or more 1064 (11) 1054 (11) 1105 (10) 712 (7)
Cognitive impairment
No 8063 (48) 8103 (48) 8495 (51) 8511 (51)
Yes 896 (5) 901 (5) 944 (6) 950 (6)
Health literacy
Low 1108 (7) N/A N/A 915 (5)
Medium 1805 (11) N/A N/A 1506 (9)
High 5989 (36) N/A N/A 6868 (41)
Alcohol consumption
1–2 times/week or less 5256 (31) 5099 (30) 5757 (34) 5725 (34)
3–4 times/week or more 2888 (17) 2818 (17) 3346 (20) 3137 (19)
Physical activity level
Sedentary 556 (6) 686 (7) 835 (8) 801 (8)
Low 2309 (25) 2263 (23) 2562 (23) 2452 (24)
Medium 4688 (50) 4884 (50) 5388 (49) 4996 (49)
High 1744 (19) 1972 (20) 2254 (20) 2014 (20)
Smoking status
Never 3472 (37) 3770 (39) 4336 (40) 3827 (38)
In past 4482 (48) 3485 (46) 5001 (46) 5000 (49)
Current smoker 1475 (16) 1510 (15) 1545 (14) 1312 (13)
Diet
Eats ‘5-a-day’ N/A 2592 (15) 3869 (23) 4972 (30)
Does not eat ‘5-a-day’ N/A 2142 (13) 3089 (18) 3791 (23)
Access to GP
Very/quite easy 7663 (46) N/A 8625 (51) 8258 (49)
Difficult/unable to attend 378 (2) N/A 515 (3) 518 (3)
Social detachment
Not detached 5956 (36) 5954 (35) 7024 (42) 6704 (40)
Detached 1089 (6) 996 (6) 1265 (19) 1260 (8)
Locus of control
Internal 1874 (11) 1811 (11) 2100 (13) 2154 (13)
External 6264 (37) 6287 (37) 6995 (42) 6658 (40)
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Covariate Wave 2, n (%) Wave 3, n (%) Wave 4, n (%) Wave 5, n (%)
Lives alone
No 3452 (21) 3584 (21) 4062 (24) 3754 (22)
Yes 5740 (34) 5855 (35) 6584 (39) 6038 (58)
Married/civil partnership
No 3162 (34) 3232 (33) N/A 3341 (33)
Yes 6269 (66) 6538 (67) N/A 6927 (67)
N/A, not applicable.
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Appendix 6 Complete breakdown of longitudinal
quality of care modelling results
Diabetes
Characteristic OR 95% CI
Age (years)
50–64 1.0 –
65–74 1.1 0.8 to 1.4
75+ 0.9 0.7 to 1.2
Sex
Female 1.0 –
Male 1.0 0.8 to 1.1
NS-SEC
Routine 1.0
Intermediate/managerial and professional 1.2 0.9 to 1.5
Education
None 1.0 –
Up to degree level 1.2 0.9 to 1.5
Wealth
Quartile 1 1.0 –
Quartile 2 1.2 0.9 to 1.7
Quartile 3 1.3 0.9 to 1.8
Quartile 4 1.1 0.8 to 1.6
Quartile 5 1.5 1.0 to 2.2
Eyesight
Less than excellent 1.0 –
Excellent 1.0 0.8 to 1.4
Hearing
Less than excellent 1.0 –
Excellent 1.2 0.8 to 1.6
Chronic pain
None 1.0 –
Mild/moderate 0.8 0.5 to 1.2
Severe 1.2 0.8 to 1.6
General health
Less than excellent 1.0 –
Excellent 1.0 0.6 to 1.5
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Characteristic OR 95% CI
Limiting illness
None 1.0 –
Has limiting long-standing illness 1.0 0.8 to 1.3
ADL
None/one 1.0 –
Two or more 1.0 0.9 to 1.1
IADL
None/one 1.0 –
Two or more 0.9 0.8 to 1.0
Access to GP
Very easy 1.0 –
Quite easy 0.9 0.7 to 1.2
Difficult/can’t go 1.1 0.6 to 1.8
Cognitive impairment
No 1.0 –
Yes 0.5 0.4 to 0.7
BMI (kg/m2)
Under-/normal weight 1.0 –
Overweight 1.1 0.7 to 1.7
Obese 1.3 0.8 to 2.0
Alcohol
Infrequently 1.0 –
Daily 0.9 0.7 to 1.3
Marital status
Lives with partner 1.0 –
Lives alone 1.7 1.3 to 2.0
HbA1c
< 7.5% DCCT 1.0 –
≥ 7.5% DCCT 1.1 0.8 to 1.4
Smoking
Never 1.0 –
Past or present 0.9 0.7 to 1.1
Physical activity
Sedentary 1.0 –
Low 1.6 0.9 to 2.6
Medium 1.4 0.9 to 2.2
High 1.8 1.0 to 3.3
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Characteristic OR 95% CI
CASP-19
Low 1.0 –
Medium 1.1 0.8 to 1.5
High 1.2 0.9 to 1.6
Rose angina
No 1.0 –
Yes 1.1 0.7 to 1.7
MAP
< 110mmHg 1.0 –
≥ 110mmHg 0.9 0.6 to 1.3
CES-D depression
Not depressed 1.0 –
Depressed 0.8 0.6 to 1.1
Social detachment
Not detached 1.0 –
Detached 1.3 0.9 to 2.0
MAP, mean arterial pressure.
Cerebrovascular disease
Characteristic OR 95% CI
Age (years)
50–64 1.0 –
65–74 1.0 0.5 to 2.1
75+ 0.9 0.4 to 1.9
Sex
Female 1.0 –
Male 0.8 0.4 to 1.5
NS-SEC
Routine 1.0 –
Intermediate/managerial and professional 0.9 0.5 to 1.6
Education
None 1.0 –
Up to degree level 0.9 0.5 to 1.7
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Characteristic OR 95% CI
Wealth
Quartile 1 1.0 –
Quartile 2 0.4 0.1 to 1.1
Quartile 3 0.4 0.1 to 1.0
Quartile 4 0.2 0.1 to 0.5
Quartile 5 0.5 0.2 to 1.3
Eyesight
Less than excellent 1.0 –
Excellent 0.9 0.3 to 2.5
Hearing
Less than excellent 1.0 –
Excellent 0.6 0.3 to 1.2
Chronic pain
None 1.0 –
Mild/moderate 0.6 0.2 to 1.4
Severe 0.9 0.4 to 2.1
General health
Less than excellent 1.0 –
Excellent 0.5 0.2 to 1.6
Limiting illness
None 1.0 –
Has limiting long-standing illness 1.2 0.6 to 2.1
ADL
None/one 1.0 –
Two or more 1.3 1.0 to 1.7
IADL
None/one 1.0 –
Two or more 1.1 0.8 to 1.3
Access to GP
Very easy 1.0 –
Quite easy 1.3 0.6 to 2.7
Difficult/can’t go 1.2 0.3 to 5.1
Cognitive impairment
No 1.0 –
Yes 1.0 0.4 to 2.6
BMI (kg/m2)
Under-/normal weight 1.0 –
Overweight 1.4 0.6 to 3.5
Obese 1.9 0.6 to 6.3
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Characteristic OR 95% CI
Alcohol
Infrequently 1.0 –
Daily 0.6 0.3 to 1.1
Marital status
Lives with partner 1.0 –
Lives alone 1.3 0.7 to 2.6
HbA1c
< 7.5% DCCT 1.0 –
≥ 7.5% DCCT 0.8 0.3 to 2.1
Smoking
Never 1.0 –
Past or present 0.6 0.3 to 1.1
Physical activity
Sedentary 1.0 –
Low 2.8 0.7 to 12.1
Medium 1.6 0.4 to 6.2
High 1.4 0.3 to 7.2
CASP-19
Low 1.0 –
Medium 0.3 0.1 to 0.8
High 0.3 0.1 to 0.9
Rose angina
No 1.0 –
Yes 1.3 0.4 to 4.1
MAP
< 110mmHg 1.0 –
≥ 110mmHg 2.0 0.4 to 11.1
CES-D depression
Not depressed 1.0 –
Depressed 1.6 0.7 to 3.6
Social detachment
Not detached 1.0 –
Detached 2.5 0.7 to 8.3
MAP, mean arterial pressure.
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Hypertension
Characteristic OR 95% CI
Age (years)
50–64 1.0 –
65–74 2.2 1.6 to 3.1
75+ 3.2 2.0 to 5.3
Sex
Female 1.0 –
Male 0.9 0.6 to 1.1
NS-SEC
Routine 1.0 –
Intermediate/managerial and professional 0.9 0.6 to 1.2
Education
None 1.0 –
Up to degree level 0.9 0.7 to 1.2
Wealth
Quartile 1 1.0 –
Quartile 2 0.9 0.6 to 1.5
Quartile 3 1.2 0.8 to 1.9
Quartile 4 0.7 0.5 to 1.1
Quartile 5 1.0 0.6 to 1.5
Eyesight
Less than excellent 1.0 –
Excellent 1.4 0.9 to 2.2
Hearing
Less than excellent 1.0 –
Excellent 1.1 0.7 to 1.5
Chronic pain
None 1.0 –
Mild/moderate 0.9 0.6 to 1.3
Severe 0.8 0.5 to 1.5
General health
Less than excellent 1.0 –
Excellent 0.9 0.6 to 1.4
Limiting illness
None 1.0 –
Has limiting long-standing illness 1.1 0.8 to 1.5
ADL
None/one 1.0 –
Two or more 1.0 0.9 to 1.2
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Characteristic OR 95% CI
IADL
None/one 1.0 –
Two or more 1.0 0.8 to 1.2
Access to GP
Very easy 1.0 –
Quite easy 1.0 0.7 to 1.4
Difficult/cannot go 1.6 0.6 to 4.1
Cognitive impairment
No 1.0 –
Yes 1.1 0.5 to 2.4
BMI (kg/m2)
Under-/normal weight 1.0 –
Overweight 1.3 0.8 to 1.9
Obese 1.0 0.7 to 1.6
Alcohol
Infrequently 1.0 –
Daily 0.9 0.7 to 1.2
Marital status
Lives with partner 1.0 –
Lives alone 1.0 0.7 to 1.4
HbA1c
< 7.5% DCCT 1.0 –
≥ 7.5% DCCT 2.6 0.5 to 12.7
Smoking
Never 1.0 –
Past or present 0.9 0.7 to 1.2
Physical activity
Sedentary 1.0 –
Low 1.1 0.5 to 2.5
Medium 0.9 0.4 to 1.9
High 0.7 0.3 to 1.6
CASP-19
Low 1.0 –
Medium 1.0 0.7 to 1.4
High 0.9 0.6 to 1.4
Rose angina
No 1.0 –
Yes 1.3 0.6 to 2.9
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Characteristic OR 95% CI
MAP
< 110mmHg 1.0 –
≥ 110mmHg 1.4 0.9 to 2.1
CES-D depression
Not depressed 1.0 –
Depressed 0.8 0.5 to 1.2
Social detachment
Not detached 1.0 –
Detached 1.3 0.8 to 2.1
MAP, mean arterial pressure.
Ischaemic heart disease
Characteristic OR 95% CI
Age (years)
50–64 1.0 –
65–74 1.0 0.6 to 1.6
75+ 0.5 0.3 to 0.8
Sex
Female 1.0 –
Male 1.0 0.7 to 1.3
NS-SEC
Routine 1.0 –
Intermediate/managerial and professional 1.0 0.7 to 1.6
Education
None 1.0 –
Up to degree level 1.3 0.9 to 1.9
Wealth
Quartile 1 1.0 –
Quartile 2 0.8 0.5 to 1.4
Quartile 3 0.7 0.4 to 1.2
Quartile 4 0.9 0.5 to 1.6
Quartile 5 0.8 0.5 to 1.5
Eyesight
Less than excellent 1.0 –
Excellent 0.8 0.4 to 1.3
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Characteristic OR 95% CI
Hearing
Less than excellent 1.0 –
Excellent 0.9 0.5 to 1.5
Chronic pain
None 1.0 –
Mild/moderate 1.6 0.7 to 3.6
Severe 0.8 0.5 to 1.2
General health
Less than excellent 1.0 –
Excellent 2.3 0.5 to 9.7
Limiting illness
None 1.0 –
Has limiting long-standing illness 0.8 0.5 to 1.1
ADL
None/one 1.0 –
Two or more 1.0 0.8 to 1.1
IADL
None/one 1.0 –
Two or more 1.0 0.8 to 1.1
Access to GP
Very easy 1.0 –
Quite easy 0.8 0.5 to 1.2
Difficult/can’t go 0.8 0.4 to 1.6
Cognitive impairment
No 1.0 –
Yes 1.1 0.5 to 2.4
BMI (kg/m2)
Under-/normal weight 1.0 –
Overweight 1.1 0.7 to 1.9
Obese 0.9 0.5 to 1.5
Alcohol
Infrequently 1.0 –
Daily 1.1 0.7 to 1.7
Marital status
Lives with partner 1.0 –
Lives alone 1.6 1.1 to 2.5
HbA1c
< 7.5% DCCT 1.0 –
≥ 7.5% DCCT 0.6 0.3 to 1.2
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Characteristic OR 95% CI
Smoking
Never 1.0 –
Past or present 1.2 0.8 to 1.7
Physical activity
Sedentary 1.0 –
Low 1.8 1.0 to 3.4
Medium 1.6 0.8 to 2.9
High 2.0 0.9 to 4.5
CASP-19
Low 1.0 –
Medium 1.3 0.9 to 2.1
High 1.5 0.9 to 2.4
Rose angina
No 1.0 –
Yes 1.3 0.8 to 2.1
MAP
< 110mmHg 1.0 –
≥ 110mmHg 1.1 0.5 to 2.4
CES-D depression
Not depressed 1.0 –
Depressed 1.1 0.7 to 1.7
Social detachment
Not detached 1.0 –
Detached 1.0 0.6 to 1.3
MAP, mean arterial pressure.
Osteoarthritis
Characteristic OR 95% CI
Age (years)
50–64 1.0 –
65–74 0.8 0.6 to 1.0
75+ 1.1 0.8 to 1.4
Sex
Female 1.0 –
Male 0.9 0.8 to 1.1
NS-SEC
Routine 1.0 –
Intermediate/managerial and professional 1.0 0.9 to 1.2
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Characteristic OR 95% CI
Education
None 1.0 –
Up to degree level 1.0 0.8 to 1.2
Wealth
Quartile 1 1.0 –
Quartile 2 0.8 0.6 to 1.0
Quartile 3 0.8 0.6 to 1.0
Quartile 4 0.9 0.7 to 1.2
Quartile 5 0.8 0.6 to 1.0
Eyesight
Less than excellent 1.0 –
Excellent 1.0 0.8 to 1.3
Hearing
Less than excellent 1.0 –
Excellent 1.0 0.8 to 1.3
Chronic pain
None 1.0 –
Mild/moderate 1.0 0.8 to 1.2
Severe 1.8 1.4 to 2.2
General health
Less than excellent 1.0 –
Excellent 0.8 0.5 to 1.0
Limiting illness
None 1.0 –
Has limiting long-standing illness 1.8 1.5 to 2.1
ADL
None/one 1.0 –
Two or more 1.0 0.9 to 1.2
IADL
None/one 1.0 –
Two or more 1.0 0.9 to 1.2
Access to GP
Very easy 1.0 –
Quite easy 1.2 1.0 to 1.4
Difficult/cannot go 1.0 0.8 to 1.5
Cognitive impairment
No 1.0 –
Yes 1.2 0.8 to 1.8
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Characteristic OR 95% CI
BMI (kg/m2)
Under-/normal weight 1.0 –
Overweight 1.2 0.9 to 1.5
Obese 1.6 1.2 to 2.0
Alcohol
Infrequently 1.0 –
Daily 1.0 0.8 to 1.3
Marital status
Lives with partner 1.0 –
Lives alone 1.2 0.9 to 1.4
HbA1c
< 7.5% DCCT 1.0 –
≥ 7.5% DCCT 0.9 0.5 to 1.6
Smoking
Never 1.0 –
Past or present 1.0 0.9 to 1.2
Physical activity
Sedentary 1.0 –
Low 0.9 0.6 to 1.3
Medium 1.0 0.7 to 1.6
High 0.9 0.6 to 1.5
CASP-19
Low 1.0 –
Medium 1.1 0.9 to 1.4
High 1.0 0.8 to 1.3
MAP
< 110mmHg 1.0 –
≥ 110mmHg 1.0 0.8 to 1.4
CES-D depression
Not depressed 1.0 –
Depressed 1.1 0.9 to 1.4
Social detachment
Not detached 1.0 –
Detached 1.1 0.9 to 1.5
MAP, mean arterial pressure.
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